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ABSTRACT 
Bovine adenovirus (BAdV)-3 is a non-enveloped icosahedral DNA virus, which 
replicates in the nucleus of infected cells, and is being developed as a vector for vaccination for 
humans and animals. The genome of BAdV-3 is organized into early, intermediate and late genes 
and it has thirty three predicted open reading frames (Reddy et al., 1998). The late region of 
BAdV-3 is divided into seven families (L1-L7) (Reddy et al., 1998). One of the proteins 
expressed in the L-6 region encodes a protein called pVIII, which is a minor capsid protein 
connecting the core with the inner surface of the capsid. The objective of the current study was to 
characterize pVIII protein of BAdV-3 and to examine its role in the life cycle of BAdV-3. 
 Anti-pVIII serum detected a protein of 24 kDa at 12-48 hr post infection and an 
additional protein of 8 kDa at 24-48 hr post infection. While a 24 kDa protein is detected in 
empty capsids, only the C-terminal cleaved protein of 8 kDa is detected in the mature virion 
suggesting that amino acids 147-216 of conserved C- terminus of BAdV-3 pVIII are 
incorporated in mature virions. The pVIII protein predominantly localizes to the nucleus of 
BAdV-3 infected cells utilizing the classical importin α /β   dependent nuclear import pathway. 
Analysis of mutant pVIII demonstrated that amino acids 57-72 of the conserved N-terminus bind 
to importin α-3 with high affinity and are required for the nuclear localization. Detection of 
hexon associated with both, precursor (24 kDa) and cleaved (8 kDa) form of pVIII suggests that 
the C-terminus of pVIII interacts with Hexon.  
Based on yeast II hybrid screening assay, we identified the cellular protein DDX3 as an 
interacting protein partner of pVIII. Earlier, targeting of DDX3 by few viral proteins has defined 
its role in mRNA transport (Yedavalli et al., 2004) and induction of interferon production 
(Schroder et al., 2008; Wang et al., 2009). Here, we provide evidence regarding the involvement 
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of DDX3 in cap dependent cellular mRNA translation and show that targeting of DDX3 by the 
adenovirus pVIII protein abolishes cap-dependent mRNA translation function of DDX3 in virus 
infected cells. Adenovirus late protein pVIII interacts with DDX3 in transfected and bovine 
adenovirus (BAdV-3) infected cells. pVIII inhibited capped mRNA translation in-vitro and in-
vivo by limiting the amount of DDX3 and eIF3. Diminished amount of DDX3 and eIFs including 
eIF3, eIF4E and PABP were present in cap binding complex in BAdV-3 infected or pVIII 
transfected cells with no trace of pVIII in the cap binding complex. The total amount of eIFs 
appeared similar in uninfected or BAdV-3 infected cells.  The co-immunoprecipitation 
experiments indicated the absence of direct interaction between pVIII and eIF3, eIF4E or PABP.  
These data indicate that interaction of pVIII with DDX3 depletes eIF3, eIF4E and PABP from 
the cap-binding complex. We conclude that DDX3 promotes cap-dependent cellular mRNA 
translation and BAdV-3 pVIII inhibits translation of capped cellular mRNA by excluding 
functional cap-binding complex from the capped cellular mRNA. 
BAdV-3 infection of DDX3 positive cells significantly inhibits cellular protein synthesis 
at late times post-infection. Interestingly, knockdown of DDX3 resulted in significant reduction 
in virus yield and expression of BAdV-3 late proteins at late times post-infection. Our results 
suggest that selective translation of BAdV-3 late mRNAs observed at late time post-infection of 
DDX3 positive cells is abrogated in DDX3 knock down cells. Moreover, the reduction in the 
extent of protein synthesis is evidenced by less functional 80S and polysomes in pVIII 
expressing plasmid transfected cells. Alternatively, DDX3 and pVIII binds to BAdV-3 tripartite 
leader (TPL) and the translation of mRNAs containing TPL at their 5’ ends is enhanced in the 
presence of pVIII and DDX3 proteins. From this observation, we concluded that pVIII and 
DDX-3 might promote the translation of late viral mRNAs by interacting with TPL. 
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1. LITERATURE REVIEW 
The literature review is composed of four main parts; the first part concisely discusses 
about adenoviruses in general and bovine adenovirus (BAdV)-3 in particular, the second part 
contains a review on the pathways involved in nuclear import of proteins in eukaryotes and 
mechanisms used by viruses to import their proteins into the nucleus, followed by the third part 
which discusses about mRNA translation in eukaryotes and strategies employed by viruses to 
translate their mRNAs. Finally, the fourth part reviews about the cellular protein DDX3, its role 
in RNA homeostasis and during virus infection.   
 
1.1.ADENOVIRUSES 
Members of the family Adenoviridae are non-enveloped, icosahedral viruses that 
replicate in the nucleus (Davison et al., 2003; Berk, 2007). Their linear, double stranded DNA 
genomes are 26-45 kb in size and are characterized by an inverted terminal repeat (ITR) ranging 
in size from 36 to over 200 bp, and the presence of a terminal protein (pTP) linked to the 5’-ends 
of the genome (Davison et al., 2003). The ITR (Grable and Hearing, 1992) and pTP play key 
roles in DNA replication. Adenoviruses were first identified in the early 1950s from the adenoids 
of humans with acute respiratory infection (Rowe et al., 1953; Hilleman and Werner, 1954). So 
far, more than 120 serotypes have been isolated from mammals, birds, reptiles and fish (Berk, 
2007; International Committee on Taxonomy of Viruses and King, 2012).  Most adenoviruses 
are species specific except those isolated from humans (Roy et al., 2009). Adenoviruses have 
been used as models for studying virus-cell interactions and helped in the understanding of DNA 
replication, transcription, splicing and translation processes in eukaryotic cells (White, 1996). 
Recently adenoviruses have also been studied widely and shown a tremendous potential as viral 
2 
 
vectors because of their ability to infect both dividing and non dividing cells, capacity to package 
large foreign genes, and relative ease to produce high titer recombinants in cell culture (Shenk, 
2001; Russel, 2000). Adenoviral vectors fulfill important criteria of an ideal vaccine vector in 
terms of efficacy, safety and stability (Tastis and Ertl, 2004) and are the most widely used viral 
vectors in clinical trials (Arnberg, 2012; Wong et al., 2013). 
 
1.1.1. Transcription and DNA replication in human adenoviruses 
Early and late transcription of adenovirus genome is a two phase event occurring before 
and after DNA replication, respectively. Transcription in adenoviruses is usually followed by a 
series of splicing events (Russell, 2000). The first region of the viral genome to be transcribed, 
which appears within 1hr of virus infection, is E1A (Russel, 2009). E1A is a potent trans-
activator capable of regulating the transcription of cellular genes and the expression of other 
early viral proteins in infected cells (Russell, 2000). Though it does not bind DNA directly, it 
interacts with the DNA binding domains of transcription factors bound to the promoters (Liu and 
Green, 1994). E1A gene products are also essential for inducing the host cell to enter into S-
phase for viral genome replication (Berk, 2007; Turnell and Mymryk, 2006; Ferrari et al., 2008). 
In addition, E1A can also induce transcriptional repression (Berk, 2005), apoptosis (Frisch and 
Mymryk, 2002) and suppression of the production of nitric oxide, an antiviral effector of innate 
immunity by the modulation of the inducible nitric oxide synthase gene increasing the 
survivability of the virus in the cell (Higashimoto et al., 2006). The pro-apoptotic ability of E1A 
is counteracted by the E1B proteins, and together E1A and E1B proteins are sufficient to 
transform cells. E1B 55k protein inhibits apoptosis by repressing the transcription of p53 
activated genes (White, 2001). 
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The E2 region encodes proteins that are essential for viral DNA replication (Berk, 2007). 
The viral DNA binding protein (DBP) is encoded by the E2A region, while the E2B region 
encodes the viral DNA polymerase (Pol) and the pre-terminal proteins (pTP) that are 
indispensable for viral genome replication (Berk, 2007). 
The E3 region encodes non-essential genes and transcribes nine messages that are 
generated by alternate splicing. Its transcription is under the control of the E1A responsive 
promoter. The proteins encoded in the E3 region are mainly involved in blocking the host’s 
immune responses to viral infection (Horwitz, 2004).   
The E4 region produces 18 messages that are produced by alternate splicing and encodes 
seven proteins that have various functions in the virus infected cells (Weitzman and Ornelles, 
2005). These proteins function in regulating viral DNA synthesis, viral RNA splicing, late viral 
protein synthesis, cell transformation and oncogenecity, early to late switch in viral infection and 
antagonizing the host immune responses (O’shea et al., 2005; Tauber and Dobner, 2001). E4orf4 
binds to the cellular phosphatase 2A (PP2A) and activates the dephosphorylation of SR proteins 
and regulates adenovirus alternate splicing (O’shea et al., 2005). 
The combined action of three viral proteins namely, Pol, pTP and DBP, encoded by the 
E2 region are essential for adenoviral DNA replication. In addition, two cellular transcription 
factors namely nuclear factor I (NFI) and NFIII (Oct-1), are required for recruiting the Pol and 
pTP proteins to its binding site on the viral DNA and stabilizing the protein-DNA interaction 
(Van Breukelen et al., 2003). The cis-acting DNA sequence that acts as an origin (Ori) of DNA 
replication is contained in the inverted terminal repeat (ITR) where the preinitiation complex 
(PC) composed of both viral and cellular proteins are assembled (Coenjaerts et al., 1994). DNA 
replication normally starts 5 to 8hrs post infection when cells are infected with either human 
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adenovirus (HAdV)-5 and HAdV-2 at a multiplicity of infection (MOI) of 10 (Berk, 2007). A 
protein priming at either ends of the linear viral genome initiates DNA replication, which is 
catalyzed by the viral polymerase that covalently links the β-OH group of a serine residue in pTP 
and the α-phophoryl group of the terminal dCMP residue (de Jong et al., 2003). The viral Pol 
then uses the 3’-OH group of the pTP/dCMP complex as a primer for the synthesis of the nascent 
strand (de Jong et al., 2003). Then, DBP together with the viral Pol elongate the chain by a strand 
displacement mechanism. The displaced strand can duplicate by base pairing of the ITRs 
forming a panhandle structure on which a second round of DNA synthesis may be initiated 
(Wang and Pearson, 1985) 
The expression of intermediate proteins IVa2 and pIX, is dependent on DNA replication. 
However, their transcripts appear earlier than late gene transcripts (Reddy et al., 2010; 
Ostapchuk et al., 2011) and function as a transcriptional activator of the major late promoter 
(MLP), which controls the expression the major late transcription unit (MLTU)  (Russel, 2009). 
The primary MLTU in HAdV-5 is differentially spliced into more than 20 different mRNAs that 
encode viral structural (hexon, penton, fiber, IIIa, V, VI, VII, VIII, IX, and μ), non-structural 
proteins (52K, 100K, 33K, and 22K) and the core viral protease (Russel, 2009). The late mRNAs 
are grouped into five families (L1 to L5) in human adenoviruses based on their usage of common 
polyadenylation sites. In addition, mRNAs transcribed from the MLP contain an identical 5’ 
non-coding segment, which is called the tripartite leader (TPL) that enhances the translation of 
late viral mRNAs (Berk, 2007).   
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1.1.2. Bovine adenovirus 
Bovine adenovirus (BAdV) was first isolated in the 1960s from an apparently healthy 
cow (Darbyshire et al., 1965). To date, eleven serotypes (Lehmkuhl and Hobbs, 2008) of BAdV 
have been isolated from both healthy animals (Darbyshire et al., 1965) and animals with 
respiratory or enteric diseases (Lehmkuhl et al., 1975; Smyth et al., 1996). The BAdV serotypes 
are grouped under Mastadenovirus (BAdV-1, BAdV-2, BAdV-3, BAdV-9 and BAdV-10) or 
Atadenovirus (BAdV-4, BAdV-5, BAdV-6, BAdV-7, BAdV-8 and strain Rus) genus based on 
their phylogenetic sequence proximity (Harrach, 2000; Lehmkuhl and Hobbs, 2008). The 
Mastadenoviruses are more closely related to ovine adenoviruses than with each other. Instead, 
Atadenoviruses are more closely related to each other. The BAdV type 1, 2, 3 grow relatively 
well in established bovine cell lines. These viruses induce irregularly shaped single nuclear 
inclusion bodies. The other BAdV types (type 4, 5, 6, 7, 8, and 10) form multiple inclusion of 
circular shape and can be propagated in low passage cultures of calf testicular or thyroid cells 
(Bartha, 1969). Darbyshire et al., 1966 also demonstrated that BAdVs can induce tumors in 
rodents and can transform non-permissive cells in tissue culture.  
 
1.1.3. Bovine adenovirus type-3 
Among known BAdV serotypes, bovine adenovirus-3, which belongs to the 
Mastadenovirus genus, is the best characterized (Reddy et al., 1998; Reddy et al., 1999a). 
Experimental infections of cattle with BAdV-3 produce either subclinical infections with the 
induction of the production of neutralizing antibodies (Mittal, 1999) or mild respiratory disease 
(Lehmkuhl et al., 1975). As BAdV-3 lacks virulence, it is being developed and evaluated as a 
6 
 
vector for vaccination and gene therapy for humans and animals (Mittal et al., 1995; 
Zakhartchouk et al., 1998; Zakhartchouk et al., 1999; Reddy et al., 1998).  
 
1.1.4. Molecular biology of BAdV-3 
1.1.4.1. Structure and genome organization 
BAdV-3 is a 75nm in diameter, non enveloped icosahedral particle containing a double 
stranded DNA genome. The genome of BAdV-3 is 34, 446 base pairs with 54% GC content 
(Reddy et al., 1998). The genome is flanked by 195bp inverted terminal repeats (ITRs) on either 
end (Shinagawa et al., 1987). Unlike other adenoviruses, the ITRs of BAdV-3 are longer and 
contain a high GC content (Reddy et al., 1998). The genome of BAdV-3 is organized into early, 
intermediate and late genes and it has thirty three predicted open reading frames (Reddy et al., 
1998; Reddy et al., 1999a; Kulshreshtha, 2009) (Figure 1.1.1). Like other adenoviruses, the 
packaging domain is located in the left end of the viral genome overlapping the transcriptional 
control region of E1A (Xing et al., 2003; Xing and Tikoo, 2007).  Unlike HAdVs, the E1A 
region of BAdV-3 genome appears to be required for DNA packaging (Xing et al., 2003; Xing 
and Tikoo, 2006; Xing and Tikoo, 2007). 
The early (E) region is composed of four transcriptional units (E1 to E4). On the other 
hand, the late region is composed of seven transcriptional units, L1 to L7 (Figure 1.1.1) (Reddy 
et al., 1998; Reddy et al., 1999a; Kulshreshtha, 2009). 
The E1 region of BAdV-3 has two open reading frames encoding for E1A and E1B. 
Unlike HAdV, E1A and E1B regions are expressed from the same transcriptional unit and have 
the same polyadenylation site (Reddy et al., 1999).  Though the TATA or CAAT boxes are 
absent in the regions between the left ITR and upstream of the E1A start codon, the expression of 
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the E1A open reading frame is driven by a promoter located within the ITR (Xing and Tikoo, 
2006).  The E1A region produces six transcripts by alternate splicing that encode for three 
proteins namely  211R, 115R and 100R (Reddy et al., 1999a). The E1A proteins are essential for 
virus replication and functions in trans-activation of the expression of early viral genes (Reddy et 
al., 1999b; Zhou et al., 2001). In contrast, E1B codes for only two overlapping mRNAs E1B
small
 
and E1B
large
 that are homologues of E1B 19K and E1B 55K proteins of HAdV-5, respectively 
(Zheng et al., 1994). Both E1B
small
 and E1B
large
 proteins appear to be essential for virus 
replication (Zhou et al., 2001; Zakhartchouk et al., 2001). 
The E2 region of BAdV-3, which is transcribed from the complementary strand, codes 
for proteins that are essential for viral DNA replication (Reddy et al., 1998). The E2 region codes 
for ORFs E2A and E2B.  The E2A transcript codes for the DBP (432 amino acids long), which 
has 38 to 47% sequence identity with the DBP of other Mastadenoviruses (Reddy et al., 1998). 
The DBP is involved in DNA binding, initiation and maintenance of DNA replication and is 
expressed in great quantity during the early and late phase of the life cycle of BAdV-3 (Linne 
and Philipson, 1980, Zhou et al., 2001a). DBP is used for determination of BAdV-3 titer based 
on immunohistochemical detection of its expression in infected cells (Zhou et al., 2001a).  The 
E2B transcripts encoding DNA Pol and pTPs are 3’ co-terminal (Reddy et al., 1998). The BAdV-
3 DNA Pol and pTP proteins which have 56 to 62% and 58 to 60% homology, respectively with 
DNA Pol and pTP proteins of other members of the Mastadenovirus genus.  The proteins are 
essential for viral DNA replication (Baxi et al., 1998).  
Like in HAdVs, the E3 region of BAdV-3 is located in the region between genes 
encoding pVIII and fiber proteins (Reddy et al., 1998). BAdV-3 E3 is 1.5Kb, smaller than the E3 
region of HAdVs sharing the same polyA with pVIII, 33K and 100K (Mittal et al., 1992). 
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Figure 1.1.1 Transcription map of BAdV-3. Arrows indicate location and direction of 
transcripts. Major late promoter (MLP); The number depict the map units (m.u); Early (E) 
transcripts. Late (L)  transcripts.  (Adapted from Reddy et al., 1998). 
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Transcription analysis of BAdV-3 E3 detected five transcripts, which have the potential to 
encode four proteins of 284, 121, 86 and 82 amino acids (Idamakanti et al., 1999). The 121R 
protein (~14.5kDa) has a limited sequence similarity to the 14.7kDa protein of HAdV-5; 
however they are serologically and functionally related to each other (Idamakanti et al., 1999; 
Zakhartchouk et al., 2001). The E3 region is not essential for virus replication (Zakhartchouk et 
al., 1998; Zakhartchouk et al., 1999) and has been used as a site for insertion and expression of 
foreign genes (Zakhartchouk et al., 1998; Baxi et al., 2000). 
E4 region of BAdV-3 lies in the right end of the genome and is transcribed from right to 
left on the left strand of the genome (Reddy et al., 1998). Seven transcripts are produced from the 
E4 region that encodes five proteins namely 143R, 69R, 286R, 143R2 and219R (Baxi et al., 
1999). The proteins encoded by the E4 region are not essential for viral replication (Baxi et al., 
2001). 
Like in HAdVs, the genes encoding for BAdV-3 pIX and IVa2 proteins are classified as 
intermediate region genes (Reddy et al., 1998). The pIX and IVa2 proteins of BAdV-3 show 
similarity of 16 to 28% and 29 to 69% with pIX and IVa2 proteins of other adenoviruses, 
respectively (Reddy et al., 1998). The transcript of BAdV-3 encoding pIX is 3’ co-terminal with 
E1A and E1B regions (Zheng et al., 1999). The IVa2 uses a polyadeynylation signal unique from 
that of pTP and DNA Pol, while they are 3’ co-terminal in HAdVs (Baxi et al., 1998; Zheng et 
al., 1999). Protein pIX is part of the viral capsid with its C-terminal region exposed on the 
surface of the capsid, which can be  used as a site for incorporation of targeting ligands 
(Zakhartchouk et al., 2004). 
BAdV-3 late regions encode both structural and non structural proteins. Like in HAdVs, 
the late regions of BAdV-3 are transcribed under the control of the MLP that contains the 
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canonical TATA box, inverted CAAT box, the transcriptional factor USF binding site and the 
initiator element (Reddy et al., 1998). Like HAdVs, all the late transcripts of BAdV-3 contain the 
non-coding TPL (205 nucleotides in length) sequence at their 5’ ends (Reddy et al., 1998). The 
BAdV-3 TPL is a spliced product of three small exons and is located within the non coding 
strands of the DNA Pol and the pTP genes, respectively (Reddy et al., 1998). The first exon is 40 
nucleotides long and is located adjacent to the MLP, the second is 78 and the third is 87 
nucleotides long. The late transcripts of BAdV-3 are divided into seven families (L1 to L7) based 
on usage of common 3’ polyadenylation sites (Reddy et al., 1998). 
The L1 region comprises four late region genes that have common poly(A) signals (52K, 
IIIA, III, and pVII). The 52K protein is expressed as 40kDa nuclear protein in virus infected 
cells. The 52K protein uses the classical importin α/β pathway to localize into the nucleus by 
preferentially binding with importin-α3 and also requires nuclear localization signal located at 
amino acids 102 to 110 (Paterson et al., 2012). BAdV-3 52K interacts with the viral pVII protein 
and the cellular NFkB-binding protein (NFBP) (Paterson, 2010). BAdV-3 IIIa protein shares 
sequence identities of 25 to 57% to the IIIa proteins of other adenoviruses. Protein IIIa has a 
predicted protease cleavage site located 19 residues from the C-terminus (Reddy et al., 1998). 
The BAdV-3 pIII is a penton base protein and contains MDV (Methionine-Aspartic acid-Valine) 
motif instead of the RGD (Arginine-Glycine-Aspartic acid) motif found in HAdV-5 (Reddy et 
al., 1998). pVII of BAdV-3 is highly basic like other proteins having DNA binding function and  
has a consensus protease cleavage site located 19 nucleotides from the N-terminus of the protein 
(Reddy et al., 1998). BAdV-3 pVII contains a functional mitochondrial localization signal, which 
helps pVII to locate to Mitochondria (Anand et al., 2014). Mitochondrial localization of BAdV-3 
pVII appears to help in the retention of Ca2+ in the mitochondria thus increasing the levels of 
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ATP and maintaining the mitochondrial membrane potential (MMP) in transfected  and virus 
infected cells (Anand et al., 2014). 
The L2 region of BAdV-3 codes for a single transcript that expresses pV protein. It 
contains a bipartite nuclear localization signal in the central region of the protein. It shares a 
protein sequence similarity of 28 to 41% with other members of the Mastadenovirus genus. In 
addition, the pV sequence has a high content of basic amino acids (Reddy et al., 1998) 
The L3 region of BAdV-3 encodes a single transcript that expresses pX (µ) protein. The 
protein contains two predicted adenovirus specific protease cleavage sites. pX is rich in basic 
amino acids and contains a conserved nuclear localization signal (Reddy et al., 1998). 
The L4 region produces a transcript that codes for protein pVI. It shares 32 to 39% 
protein sequence similarity with the pVI proteins of other adenoviruses. It is a minor component 
of the virion and contains two consensus viral cleavage sites after residues 33 and 252 (Reddy et 
al., 1998). 
The L5 region of BAdV-3 encodes hexon and the viral protease proteins. In contrast to 
other adenoviruses, hexon and proteases ORFs do not overlap.  BAdV-3 hexon has protein 
sequence identity of 66 to 71% with other adenoviruses (Reddy et al., 1998). BAdV-3 hexon is 
expressed as a 98kDa protein in infected cells (Kulshrestha et al., 2004). BAdV-3 protease shares 
a 60% sequence identity with proteases of other adenoviruses (Reddy et al., 1998). DNA binding 
residues of BAdV-3 protease and HAdV-2 protease are conserved (Gupta et al., 2004) 
The L6 region of BAdV-3 encodes the structural protein pVIII and the non-structural 
proteins 100K, 22K and 33K (Reddy et al., 1998; Kulshreshtha, 2009). Protein 100K is the 
largest non-structural protein encoded by members of Mastadenoviruses. BAdV-3 100K shares 
27 to 52% protein sequence identity with other adenoviruses (Reddy et al., 1998; Kulshreshtha et 
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al., 2004).  100K protein appears to localize both in the nucleus and cytoplasm with the nuclear 
localization signal located between aminoacids 624 to 637. BAdV-3 protease cleaves 100K 
protein at two identified adenovirus specific protease cleavage sites; amino acids 740-745 and 
781-786 and only the C-terminal cleaved portion of 100K localizes in the nucleus. However, 
cleavage is not essential for virus replication, but was shown to be involved in lysis of infected 
cells for release of mature virions. 100K protein also interacts with BAdV-3 33K protein and 
cellular dynein light chain (DYNLL)-1 (Makadiya, 2013). 
33K protein is a product of spliced transcript and it shares N-terminus 138 amino acids 
with 22K protein. Both 22K and 33K proteins localize in the nucleus and play a role in virus 
assembly, specifically in efficient capsid-viral DNA interactions (Kulshreshtha et al., 2004). The 
33K protein of BAdV-3 trans-activates the MLP (Kulshreshtha, 2009). The BAdV-3 33K 
interacts with bovine presenilin-1-associated protein / mitochondrial carrier homolog 1 (BoPSAP 
/ BoMtch1) and the BAdV-3 proteins 100K and pV proteins (Kulshreshtha, 2009). Deletion 
mutant analysis of 33K protein indicated that amino acids 201 to 240 containing RS 
(Arginine/Serine) repeats are required for nuclear localization and its nuclear import is mediated 
by both transportin and importin α/β dependent pathways. Moreover, mutations of RS from wild 
type BAdV-3 proved to be lethal (Kulshreshtha et al., 2014). Association of BAdV-3 33K 
protein with BoPSAP appears to inhibit the pro-apoptotic activity of BoPSAP suggesting a role 
of BAdV-3 33K as an anti apoptotic protein (Kulshreshtha, 2009). pVIII of BAdV-3 is a minor 
capsid protein with 216 aminoacids and it contains two predicted viral protease cleavage sites 
(Reddy et al., 1998). 
The L7 region of BAdV-3 encodes fiber protein which show low protein sequence 
identity (22-27%) with fiber protein encoded by other adenoviruses.  The fiber protein 
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determines the tissue tropism of BAdV-3 (Wu and Tikoo, 2004). The BAdV-3 fiber is expressed 
as a102kDa nuclear protein, which is comprised of tail, shaft and knob regions. The shaft region 
of BAdV-3 fiber protein contains a very long shaft region as compared to HAdV-5 and has 
several bends (Ruigrok et al., 1994). The protein contains a nuclear localization signal in the N-
terminal region, which appears essential for efficient replication of BAdV-3 (Wu et al., 2007).  
A brief summary of the early, intermediate and late gene expression of BAdV-3 including 
a short description of the known functions and properties of each viral protein is summarized in 
Tables 1.1.4.1, 1.1.4.2 and 1.1.4.3.  
 
1.2.NUCLEAR IMPORT OF PROTEINS IN EUKARYOTES 
The different compartments of the eukaryotic cell are separated by membranes. The 
double membrane nuclear envelope separates the nucleus and the cytoplasm; however, molecules 
should be selectively transported between the two compartments for the cell to function properly.  
For example, after transcription occurs in the nucleus, the RNA should be exported into the 
cytoplasm for protein translation to take place. Similarly, proteins that have functions in the 
nucleus needs to be imported into the nucleus after being synthesized in the cytoplasm (Cook et 
al., 2007). 
 
1.2.1. Nuclear pore complex 
The only gate of molecules between the cytoplasm and the nucleus is a massive proteinacious 
channel termed the nuclear pore complex (NPC) that is rooted in the nuclear membrane (Cook et 
al., 2007; Vasu and Forbes, 2001). The NPC is a huge multi-protein complex with a total mass of  
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Table 1.1.4.1. Early BAdV-3 gene expression 
 
Region 
 
ORF 
 
Proteins 
 
Remarks 
 
 
 
 
E1 
 
 
E1A 
211aa The proteins don’t have predicted classical nuclear 
localization signal. Localize into the nucleus through 
their interaction with cellular proteins. They are 
required for virus replication and trans-activation of 
early viral genes (Reddy et al., 1999a; Zhou et al., 
2001) 
115aa 
 
100aa 
 
 
E1B 
 
E1Bsmall 
E1B has independent promoter and polyadenylation 
site from E1A.  E1B small is a homologue of HAdV-
5 19kDa protein. Localizes in the nucleus and is 
essential for virus replication, but dispensable in 
some cells types (Zheng et al., 1994:  Zhou et al., 
2001) 
 
E1Blarge 
Homologue of HAdV-5 55kDa protein. Localizes in 
the nucleus and is required for virus replication 
(Zakhartchouk et al., 2004) 
 
 
 
 
E2 
 
E2A 
DNA binding 
protein 
(DBP) 
Has a conserved “C” terminus which is involved in 
DNA binding, initiation and maintenance of DNA 
replication and transcriptional control of the major 
late promoter (Linne and Philipson, 1980; Zhou et 
al., 2001a) 
 
E2B 
Viral DNA 
polymerase 
Localizes in the nucleus by forming a heterodimer 
with pTP. Has a conserved zinc finger motifs as is in 
other Mastadenovirus genus that are essential for 
viral DNA replication (Baxi et al., 1998) 
Pre-terminal 
protein (pTP) 
Has a strong nuclear localization signal. It contains a 
conserved YSRLVYR motif that is required for 
protein priming of DNA replication initiation (Baxi 
et al., 1998) 
 
 
E3 
  
Four proteins 
of 284, 121, 
86 or 82 
amino acids 
Not essential for virus replication. Replication 
competent E3 deleted BAdV-3 has been generated. 
The 284R protein is glycosylated. The E3 gene 
products of HAdV-5 suppress host immune 
responses (Weeks and Jones, 1985; Wold et al., 
1995; Horwitz, 2004). 121R protein was shown to 
protect mouse cells from TNF-mediated cell lyses 
(Zakhartchouk et al., 2001) 
 
 
E4 
ORF1 143R Not required for BAdV-3 replication on cultured 
cells. 143R, 69R and 143R2 do not have homologues 
in other adenoviruses and appears to be unique to 
BAdV-3 (Baxi et al., 2001) 
ORF2 69R 
ORF3 286R 
ORF4 143R2 
ORF5 219R 
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Table 1.1.4.2. Intermediate BAdV-3gene expression 
 
Region 
 
ORF 
 
Proteins 
 
Remarks 
 
E1 
 
E1B 
 
pIX 
Component of viral capsid. The C-terminus is 
exposed on the surface of the viral capsid and it acts 
as a site for incorporation of ligands (Reddy et al., 
1999b; Zakhartchouk et al., 2004) 
 
E2 
 
E2B 
 
IVa2 
Has a polyadenylation signal unique from that of pTP 
and DNA Pol (Baxi et al., 1998; Zheng et al, 1999) 
 
Table 1.1.4.3. Late BAdV-3 gene expression 
 
Region 
 
Proteins 
 
Remarks 
 
 
L1 
52K Predominantly localizes into the nucleus through the 
classical importin α/β pathway. 52K interacts with the viral 
pVII protein and the cellular NFkB-binding protein 
(NFBP) (Paterson et al., 2012) 
IIIa Contains a putative viral protease cleavage site. 
 
Penton 
Lacks the conserved RGD motif for integrin binding. It 
also lacks a leucine-aspartic acid-valine motif but 
contains a methionine-aspartic acid-valine (MDV) motif 
(Reddy et al., 1998) 
 
pVII 
pVII is the major coat protein and has a cleavage site for 
the adenovirus protease (MYGG ۸A) (Reddy et al.,1998) 
 
L2 
 
pV 
pV is a core protein and it contains a bipartite nuclear 
localization signal (Reddy et al., 1998) 
 
L3 
 
pX (µ) 
Contains two viral protease specific cleavage sites at 
residues 31 and 50 and is rich in basic amino acids and has 
a conserved nuclear localization signal (Reddy et al., 1998) 
 
L4 
 
pVI 
pVI is a minor component of the virion. Contains two 
consensus viral protease cleavage sites after residues 33 
and 252 (Reddy et al., 1998) 
 
 
 
 
 
L5 
 
 
 
Hexon 
Unlike in other adenoviruses, BAdV-3 hexon has no 
overlapping ORFs. Like other adenoviruses it has loops 
exposed on the external surfaces that contains hyper 
variable regions(Hu et al., 1984; Crawford-Miksza and 
Schnurr, 1996; Reddy et al., 1998) 
 
Viral protease 
Shows homology with proteases of other adenoviruses 
(Reddy et al., 1998). DNA binding residues of the protein 
are conserved between BAdV-3 and HAdV-2 (Gupta et al., 
2004) 
 100K The largest non structural protein. Cleaved at two sites by 
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L6 
adenovirus protease. The C-terminal fragment localizes in 
the nucleus. 100K interacts with BAdV-3 33K and the 
cellular protein DYNLS-1 (Makadiya, 2013). 
 
22K 
Non structural protein that localizes in the nucleus and 
involves in capsid assembly, especially in the 
encapsidation of viral DNA (Kulshreshtha et al., 2004). 
 
 
33K 
33K is also a non structural protein that localizes in the 
nucleus. It helps in capsid assembly and efficient DNA 
capsid interaction. In addition it is involved in trans 
activation of the MLP (Reddy et al., 1998; Kulshreshtha, 
2009). 
 
pVIII 
pVIII is a structural protein that contains two viral protease 
cleavage sites (Reddy et al., 1998) 
 
L7 
 
Fiber 
The fiber has a nuclear localization signal. 22-27% 
homologous with fiber of other adenoviruses. It has a tail, 
shaft and knob domain. The shaft is quite long with several 
bends (Ruigrok et al., 1994; Reddy et al., 1998). 
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~125MDa (Adams and Wente, 2013) that lies across the nuclear membrane (Wente and Rout, 
2010) and harbors ~65nm long central aqueous channel. It is mainly composed of glycoprotein 
called gp210 (Kahms et al., 2011). The NPC has an octagonal symmetry and can be divided into 
three basic components; the nuclear basket, the central core and the cytoplasmic fibrils (Figure 
1.2.1) (Beck et al., 2004). The central framework forms a cylindrical structure with eight 
cytoplasmic filaments and the nuclear basket is made up of eight filaments that join into a distal 
ring. The NPC is asymmetric with respect to its cytoplasmic and nuclear extensions (Kahms et 
al., 2011). Each NPC is composed of ~30 proteins called nucleoporins (Nups) that line the 
central transport channel of the pore. They are present in copies of eight or multiples of eight 
(Rout et al., 2000).  About two thirds of the Nups appear to be evolutionarily conserved between 
yeast and mammals (Vasu and Forbes, 2001; Allen et al., 2000). The Nups contain FG, FxFG 
and GLFG repeats that provide binding sites for nuclear import and export factors, and are 
directly involved in energy dependent nuclear transport (Bayliss et al., 2000; Bayliss et al., 
2002). The Nups are mainly divided in to three classes namely; transmembrane proteins, beta 
propeller folds, and alpha solenoid folds (Tran and Wente, 2006; Lim et al., 2008)   
 
1.2.2. Nuclear import pathways 
Nuclear protein import is a directional active translocation of proteins from the cytoplasm 
into the nucleus (Marfori et al., 2011). Proteins that are transported in an energy dependent 
mechanism need to possess a special sequence called nuclear localization signal (NLS) 
(Wagstaff and Jans, 2009) and require soluble cytosolic nuclear transport receptors and proteins 
of the nuclear pore complex (Sorokin et al., 2007). 
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The prototype monopartite and bipartite cNLS are the NLS of SV-40 T antigen 
(PKKKRKV) and nucleoplasmin protein (KRPAATKKAGQAKKKK), respectively (Lange et 
al., 2007). The cNLS makes hydrogen bonds with conserved aspargines of the Imp-α H3 helices 
and the NLS peptide insert into the cNLS binding groove of Imp-α containing two lysine binding 
pockets. The lysine side chains of the NLS and the tryptophans of Imp-α involve in hydrophobic 
interactions with each other. In addition, the basic NLS lysines interact with the surrounding 
acidic residues of Imp-α (reviewed in Cook et al., 2007). Furthermore, cargos that carry non 
classical NLS can also directly interact with Imp-β and are imported into the nucleus in Imp-α 
independent/Ran dependent mechanism. Examples include, NLS of Rev and Tat proteins of HIV 
(Gu et al., 2011; Truant and Cullen, 1999), the ribosomal proteins L23a and L5 (Jakel and 
Gorlich, 1998), Cyclin B1 (Moore et al., 1999) and other several proteins like the transcription 
factors CREB, Jun and Fos (Forwood et al., 2001).  
 
1.2.2.1. Nuclear localization signals 
Smaller macromolecules, ions and metabolites passively diffuse into the nucleus. While 
the import of molecules larger than 40kDa is mediated by special amino acid targeting sequences 
on import substrates called Nuclear Localization Signals (NLS). The best characterized nuclear 
localization signals termed “Classical (c)” NLS are composed of one cluster (monopartite) or 
two clusters (bipartite) of basic amino acids separated by ~10-12 amino acid spacer (Lange et al., 
2007). Although variety of proteins uses cNLS for localization to the nucleus, many nuclear 
proteins use unconventional NLS which do not match with the well defined consensus cNLS 
(reviewed in Fried and Kutay, 2003).  Among the proteins annotated in GenBank, 57% of the 
proteins that are identified to localize in the nucleus contain cNLS (Lange et al., 2007). 
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However, recent reports suggest that many proteins utilize a number of non classical NLSs for 
transport to the nucleus (Christophe et al., 2000). A variety of other sequence motifs have been 
identified that direct proteins into the nucleus (Gorlich, 1997). For example, the c-myc protein 
contains non-classical NLS consisting of nine amino acids, PAAKRVKLD, of which only three 
are basic amino acid residues (Dang and Lee, 1988). The NLS of the heterogeneous nuclear 
ribonucleoprotein A1 (hnRNP A1) known as M9 is composed of 38 amino acids, which is 
essential for both nuclear import and export (Siomi and Dreyfuss, 1995). The NLS of the 
ribosomal protein rpL23a called BIB, which consists of a basic residues rich 42 amino acid 
sequence (Jakel and Gorlich, 1988).  
 
1.2.2.2. Protein transport receptors (importins) 
Selective transport of macromolecules from the cytoplasm to the nucleus is mediated by 
soluble cytosolic nuclear import factors called karyopherins or importins. These proteins have 
also been referred to as NLS receptors or Nuclear Pore Targeting Complex (Gorlich and Mattaj, 
1996).  The NLS of cargo proteins is recognized and bound by the 60kDa protein named 
importin-α in the cytoplasm that has six different isoforms in mammals, displaying  differing 
tissue expression patterns, and act as an adaptor protein for importin-β mediated nuclear 
transport (Pemberton and Paschal, 2005).  Importin α- interacts directly with the 90kDa 
importin-β (which is also termed as p97, karyopherin-β, and PTAc in mammals [Sorokin et al., 
2007]) through its importin-β-binding domain (IBB) which is located in the amino terminus of 
importin-α between residues 10 and 55 (Gorlich et al., 1996a; Xu et al., 2010). In addition to 
IBB, importin-α also contains a highly structured domain consisting of ten tandem Armadillo 
(ARM) repeats in its C-terminus. The ARM repeats are relatively hydrophobic and contain three  
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Figure 1.2.1 Schematic diagram of the nuclear pore complex (Adapted from Allen et al., 
2000) 
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α-helices (termed H1, H2, and H3). The ARM repeats assemble into a spherical, twisted 
structure with a long groove that serves as a binding site for monopartite and bipartite NLS. 
These structures show a higher degree of conservation between different variants of 
importin-α (Marfori et al., 2011). The tenth ARM repeat also serves as a binding site for the 
exportin CAS (cellular apoptosis susceptibility) (Herold et al., 1998).  The IBB and ARM repeat 
domains are conserved across different variants of importin-α. However, other regions tend to be 
poorly conserved and have therefore been termed variable regions (Goldfarb et al., 2004). In 
addition to the sequences that bind to importin-β and NLS, importin-α possesses a leucine-rich 
nuclear export signal (NES) for its quick return to the cytoplasm (Cortes et al., 1994).  
IBB domain interacts either in cis with the cNLS binding groove or in trans with 
importin-β. When importin-α is free in the cytoplasm (not bound to an NLS cargo), its IBB is not 
exposed to importin-β. Through these interactions it acts as a competitive inhibitor to regulate 
the binding of the NLS cargo to the nascent targeting complex. By doing so, it controls the 
ternary complex assembly and disassembly (Goldfarb et al., 2004). Importin-β1 is a family of 
closely related proteins, including nuclear export factors Crm1 and CAS, and the nuclear import 
factor transportin, but only importin-β1 participate in importin-α dependent nuclear import 
processes (Chook and Suel, 2011). Importin-β1 interacts with the NLS adaptor importin-α 
(Cingolani et al., 1999), Ran (Chook and Blobel, 1999; Lee et al., 2005), cargo proteins 
(Mitrousis et al., 2008) and Nups (Bayliss et al., 2000). Its large surface area and the inherent 
flexibility of the solenoid structure enable it to bind with a wide variety of proteins (Forwood et 
al., 2010). importin-β1 contains 19 tandem HEAT repeats (named after the proteins in which 
they were first identified:Huntingtin, Elongation factor 3, the A subunit of protein phosphatase 
A, and Tor1 kinase), each consisting of two α-helices in a hairpin structure. They are arranged in 
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a superhelix comprising two helices; the helix A (convex face) and helix B (concave face). The 
other binding partners of importin-β1 interact with the concave face of importin-β1 except Nups 
which bind to the convex face (reviewed in Marfori et al., 2011). The interaction between 
importin-β and importin-α involves HEAT repeats 7-19 (Cingolani et al., 1999). 
The cargo-importin-α/β ternary complex is then docked into the cytoplasmic periphery of 
the NPC via the action of importin-β (Pemberton and Paschal, 2005).  Importin-β binds to GLFG 
or FXFG repeat domains of different Nups in-vitro and mediates the interactions with the NPC 
that drive translocation into the nucleus (Bednenko et al., 2003). Lastly, the import-ligand 
complex has to be moved ~100nm across the NPC by an energy dependent, Ran dependent 
mechanism. Then, nuclear import is completed by the dissociation of the import substrate and the 
nuclear import factors (Stewart, 2007). The dissociation of the trimeric complex is mediated, in 
part, by the binding of the small nuclear GTPase Ran-GTP to importin-β.  Cargo proteins can 
also be transported through direct interactions with importin-β (Xu et al., 2010). The schematic 
of Imp α/β heterodimer pathway mediated nuclear import of proteins is shown in Figure1.2.2. 
 
1.2.2.3. Nuclear import cycle  
A small GTPase Ran is essential for the energy dependent import and export of 
molecules across the NPC (Stewart, 2007). The hydrolysis of GTP by Ran (Ras related nuclear 
protein) is required for the translocation of the cargo-Importin-α/β complex through the NPC. 
This process is facilitated by NTF2 (the nuclear transport factor 2). Ran is a 25kDa protein that is 
predominantly located in the nucleus (Moore, 1998). The unique feature of the RanGTPase cycle 
is the predominantly cytoplasmic pattern of cellular distribution of its regulators RanGAP (the 
main GTPase activating protein) and RanBP1 (Ran binding protein), which together can achieve
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Figure 1.2.2 The mechanism of importin α/β hetetrodimer dependent/Ran dependent import of proteins into the nucleus (Adapted 
from Stewart, 2007)
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maximum GTPase activity. In contrast, RCC1 (the nucleotide exchange factor of Ran) is 
predominantly nuclear. As a result, there is a steep gradient of RanGTP across the NPC with a 
high level in the nucleus and a low level in the cytoplasm (Sorokin et al., 2007). This controls the 
formation of Importin-cargo complexes by facilitating the assembly in the cytoplasm (low Ran-
GTP) and by facilitating the dissociation in the nucleus (high Ran-GTP) (Stewart, 2007). 
The dissociation of the cargo-Importin-α/β complex starts with the interaction of Ran-
GTP to three different regions of importin-β, which results in an allosteric conformational 
change of Imp-β that finally displaces the cargo and hinders the interaction between IBB domain 
of Imp-α and Imp-β (Lee et al., 2005; Chook and Blobel, 1999). 
Importins are exported back to the cytoplasm as complexes with Ran-GTP by binding 
with the nuclear export proteins (CAS, exprotin1/Crm1p). Once in the cytoplasm, the RanGAP 
and the RanBP1 (exclusively cytoplasmic) / RanBP2 located on the cytoplasmic fibrils of the 
NPC) accelerate the conversion of RanGTP into RanGDP resulting in the dissociation of Ran 
from the complex which ultimately releases its cargo from the export receptor. Ran is actively 
imported back to the nucleus by the action of the transport factor p10/NTF-2, which specifically 
binds to RanGDP and converts Ran-GDP to Ran-GTP by nucleotide exchange releasing Ran 
from p10/NTF2 (Sorokin et al., 2007).  
 
1.2.2.4.Ran independent nuclear transport of proteins 
There are alternate nuclear import pathways that have been described, which are totally 
independent of Ran. For instance, importin-β1, β-catenin (Wagstaff and Jan, 2009), transportin-
1(Nakielny and Dreyfuss, 1998), transportin 3 (Kataoka et al., 1999) can be imported into the 
nucleus independent of Ran, but by directly binding with proteins of the NPC. The nuclear 
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export factor Crm1 also binds to Nup214 and migrates into the nucleus without requiring Ran 
(Fornerod et al., 1997). The nuclear import of calcium binding protein calmodulin (CaM) 
depends on the concentration of Ca
2+
 in the cytoplasm and CaM binding proteins are translocated 
through the NPC in the absence of Ran (Hanover et al., 2009). In addition, cNLS containing 
proteins that are recognized by CaM can be transported into the nucleus without GTP hydrolysis, 
but in the presence of ATP in CaM dependent pathway (Sweitzer and Hanover, 1996). 
 
1.2.2.5.Pathways for nuclear import of adenoviral proteins 
Adenovirus genome replication and capsid assembly take place in the nucleus. Hence, 
viral proteins synthesized in the cytoplasm need to be imported into the nucleus to achieve 
replication, the assembly of capsids and ultimately the production of infectious progeny virus. 
Even though extensive work has not been done characterizing the mechanisms of nuclear import 
of adenovirus proteins, studies on small number of adenovirus proteins have shown the use of 
different nucleocytoplasmic shuttling receptor pathways. 
Structural proteins: Protein pVII of HAdV-5 has been shown to contain three NLS 
containing regions (amino acids 82 to 114, 115 to 169 and 155 to 199) (Wodrich  et al 2006). 
Protein pVII and its NLS domains specifically bind to nuclear import receptors (Imp-α, Imp-β, 
Imp-7 and transportin).  Another report also demonstrated that pVII interacts with Imp-α, Imp-β, 
Imp-7 and transportin, but it is only transportin that interacts with mature VII (Hindley et al., 
2007). Since pVII is tightly associated with the adenovirus genome and can act as an adaptor 
connecting the genome with nuclear import machinery and help in the delivery of adenovirus 
genome into the host nucleus preferentially through transportin mediated pathway (Lee et al., 
2003; Wodrich et al., 2006). Protein V of human adenovirus is translocated into the nucleus in an 
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energy dependent mechanism by either transportin (1, 2 or 3) or Imp-α/β heterodimer mediated 
import pathway (Hindley et al., 2007).  
The hexon protein that constitutes the largest mass of adenovirus is cytoplasmic when 
expressed alone and does not have known NLS (Russell and Kemp, 1995).  The nuclear import 
of hexon in virus infected cell is mediated by protein pVI, which acts as an adaptor linking hexon 
to the transport receptors and shuttles between the cytoplasm and the nucleus (Wodrich et al., 
2003). The C-terminal peptide of pVI contains the NLS and NES, which is cleaved during virus 
maturation and is sufficient to import carrier molecules through the Imp-α/β import pathway 
(Wodrich et al., 2003). The fiber protein of BAdV-3 contains a NLS that are composed of basic 
residues (
14
PYKAKRP
20
). Substitution of the basic (KKR) residues with acidic (EEE) residues 
inhibits nuclear import of the protein. Mutating the NLS of the fiber in BAdV-3 did not affect 
formation of viral particles, but reduced virus growth which may be due to poor formation of 
infectious viral particles (Wu et al., 2004).  
Non-structural proteins: Adenovirus E1a protein that functions in transcriptional control 
of adenovirus genes contains a pentameric NLS in its C- terminus, which directs nuclear 
accumulation of the protein (Lyons et al., 1987), mediated by Imp-α3 (Kohler et al., 2001).  
Similarly, the E1B-55K protein contains a C-terminal NLS and an N-terminal leucine-rich NES 
and shuttles between the nucleus and the cytoplasm (Pollard and Malim, 1998). The N- terminus 
of HAdV- 2 E4-6/7 protein (Schaley et al., 2005) and the C-terminus of HAdV-5 E4-ORF6 
protein (Orlando and Ornelles, 1999) contain an arginine-rich nuclear localization signal. 
The nuclear import of BAdV-3 L1-52K protein is mediated by Imp-α3 and three basic 
residues (
105
RKR
107
) are essential for nuclear localization of the protein (Paterson et al., 2012). 
Likewise, the C- terminus of HAdV-5 L4-100K protein contains a functional NLS (Cuesta et al., 
27 
 
2004). Reports also indicate that 100K protein helps in the nuclear localization of hexon protein 
(Hong et al., 2005). 
 
1.3. mRNA TRANSLATION IN EUKARYOTES 
Translation of mRNA is a post transcriptional mechanism that controls gene expression. 
It occurs after mRNA biogenesis, which typically starts with the transcription of mRNAs in the 
nucleus, followed by mRNA processing that includes capping at the 5’ end, splicing and 
polyadenylation,  ribonucleoprotein (RNP) assembly and export of mature RNPs (mRNP) to the 
cytoplasm via the NPC.  
The translation process is generally divided into initiation, elongation and termination 
stages. However, translation is principally regulated at the initiation stage. Translation initiation 
is considered a rate limiting factor for overall protein synthesis in eukaryotes (Sonenberg and 
Hinnebusch, 2009). While the majority of eukaryotic mRNAs are translated by a scanning 
mechanism, initiation of few mRNAs is mediated by internal ribosome entry sites (IRES) 
(Jackson et al., 2010). 
 
1.3.1. Cap dependent translation 
Translation initiation involves several steps of protein-mRNA and protein-protein 
interactions. Structural elements like the 5’cap and the 3’ polyA tail are important determinants 
of these interactions (Van Der Kelen et al., 2009). The initiation process starts with the 
interaction of eukaryotic initiation factor (eIF)2-GTP complex with Met-tRNAi  forming 
eIF2/GTP/Met-tRNAi ternary complex, which is bound by a preformed 40S-eIF3-eIF1A leading 
to the formation of 43S pre-initiation complex (PC) (Lopez-Lastra et al., 2005). The binding of 
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the ternary complex with the 40S ribosome is an essential step in translation initiation. The 
ternary complex then binds with other eIFs and facilitates the delivery of Met-tRNAi into the P 
site of the 40S ribosome (Hinnebusch, 2000). This is followed by recruitment of 43S pre-
initiation complex by eIF3 and eIF4F complex to the 5’ end of the mRNA.  
The binding of 43S complex to the mRNA is enhanced by the recognition of m
7
G cap at 
the 5’- end of mRNA by the cap binding protein subunit of eIF4F, eIF4E and eIF3 bound to 43S 
complex. Then, the mRNA bound ribosomal complex scans through the 5’ untranslated region 
(UTR) of the mRNA untill the recognition of first AUG to form a 48S initiation complex through 
base pairing of the initiation codon to the anticodon of initiator tRNA. Finally, the 60S ribosomal 
subunit will join to form a functional 80S ribosome, leaving Met-tRNAi in the ribosomal P site 
(Sokabe et al., 2011) (Figure 1.3.1).  
 
1.3.2. Mechanism of recruitment of 43S preinitiation complex (PC) 
The 5’ ends of most eukaryotic mRNAs contain a special sequence called m7G cap, 
which facilitates mRNA translation initiation by acting as a recruitment site for 43S PC. It is also 
involved in splicing and nucleocytoplasmic transport of mRNAs and protecting mRNAs from 5’ 
to 3’ exonuclease degradation (Jackson et al., 2010). ATPase and the helicase activity are 
required for mRNAs that contain secondary structures at their 5’ UTR to facilitate the 
recruitment of the 43S PC at the m
7
G Cap and for the subsequent scanning (Pestova and 
Kolupaeva, 2002). The eIF4F complex (which is composed of the cap binding complex eIF4E, 
the scaffold protein eIF4G, and the ATP dependent RNA helicase eIF4A) is central in mediating 
the recruitment of 43S PC to the 5’ Cap (Jackson et al., 2010) (Figure 1.3.1).  
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The eIF4F subunit eIF4E directly interacts with the 5’ cap structure of mRNAs and recruit the 
translation machinery to the 5’ end of mRNAs. Under normal physiological conditions, eIF4E is 
bound by 4E-BPs (4E-binding proteins) (Rong et al., 2008). The binding affinity of 4E-BPs for 
eIF4E is regulated by the phosphorylation of the specific serine/threonine residues in 4E-BP 
proteins (Fischer, 2009; Fadden et al., 1997). The hypo-phosphorylated 4E-BP strongly binds to 
eIF4E and drastically reduces translation initiation; however, when hyper-phosphorylated, its 
binding to eIF4E is blocked and translation initiation is enhanced (Jia et al., 2012). Exposure of 
the cells to the external stimuli like cytokines, hormones, mitogens, growth factors induce hyper-
phosphorylation of 4E-BPs, while deprivation of nutrients or growth factors results in 
dephosphorylation of 4E-BPs (Holcik and Sonenberg, 2005). The FRAP/mTOR (FKB12-
rapamycin associated protein/mammalian target of rapamycin) pathway is required for the 
phosphorylation 4E-BP1 (Gingras et al., 2001). Generally, while the eIF4F formation is 
presumed to be largely regulated by eIF4E (Rau et al., 1996), the eIF4E activity is controlled by 
the regulation of its transcription, phosphorylation of the eIF4E protein (i.e. eIF4E 
phosphorylation is correlated with increased translation rate) and by its interaction with 
translational repressor proteins (Pause et al., 1994). The eIF4E is phosphorylated by MAP 
(mitogen activated protein) kinase signal integrating kinases Mnk1 and Mnk2 at Ser209 in 
mammals (Raught and Gingras, 1999). 
The scaffolding protein eIF4G couples the mRNA and the translation machinery by 
multiple protein-mRNA and protein-protein interactions. eIF4G contains binding sites for eIF4A, 
eIF4E, eIF3 and poly A binding protein (PABP) (Jackson et al., 2010). The N-terminus of eIF4G 
binds with eIF4E (Mader et al., 1995), and the middle and C- terminus interacts with eIF4A 
(Imataka and Sonenberg, 1997). The binding of eIF4G with eIF3 (part of the 43S PC) brings the
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Figure 1.3.1 Cap dependent mRNA translation initiation in eukaryotes (Adapted from Gingras et al., 1999). 
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40S ribosomal subunit to the 5’ cap of the mRNA. The middle region of eIF4G contains eIF3 
binding motif (Pestova et al., 2007). In addition, the N-terminus of eIF4G also contains a PABP 
binding domain (Imataka et al., 1998).  
The 46kDa eIF4A protein is a member of DEAD-box family and possesses RNA 
dependent ATPase activity and bidirectional RNA helicase activity. The intrinsic ATPase and 
the helicase activities of eIF4A are very weak. However, it’s ATPase and the helicase activities 
are strongly stimulated by eIF4B. Nevertheless, the eIF4A and the eIF4B do not directly interact 
with each other (Andreou and Klostermeier, 2013). The eIF4B interacts with ribosomal 18S 
rRNA and mRNA (Methot et al., 1996) and is also involved in 48S complex assembly (Pestova 
et al., 1996b). The ATPase and helicase activity of eIF4A has also been reported to be enhanced 
by eIF4H. Even though the precise role of eIF4A in unwinding secondary structures in the 
mRNA is not clear, the most acceptable model on binding of 43S PC to the mRNA is that eIF4F 
helps in delivering eIF4A to the 5’ end of the mRNA, then eIF4A unwinds the complex 
secondary structures and produce a single stranded RNA, which allows 43S PC recruitment 
(Andeou and Klostermeier, 2013).   
 
1.3.3. mRNA circularization during translation initiation 
The circularization of mRNA is a central feature for eukaryotic mRNA translation 
initiation, which acts as a proof reading mechanism ensuring that only properly processed and 
intact mRNAs are translated. Besides, circularization of mRNA enhances efficient recycling of 
translation factors and also helps in the stabilization of the mRNA (Weill et al., 2012). The 
circularization of mRNAs is facilitated by the interaction of the cap with the PABP, eIF4G and 
eIF4E proteins (Weill et al., 2012).  Except histones, all eukaryotic cellular mRNAs are post 
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transcriptionally modified by the addition of a 3’ poly (A) tail, which is involved in mRNA 
translation initiation activation (Jacobson, 1996). It functions interdependently with the 5’ cap to 
induce a synergistic enhancement of translation (Eckmann et al., 2010). In addition to eIF4E 
binding domain, eIF4G contains a conserved PABP binding site, Pab1p. Additionally, Pab1p and 
eIF4E also contains putative binding sites for eIF3 and RNA (Gross and Kleimann, 2013; 
Kahvejian et al., 2005). The eIF4E-eIF4G-Pab1p complex confers high affinity for the entry of 
40S ribosomal subunit and may also stimulate the activity of the other translation initiation 
factors like eIF4A (Wells et al., 1998). In addition, PABP joins the 40S and 60S ribosomal 
subunits, stabilizes the eIF4F-cap complex and induces the association of the PIC to the 5’ end of 
the mRNA (Kahvejian et al., 2005). 
 
1.4. mRNA TRANSLATION IN VIRUSES 
Both RNA and DNA viruses are totally dependent on the host translational machinery for 
viral protein synthesis. The ensuing viral protein synthesis is essential for viral genome 
replication and progeny virus production. For viral mRNA translation initiation to occur, viruses 
need to recruit cellular ribosomes to their mRNAs. Almost all viruses have developed a strategy 
to hijack the cellular translation initiation factors and signaling pathways that control the host 
translation machinery. 
 
1.4.1. Cap mediated translation 
In eukaryotic cell co-transcriptional event, a cap structure is added to the nascent 5’-
triphosphate of a mRNA in the nucleus that ensures efficient translation of the mRNAs in the 
cytoplasm. One of the benefit of mRNA capping in eukaryotes is to identify foreign RNAs 
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including viral transcripts; however, viruses have developed a strategy to protect their mRNAs 
from the host innate immune system either by adding a cap moiety (7-methyl-Gppp, p is a 
phosphate group) on their 5’ ends that is indistinguishable from cellular mRNA cap structures or 
by covalently attaching a peptide at the 5’ end of the viral mRNAs. In addition to helping escape 
from the innate immune surveillance, capping confers efficient translation of viral mRNAs using 
the host translation machinery (Decroly et al., 2012).  As compared to eukaryotic mRNA 
capping, capping of viral mRNAs is diverse in terms of the genetic components, the protein 
domain organization, the enzyme structure and the reaction mechanisms (Decroly et al., 2012).  
Viruses like Reoviridae and Poxviridae use a RNA capping pathway that is similar to the 
eukaryotic cells. These viruses appear to encode their own RNA capping machinery, which led 
to the discovery of RNA cap (Ferron et al., 2012). The conventional eukaryotic mRNA capping 
mechanism involves hydrolysis of the 5’-triphosphate by an RNA 5’ phosphatase (RTPase) to 
yield 5′ ppN, followed by the addition of cap structure by the capping enzyme 
(guanylyltransferase [GTase]) by transfering Gp from a Gppp donor to form the cap structure, 
GpppN. Then, the cap is methylated by a RNA cap guanine N-7-methyltransferase (N-7 MTase) 
by transfering a methyl group from S-adenosyl-L-methionine (SAM) to yield 7
m
GpppN and S-
adenosyl homocysteine providing a minimal RNA cap chemical structure named cap-0 
(m
7
GpppNp), This methylated cap can then be subsequently methylated by a ribose-2′-O (2′-O) 
methylase to yield 7
m
GpppN
m
  (Furuichi and Shatkin, 2000), which is recognized by the 
translation initiation factor eIF4E (Decroly et al., 2012).  
Viruses have evolved different viral mRNA capping mechanisms. For instance, most 
viruses that synthesize their mRNAs using cellular RNA Pol II exploit the cellular capping 
machinery including RNA viruses that belong to Retroviridae and Bornaviridae (reviewed in 
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Decroly et al., 2012). Three major human pathogen families, Arenaviridae, Bunyaviridae and 
Orthomyxoviridae acquire a cap structure from cellular mRNA by a mechanism called ‘cap 
snatching’ which involves the removal and transfer (snatching) of the cap from the cellular 
mRNA to their own pre-mRNA through endonucleolytic cleavage. The stolen cap is then used to 
prime synthesis of viral RNA by the viral polymerase (Ferron et al., 2012; Decroly et al., 2012). 
The L protein of Arenaviridae and Bunyaviridae contains the structural endonuclease domain 
that is involved in the cap snatching. The viruses with single stranded (ss) RNA genome 
synthesize their own cap by ‘conventional’ (the sequential action of RTPase, GTase and MTases) 
(eg rabies virus) or ‘unconventional’ mechanisms (e.g. influenza, lassa, hantaan and rift valley 
viruses) (Ferron et al., 2012). The best characterized conventional viral-RNA capping system is 
that exemplified by the double stranded DNA virus vaccinia virus. They  acquire their cap by a 
conventional mechanism using a viral encoded multifunctional mRNA cap synthesizing enzyme 
(D1), which has domains for RTPase, GTase and N7MTase  (Cong and Shuman, 1995). In 
addition double stranded RNA viruses like those in the Reoviridae family use similar 
mechanisms as vaccinia virus (Decroly et al., 2012). 
 In contrast, some viruses evolved mechanisms to generate viral mRNA caps using 
‘unconventional’ means. For instance, the ss (-) RNA virus vesicular stomatitis virus (VSV) (a 
prototype of non segmented negative sense RNA viruses) can synthesize their own cap, which is 
similar to the cellular RNA cap, but use a different mechanism (Ogino and Banerjee, 2007). In 
these viruses, the capping enzyme transfers the RNA to Gpp rather than Gp into the 5’ end of 
RNA (Ogino and Banerjee, 2007). In addition, the VSV mRNA cap methylase activities are 
unique in that the G-N-7 and 2′-O methylase activities use a single S-adenosyl-L-methionine 
(SAM) binding site (Li et al, 2006). Generally, the L-protein of VSV and others in the 
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Mononegavirales have RNA-dependent RNA polymerase (RdRp) and RNA cap synthesis 
activitities (Murphy and Grdzelishvili, 2009). On the other hand, the ss (+) RNA alphaviruses of 
Togaviridae like Sindbis and Similki forest virus synthesize a cap only up to a cap-0 structure via 
a non conventional mechanism. The Nsp1 protein encoded by these viruses has guanine-7-
methyltransferase activity (Mi and Stollar, 1991; Laakkonen et al., 1994). Furthermore, Ahola 
and Kaariainen, 1995 reported that the viral mRNA cap complex in these viruses consists of 7-
methyl-GMP (m7GMP) linked to nsPl, which is unique to alphaviruses in mRNA cap formation, 
where the methylation of the guanine precedes the bonding with the 5' end of the RNA. 
Interestingly, some other viruses like members of Caliciviridae family, covalently attach viral 
encoded peptides at their 5’ ends, which directly binds to eIF4E and initiates the viral mRNA 
translation (Goodfellow et al., 2005). 
 
1.4.2. Internal ribosome entry site (IRES) 
The IRES is a highly specialized RNA sequence which is present at the 5’-end of certain 
viral genomes and functions in recruiting ribosomes to the mRNA in a cap-independent 
mechanism. First discovered in picornaviruses (Jang et al., 1988; Pelletier and Sonenberg, 1988), 
IRESs are highly structured and can promote end-independent 40S ribosomal entry without the 
need for free the 5’ ends in IRES containing mRNAs  (Hellen and Sarnow, 2001) (Figure 1.4.1). 
The IRESs are classified into four structural groups; Type 1 (poliovirus), Type 2 
(EMCV), Type 3 (hepatitis C virus) and Type 4 IRESs (cricket paralysis virus) (Kieft, 2008). 
The classification is based on IRES’s secondary structures, the ability of the IRES to operate in 
rabbit reticulocyte lysate with or without supplementation, the requirement for the eIFs and the 
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location of the start codon relative to the start of recruitment of the 40S ribosomal subunit (Kieft, 
2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4.1 Schematic of different types of mRNA translation initiation (Adapted from 
Lopez-Lastra et al., 2005). 
 
 
 
1. IRES mediated translation 
2. Ribosome frame shifting 
3. Ribosome shunting 
4. Leaky scanning 
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In encephalomyocarditits virus (EMCV) IRES dependent mRNA translation, except for eIF4E 
and the N-terminal domain of eIF4G to which eIF4E binds, all sets of eIFs that are essential for 
cap dependent translation are required (Pestova et al. 1996a; Pestova et al., 1996b). In EMCV, 
the domain of the IRES (i.e. type 2 IRES) close to the initiation codon is bound by eIF4G, 
followed by recruitment of eIF4A and binding of the 43S preinitiation complex to IRES 
(Kolupaeva et al., 2003). 
 The mechanism of recruitment of eIFs and ribosome to the mRNA is similar in Type 1 
and 2 IRESs (de Breyne et al., 2009). The sequences and secondary structures of type 3 and type 
4 IRESs are quite distinct from each other and with that of type 1 and type 2 IRESs. Both Type 3 
and 4 IRESs involve eIF independent interaction with the 40S ribosome and influence the entry, 
positioning and fixation of mRNA in the ribosomal decoding channel by inducing 
conformational changes in the ribosome (Hellen, 2009).  
 
1.4.3. Frame shifting 
Frameshifting is a change or shift in the ribosomes frame by one or two nucleotides 
during translation (Figure 1.4.1). Generally, programmed frame shifting occurs at shift prone 
sites in response to stimulatory signals within the mRNA. In response to those signals, ribosomes 
are induced to move into the -1 reading frame in a 5’ direction and start translation in the new 
reading frame (Dinman, 2012). The cis acting signals that are essential for ribosomal frame 
shifting are well characterized. However, the mechanism is not well understood (Brierley, 1995). 
Frame shift signals have been identified from several double and single stranded RNA viral 
families including Astroviridae, Luteoviridae, Retroviridae, Togaviridae, Totiviridae, and 
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Coronaviridae (Brierley, 1995). In Rous sarcoma virus (RSV), the gag-pro, gag-pol or pro-pol 
mRNA overlaping regions contain heptanucleotide stretch with homopolymeric triplets 
(XXXYYYZ). Based on this observation, a simultaneous slippage model of frame shifting was 
proposed that suggests two adjacent ribosome-bound tRNAs in the zero reading frame (X-XXY-
YYN) slip back simultaneously by one nucleotide at the time of the frame shift so that both 
tRNAs are in the -1 phase (XXX-YYY) and are base paired to the mRNA in at least two out of 
three anti-codon positions (Dinman, 2012). In addition, efficient frame shifting requires a 
downstream structure called RNA pseudo-knot, which is formed when nucleotides in the loop 
region of a hairpin-loop base pair with other regions in the mRNA (Giedroc and Cornish, 2009). 
Replacing the pseudo-knots with other stable RNA structures significantly reduce the efficiency 
of ribosomal frame shifting (Brierley et al., 1991; Chen et al., 1995). Mostly, the distance 
between the slippery sequence and the downstream stimulator appears to be limited to only 5 and 
8 nucleotides (Brierley et al., 1992; Kollmus et al., 1994). The degree and the extent of 
involvement of viral or cellular factors in the ribosomal frame shifting during the course of virus 
infection is not yet well elucidated (Dinman, 2006).   
 
1.4.4. Leaky scanning 
Leaky scanning is a mechanism of translation initiation by which ribosomes bypass the 
first AUG codon and initiate instead at a second or, sometimes, third AUG codon (Figure 1.4.1). 
This has an advantage of producing multiple proteins from one mRNA (Kozak, 1991a). Leaky 
scanning may also occur when initiation happens at a non AUG codon, such as CUG, ACG or 
GUG (Kozak, 1991b). Several viruses including human immunodeficiency virus (HIV) employ 
leaky scanning mechanism and economise on their coding space. For instance, the envelope 
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glycoprotein (ENV) of HIV-1 is translated by leaky scanning and relies on suboptimal 
translation initiation codons at the upstream rev or vpu AUGs (Schwartz et al., 1990). The E7 
oncoprotein of human papilloma virus (HPV) type 16 is translated by a leaky scanning 
mechanism from E6/E7 bicistronic mRNA (Stacey et al., 2000). In addition, the rabies virus 
phosphoprotein (Chenik et al., 1995) and certain bicitronic mRNAs of severe acute respiratory 
syndrome corona virus (SARS-CoV) also produce protein via leaky scanning mechanism 
(Schaecher et al., 2007; Xu et al., 2009; Yang et al., 2009).  
 
1.4.5. Ribosome shunting 
Ribosome shunting is a mechanism by which the scanning 40S ribosomal subunit 
physically bypasses (shunts) a hairpin loop and strong secondary structures in the 5’ untranslated 
region that would block the scanning process, thereby preserving the secondary structure of the 
shunted region (Lopez-Lastra et al., 2010) (Figure 1.4.1). Shunting was first characterized in 
plant retroviruses namely cauliflower mosaic virus (CaMV) 35S RNA (Futterer et al., 1993) and 
then in Rice tungro bacilliform virus (RTBV) (Futterer et al., 1996). Subsequently, it was 
observed in other viruses including HPV (Remm et al., 1999), duck hepatitis B pararetrovirus 
(Sen et al., 2004), Sendai paramyxovirus (de Breyne et al., 2003) and adenovirus late mRNAs 
(Yueh and Schneider, 1996; Yueh and Schneider, 2000). All adenovirus late mRNAs contain an 
identical 5’ non-coding segment called the tripartite leader (TPL) (an extensive unstructured 5’ 
end, followed by a group of stable hairpin structures) which acts as a cis-acting shunting element 
(Yueh and Schneider, 1996; Yueh and Schneider, 2000). Host cellular protein synthesis is 
inhibited during adenovirus infection; however, the TPL and 100K protein of adenoviruses form 
a complex and enhance association of eIF4G and PABP. By doing so, they facilitate the selective 
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translation of late viral mRNAs by promoting ribosome shunting (Xi et al., 2004; Xi et al., 
2005). 
 
1.5. INHIBITION OF mRNA TRANSLATION BY VIRUSES 
Viruses are dependent on host translation machinery for translation of viral mRNAs. 
Regardless of the mechanism used to produce mRNA, viruses recruit cellular translation 
machinery to the viral mRNAs. Hence, one of the key features during host-cell infection by 
several viruses is the inhibition of cellular protein synthesis (Walsh and Mohr, 2011). Viruses 
use different mechanisms to inhibit host cellular mRNA translation. For example, certain viruses 
inactivate the eIF4F subunits, manipulate the eIF4F binding proteins or remove key structures 
like m
7
G cap from the cellular mRNAs (Schneider and Mohr, 2003). For example, poxvirus 
decapping enzyme (D9 and D10 protein) inhibits cellular protein synthesis by removing the m
7
G 
from the cellular mRNAs, however, robust transcription of viral mRNAs allow stage-specifc 
translation of viral proteins (Parrish et al., 2007). VPg protein of calciviruses directly binds 
eIF4E and recruits eIFs to viral mRNA inhibiting cellular mRNA translation. Vesicular 
stomatitis virus VSV and SV40 inhibit host protein synthesis by dephosphorylating the 4EBP1, 
which further activates the eIF4E. The 2A protease of enteroviruses and 3C protein of 
calciviruses cleave eIF4G. In addition, 3C protease of enteroviruses cleaves eIF5B and PABP 
leading to the suppression of global cellular protein synthesis. Other viral gene products interfere 
with cellular mRNA translation by directly binding with initiation factors. For example, capsid 
protein of rubella virus directly binds PABP and suppresses the host mRNA translation. The N 
protein of measles virus, M protein of Rabies virus and spike protein of SARS CoV bind with 
eIF3 and impair cellular mRNA translation (Walsh and Mohr, 2011).   
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1.6. ADENOVIRUS INHIBITION OF HOST CELLULAR PROTEIN SYNTHESIS 
Adenoviruses inhibit cellular protein synthesis by inhibiting translation of cellular capped 
mRNAs, especially during late times post infection (Dolph et al., 1988; Huang and Schneider, 
1991). Although the cellular mRNA translation is blocked during adenovirus infection, little is 
known about the identity of the proteins (viral or cellular) and the mechanisms involved in the 
process (Yueh and Schneider, 1996). Cellular mRNA translation in adenovirus infected cells is 
diminished by infection induced displacement of Mnk1 from eIF4G via direct binding of 
adenovirus 100K protein to eIF4G causing under-phosphorylation of eIF4E. However, only four 
fold reduction in host cellular mRNA translation was observed in adenovirus infected cells 
overexpressing a phosphorylation mutant of eIF4E suggesting that underphosphorylation of 
eIF4E is not the only mechanism in the process of overall suppression of global cellular protein 
synthesis in adenoviruses infected cells (Cuesta et al., 2004). 
  
1.7.DEAD BOX RNA HELICASES 
DExD/H helicase family of proteins which includes DEAD-box proteins and the related 
DEAH, DExH and DExD proteins are a closely-related family of proteins, which can be 
identified based on the differences in their shared eight conserved motifs (motifs I, Ia, Ib, II, III, 
IV, V and VI) (de la Cruz et al., 1999). They are classified under super family 2 (SF2) helicases. 
Based on the structural and the functional studies, the DEAD box family is known to be the 
largest family of RNA helicases composed of nine motifs (Figure 1.7.1). Motifs Q, I and II are 
involved in the nucleotide binding; Motifs Ia, Ib, IV and V are involved in RNA binding; Motifs 
III and possibly VI are involved in ATP hydrolysis (Reviewed in Hogbom et al., 2007) (Figure 
1.7.1).  Motif II, which is also known as the Walker B motif contains the amino acid sequence  
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Figure 1.7.1 The different motifs of the DEAD box family of RNA helicases (Adapted from 
Cordin et al., 2006). 
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D-E-A-D (asp-glu-ala-asp) from which the name DEAD box protein is derived. Each of the 
motifs of DEAD-box proteins has distinct structure and function. In addition, the  DEAD-box 
proteins are present in all eukaryotic cells and in most prokaryotes like eubacteria and 
archaebacteria, and involve in diverse biological processes, especially in almost all steps of RNA 
homeostasis including transcription, splicing, ribosome biogenesis, export, translation and decay 
(Figure 1.7.2) (Cordin et al., 2006). 
 
1.7.1. DDX3 
The DDX3 is a member of the DEAD box family of ATP dependent RNA helicases, which 
exists in two closely related forms (92% protein identity) namely DDX3X and DDX3Y. DDX3Y 
is produced specifically in the spermatocytes and is essential for the spermatogenesis while 
DDX3X is ubiquitously expressed in a wide variety of tissues and participates is several 
metabolic processes. DDX3X is a 73kDa nucleo-cytoplamic shuttling protein possessing ATPase 
and RNA helicase activities.DDX3 is essential  for mRNA transcription, pre-mRNA splicing, 
mRNA export, translation and mRNA turn over (Rocak and Linder, 2004; Kwong et al., 2007) 
(Figure 1.7.2). It is also implicated in translation initiation (Lee et al., 2008; Parsyan et al., 2011) 
and may regulate the cellular mRNA translation by interacting with specific eIFs like eIF4E and  
PABP (Shih et al., 2008, Shih et al., 2012), eIF2 (Lai et al., 2008), and eIF3 (Lee et al., 2008). 
It can also act as a scaffold for alternative protein-protein interactions. Moreover, DDX3 has also 
been shown to be involved in the regulation of innate immunity against microbial infections 
(Oshiumi et al., 2010).  
The interaction of viral proteins with cellular proteins is of vital importance in the 
regulation of virus replication, growth and survival. In recent years, viral proteins encoded by  
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Figure 1.7.2 Functions of DEAD box family of RNA helicases (Adapted from Linder and 
Jankowsky, 2011). 
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vaccinia virus (Schroder et al., 2008), hepatitis B virus (Wang and Ryu, 2010; Yu et al., 2010), 
hepatitis C virus (Ariumi et al., 2007; Owsianka and Patel, 1999) and HIV (Yedavalli et al., 
2004) have been shown to interact with DDX3, which appears to be required for the efficient 
replication of their viral genomes. The viruses accomplish this either by exploiting or 
suppressing the functions of DDX3.   
 
1.7.1.1.The role of DDX3 in DNA transcription 
The DEAD box proteins have been reported to interact with the transcription machinery 
without employing their helicase or ATPase activity. Studies suggest that DDX3 may be 
involved in the regulation of transcription. For instance, DDX3 up regulates the activity of the 
INFβ promoter through TBK-1 and IKK-e mediated INFβ promoter induction (Schroder et al., 
2008). Oshiumi et al., 2010 also showed that the C-terminal (622-662 a.a.) part of DDX3 
interacts with IPS1 (IFN-β promoter stimulator-1) also known as MAVS (mitochondrial anti 
viral signaling) and colocalize in the membrane of the mitochondria, which is important in the 
enhancement of the MAVS mediated INF-β promoter activation. On the contrary, while DDX3 
forms a complex with E-cadherin promoter and transcriptionally represses the expression of E-
cadherin, the down regulation of DDX3 promotes the transcription of E-cadherin (Botlagunta et 
al., 2008). DDX3 also induced a 2- to 4-fold up-regulation of p21
waf1/cip1
 promoter–driven 
luciferase activity. This effect of DDX3 is caused by its binding to the transcription factor Sp1, 
which requires the ATPase, but not the helicase activity of DDX3 (Chao et al., 2006). The 
mechanisms of recruitment of DDX3 to the promoter sites are not well understood. Other 
members of the DEAD-box family of proteins are also shown to be involved in transcriptional 
regulation. DDX54 (DP97) enhances the activity of the promoter of the nuclear receptor estrogen 
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receptor-α (ERα) by interacting with the AF2 domain (i.e. transcription activation domain) of 
ERα and other nuclear receptors (Rajendran et al., 2003). DDX5 (P68), another member of 
DEAD-box family of proteins mediates interactions between ERα, AF1 and the AF2 co-activator 
complex and act as a transcriptional co-activator for ERα transcription by acting as a bridge 
between the transcription factors (Watanabe et al., 2001). There is also a strong evidence that 
RNA helicase-A, a member of the DEAD box proteins acts as a bridging factor between the 
CREB-binding protein (CBP) and RNA polymerase-II, hence cooperating with CREB to activate 
transcription (reviewed in Fuller-Pace, 2006). 
 
1.7.1.2.The role of DDX3 in pre-mRNA splicing 
Splicing is a step at which the introns are removed from pre-mRNAs and exons are 
joined together to produce a continuous reading frame. Pre-mRNA splicing is a multistep process 
that involves ATP, two trans-esterification reactions and structural rearrangement of the 
spliceosome, a dynamic RNA-protein complex in which splicing takes place.  The spliceosome 
is composed of snRNPs (U1, U2, U4/U6 and U5 spliceosomal snRNPs) as well as non-snRNP 
proteins. The DDX3 protein contains a region that resembles the RS-domains in splicing factors 
like ASF/SF2 and SC-35, a domianinvolved in mediating protein-protein interactions (Kohtz et 
al., 1994; Wu and Maniatis, 1993). DDX3 and its yeast homologue ded1p were also isolated as a 
component of the spliceosome, which remain associated with mature mRNA after the splicing 
stage in an Exon junction complex (EJC) dependent manner. However, it still is unclear whether 
DDX3 is functionally involved in the process of splicing or not.  
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1.7.1.3. The role of DDX3 in mRNA export 
Since mRNA transcription and translation occur at different cellular compartments, the 
mature mRNAs after post ttranscriptional modification needs to be exported from nucleus to the 
cytoplasm by various nuclear export receptors. The two well characterized proteins that function 
as nuclear export receptor are CRM1, which exports proteins that contain a leucine-rich nuclear 
export signal (Katharine et al., 1997), ribosomal RNAs and small nuclear RNAs, and the Tip 
associated protein (TAP) which is mainly involved in exporting mature mRNAs (Katahira et al., 
1999; Lai et al., 2008). Reports suggest that DDX3 interacts with both CRM1 and TAP (Dayton, 
2004; Lai et al., 2008). The C-terminus of DDX3 is responsible for its interaction with TAP, in 
the main mRNA export pathway. Despite the evidence that DDX3 interacts with proteins in the 
mRNA export pathways, nobody has yet shown the specific roles of DDX3 in export of mature 
mRNAs (reviewed in Schroder, 2010).  
 
1.7.1.4.The role of DDX3 in mRNA translation 
DDX3 is implicated in translation initiation and may regulate the cellular mRNA 
translation by interacting with specific translation initiation factors eIF4A, eIF4E, eIF2, PABP 
and eIF3. Though few studies indicate the role of DDX3 in the repression of cap-dependent 
translation initiation (Shih et al., 2008),  recent data suggests the involvement of DDX3 in 
enhancing translation initiation (Hilliker et al., 2011; Geissler et al., 2012; Soto-Rifo et al., 
2012). The translation of β-globin mRNA was significantly reduced in DDX3 knocked down 
Hela cells transfected with plasmid DNA expressing β-globin under the control of CMV 
promoter (Lee et al., 2008).  DDX3 also may bind to poly (A)
 +
 RNAs both in the cytoplasm and 
the nucleus independent of TAP (Lai et al., 2008). Immunoprecipitation experiments show that 
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DDX3 interacts with eIF4A, eIF2α and PABP1 and the 40S ribosome subunit in enriched 
fractions of HEK293 cytoplasmic extracts. Moreover, DDX3 gene silencing results in the 
suppression of the translation of mRNAs containing complex 5’secondary structures suggesting 
the direct involvement of DDX3 in the translation process (Lai et al., 2008). On the other hand, 
Soto-Rifo et al., 2012 showed that DDX3 non-specifically binds to the 5’ end of mRNAs and 
clamps the binding of 5’ cap-binding complex, eIF4F. DDX3 interacts with the eIF4F complex 
in addition to eIF4B and poly A binding protein (PABP). Similar results have also been reported 
with the yeast homologue of DDX3, Ded1 (Hilliker et al., 2011). DDX3 knockdown or 
overexpression had a negative and positive impact, respectively on the translation of different 
reporter mRNAs indicating a general role of DDX3 in promoting protein translation (Geissler et 
al., 2012). In addition, Geissler et al., 2012 reported an RNA independent interaction of DDX3 
with ribosomal protein S6 (rpS6), a component of the 40S subunit of the ribosome and with an 
RNA binding protein, IGF2BP1/2. They have also demonstrated that DDX3 is part of 43S and 
80S ribosomal pre-initiation complexes and help in the assembly of functional 80S ribosomes.  
These results suggested that DDX3 is not required for the elongation or termination phase of the 
translation process, but important for the translation initiation process up to the assembly of 
functional 80S ribosome.  
Similarly, the yeast homologues of DDX3, Ded1p and Dbp2 are reported to be 
indispensable translation initiation factors in yeast. They are suggested to be involved in the 
unwinding of the 5’ untranslated regions in concert with eIF4A (Tarn and Chang, 2009). Another 
study shows the function of Ded1 in the scanning process by testing different mRNAs with 5’-
untranslated regions of different lengths (Berthelot et al., 2004).  
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1.7.1.5.The role of DDX3 in innate immunity 
RNA helicases play a significant role in the innate immunity against viral infections. Toll 
like receptor (TLR)-independent pattern recognition receptors (PRRs), like retinoic acid 
inducible gene-I (RIG-I/DDX58) and melanoma differentiation-associated gene 5 (Mda5) that 
are expressed in nucleated cells contribute significantly in mounting an innate immune response 
against pathogens. Both RIG-I and Mda5, classified as RIG-I like DExH family members, 
contain two N-terminal caspase recruitment domains (CARDs) and a DExD/H box RNA helicase 
domain. RIG-I/Mda5 use the mitochondrial CARD containing adaptor protein MAVS/IPS-1 that 
helps for linking detection of dsRNA to activation of TBK1 (TANK-binding kinase-1) / IKKє 
(IkB kinase-є) that phosphorylates the transcription factors IRF-3/IRF-7 which will then be 
translocated into the nucleus and activate the production of type I INF (Yoneyama et al., 2004). 
DDX3 promotes innate immunity by transiently interacting with IKKє and TBK-1. DDX3 may 
also interact with RIG-I, Mda5 and the CARD domain of MAVS, and act upstream of IKKє and 
TBK1 in the MAVS dependent signaling pathway. In addition, it has been reported that DDX3 is 
also involved in the TRIF (TIR domain containing adaptor inducing interferon-β) dependent 
TLR3/4 immune signaling pathways. However, the exact mechanism of action in all the 
indicated innate immune signaling pathways is yet to be determined (reviewed in Schroder, 
2010). 
Despite the fact that several studies show the multifunctional property of DDX3, the 
exact mechanisms employed by DDX3 in the different cellular processes that it participates in is 
not yet fully elucidated. 
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1.7.1.6. Manipulation of DDX3 by viruses 
It is clear that DDX3 participates in two basic biological processes namely RNA 
metabolism and innate immunity. Most of the studies indicate a positive role of DDX3 in innate 
immunity and RNA metabolism (mRNA synthesis to mRNA translation). Both processes are 
required by viruses since most lack the basic elements needed to complete the virus life cycle, 
from DNA replication to protein synthesis and are completely dependent on the host molecular 
machinery, most viruses also face a challenge from the host immune system during infection and 
must devise strategies to negatively regulate the immune system at different levels. Since DDX3 
appears to be involved in a number of cellular processes, the manipulation of DDX3 by specific 
viral products is attractive for the purpose of supporting viral replication and evasion from the 
immune system. 
The first virus that was identified to have a gene product that targets DDX3 was Hepatitis 
C virus (HCV) (Owsianka and Patel, 1999). Owsianka and Patel, 1999 demonstrated that the 
Core protein of HCV directly interacts with the C-terminal region (aa 553-622) of DDX3 and 
changes the normal cellular localization of DDX3 into distinct spots in the cytoplasm co-
localizing with the core protein.  Interaction of HCV Core protein with DDX3 inhibits translation 
of capped but not uncapped mRNAs in in-vitro reticulocyte lysate assay which was presumed to 
be a result of the inhibition of the function of DDX3 as an RNA helicase (Mamiya and Worman, 
1999). In addition, knockdown of DDX3 shuts off the replication of HCV suggesting the 
association of DDX3 with HCV replication complexes or incorporation of DDX3 into the HCV 
virion through interaction with the core to act as an RNA chaperone (Ariumi et al., 2007). This 
reasoning is based on a previous work that demonstrated the detection of DDX3 in the lipid 
droplets of core-expressing Hep39 cells through proteomic analysis (Sato et al., 2006).  
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Interestingly, infection of the cells with HCV does not normally bring about a difference in the 
DDX3 protein level. The exact mechanism by which the interaction of HCV and DDX3 
enhances the replication of the viral genome is still unexplained (Ariumi et al., 2007).  
DDX3 appears important for replication of HIV. The expression of DDX3 was enhanced 
in a Tat dependent manner in HIV infected cells. The Rev protein of HIV and the cellular CRM1 
protein interact with DDX3 and mediate nuclear export of the spliced viral mRNA through the 
CRM1 dependent pathway (Yedavalli et al., 2004). The Rev-viral mRNA interaction is mediated 
through the cis-acting Rev Response Element (RRE) of HIV-1 intron containing mRNAs to 
which Rev protein binds (Malim et al., 1989).  It has also been shown that the helicase function 
of DDX3 is essential for HIV mRNA export (Schroder, 2010). Exogenous expression of DDX3 
was shown to increase the expression the HIV Gag protein by 5 to 10 fold, while dominant-
negative DDX3 mutant suppressed the expression of Gag (Yedavalli et al., 2004). Moreover, 
knockdown of DDX3 gene by using anti DDX3 shRNA shuts down the replication of HIV 
without affecting cell viability (Ishaq et al., 2008). Thus, DDX3 is considered a potential target 
for the treatment of HIV infections because of its crucial involvement in the fulfillment of the 
virus’ life cycle (Yedavalli et al., 2004). 
DDX3 is also targeted by K7 protein of vaccinia virus (Schroder et al., 2008) and 
hepatitis B virus polymerase (HBV Pol) protein (Wang et al., 2009). These viruses inhibit the 
function of DDX3 in innate immunity. K7 protein of vaccinia virus associates with the N-
terminal domain of DDX3 and prevents the association of DDX3 and IKKє, subsequently 
preventing the IKKє from activation of downstream transcription factors that induce the 
production of interferons (Schroder et al., 2008). DDX3 inhibits replication of HBV by 
interacting with viral Pol in an RNA independent manner that interferes with the reverse 
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transcription activity of the virus. The exact mechanism of interference is not known. 
Interestingly, it was reported that HBV down regulates the expression of DDX3 in HBV-induced 
hepatocellular carcinoma. This might be to alleviate the inhibitory effect of DDX-3 to promote 
its own life cycle (Wang et al., 2009). Similar to K7 protein of vaccinia virus, HBV Pol dampens 
the interaction between TBK1/IKKє and DDX3 and inhibits the RIG-I and TLR-3 mediated 
interferon induction (Yu et al., 2010). 
Recently, Chahar et al., 2012 showed the co-localization of NS3 protein of West Nile 
virus (WNV) and DDX3 in the peri-nuclear region of infected cells. West Nile virus normally 
replicates in the peri-nuclear replication complexes, which are invaginations of rough 
endoplasmic reticulum membrane vesicles. The level of DDX3 in WNV infected cells increased 
by 2-4 fold.  Interestingly, siRNA knockdown of DDX3 significantly reduced the replication of 
WNV. In murine norovirus infection, DDX3 associates with the viral RNA during replication 
and the silencing of DDX3 cause 80-90% reduction in the levels of viral NS7 protein, viral yield 
and viral RNA levels suggesting that DDX3 is essential for the life cycle of norovirus (Vashist et 
al., 2012). 
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2. HYPOTHESIS AND OBJECTIVES 
Although few reports have evaluated the structure and function of BAdV-3 proteins 
(reviewed in Russel, 2000; Russel, 2009) there is still a lack of understanding of a number of the 
molecular mechanisms that function in the infected cell, principally in respect to how and why 
the virus gene products interact with cellular components. Of all the known adenoviral minor 
proteins, protein pVIII, which connects the core with the inner surface of the adenovirus capsid, 
is the least characterized (Martin, 2012). The protein is present as 120 copies /virion (Reddy et 
al., 1998) and plays a role in the stability of virion structure (Liu et al., 1985). The pVIII 
synthesized in a precursor form (Takahashi et al., 2006; Vellekamp et al., 2001) has potential 
adenovirus specific protease cleavage sites (Diouri et al., 1996). The precursor form of pVIII is 
present in immature virions, while only cleaved form of pVIII is present in mature virions 
(Chelius et al., 2002; Takahashi et al., 2006). Cleavage of pVIII by adenovirus protease appears 
essential for maturation of progeny virions (Gastaldelli et al., 2008). High resolution structural 
studies suggest that pVIII interacts with hexon and IIIa protein (Martin, 2012) in the capsid of 
human adenovirus. 
BAdV-3 pVIII is a minor structural protein that is encoded in the L6 region of the late 
transcription unit, which also encodes the non-structural proteins 33K and 100K (Reddy et al., 
1998). Protein pVIII of BAdV-3 contains 216 amino acids and contains two potential adenovirus 
specific protease cleavage sites (108IAGG↓G and 143LGGG↓S) (Reddy et al. 1998). Detailed 
molecular and functional characterization of pVIII and the role it plays in the replication of 
adenovirus is poorly studied both in human and non-human adenoviruses. Recently, using yeast 
II hybrid assay, we confirmed the interaction of pVIII of BAdV-3 with the cellular DDX3 
protein which is mainly involved in the processing of mRNA. 
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 We hypothesize that BAdV3 pVIII interacts with the cellular helicase DDX3 and 
enhances the life cycle of BAdV-3 at late times post infection by modulating eukaryotic 
initiation factors which leads to the inhibition of the translation of capped cellular mRNA and 
augmentation of viral late mRNA translation. 
The specific objectives of this work are: 
1. Characterization of polypeptide VIII of BAdV-3 
2. Confirmation of interaction of pVIII with DDX3  
3. Study the biological significance of the interaction of pVIII with DDX3  
 
The following Sections contain details of the findings of the study. 
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3. CONSERVED REGIONS OF BOVINE ADENOVIRUS-3 pVIII CONTAIN 
FUNCTIONAL DOMAINS INVOLVED IN NUCLEAR LOCALIZATION AND 
PACKAGING IN MATURE INFECTIOUS VIRION  
(Ayalew LE, Gaba A, Kumar P, Tikoo SK. 2014, Journal of General Virology doi: 10.1099/ 
vir.0.065763-0) 
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3.1. INTRODUCTION 
Adenoviruses are non enveloped DNA viruses with icosahedral capsid virions composed 
of major (hexon, penton, fiber) and minor (pIIIa, pVI, pVIII and pIX) structural proteins 
surrounding the core. The adenovirus core contains the genome (McConell & Imperiale, 2004; 
Nemerow et al., 2009)
 
and core proteins (V, VII, mu and terminal protein [TP]) that directly bind 
the viral DNA. The proteolytic cleavage of some structural proteins including pVIII by 
adenovirus encoded protease (Anderson et al., 1973; Tremblay et al., 1983; Webster, 1989) is 
required for maturation of newly formed virions. Assembly of adenoviruses occurs in the nucleus 
followed by viral DNA replication and late gene expression. Capsid formation is facilitated by 
the trimerization of hexon protein using 100K, 33K and IVa2 proteins as scaffolding proteins. 
The fiber trimers then interact with the penton base and assemble with hexon forming an intact 
capsid. 52K and IVa2 viral protein interact with the packaging domain of the viral DNA and 
function in DNA encapsidation (Ostapchuk and Hearing, 2005). 
Since assembly of adenovirus capsid takes place in the nucleus, structural proteins 
synthesized in the cytoplasm are transported to the nucleus. Migration of macromolecules from 
the cytoplasm to the nucleoplasm occurs through the nuclear pore complex (NPC) (Adam, 1999; 
Kohler et al., 1999). The NPC is composed of 50 – 100 different species of proteins called 
nucleoporins with an estimated total mass of ~125MDa in higher eukaryotes. NPCs are 
incorporated into the nuclear envelope at sites where the inner and outer nuclear membranes are 
fused. They function as gate keepers of the nucleus, performing the essential cellular role of 
mediating an exchange of proteins, nucleic acids, and other factors between the cytoplasm and 
nucleoplasm (Theerthagiri et al., 2010).  
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The NPC permits a non-selective passive diffusion of molecules smaller than 40kDa 
through the nuclear envelope via its aqueous channel of ~10nm diameter (Paine et al., 1975). 
NPCs also mediate selective active transport of particles as large as 25nm in diameter or several 
million Daltons in molecular weight (Feldherr et al., 1984). Directed transport requires energy 
and soluble factors and is triggered by short strings of amino acids called nuclear localization 
signals (NLS) on the protein to be transported into the nucleus (Davis, 1995; Gorlich & Mattaj, 
1996). The classical NLS, designated as basic type NLS, was first identified in nucleoplasmin 
(KRPAATKKAGQAKKKK) and the SV40 large T antigen (PKKKRKV)  (Dingwall & Laskey, 
1991). However, other type NLS including non classical type have been identified (Christophe et 
al., 2000).  
The L6 region of the late transcription unit of bovine adenovirus (BAdV)-3 encodes two 
non structural (33k, 100k) and one structural (pVIII) protein (Reddy et al., 1998). In an effort to 
determine the characterstics and functions of the L6 region proteins, we demonstrated that 
BAdV-3 33K interacts with 100K (Kulshrestha & Tikoo, 2008) and is involved in viral capsid 
assembly by promoting an efficient interaction between the capsid protein and the viral DNA 
(Kulshreshtha et al., 2004) and recently demonstrated that cleavage of BAdV-3 100K is not 
essential for the virus’ life cycle (Makadiya, 2013). To further advance our understanding of the 
BAdV L6 proteins we have identified that  BAdV-3 pVIII, a minor capsid protein of 216 amino 
acids is processed at  two canonical adenovirus protease specific cleavage sites (108IAGG↓G 
and 143LGGG↓S) (Reddy et al., 1998). We also identify the domains of pVIII involved in 
nuclear localization and incorporation in mature virions. 
 
58 
 
3.2.MATERIALS AND METHODS 
3.2.1. Cell lines and Viruses 
Madin Darby Bovine Kidney (MDBK) cells were grown in minimum essential medium 
(MEM; Sigma Aldrich) containing 5% fetal bovine serum and 50µg/ml gentamycin. African 
green monkey kidney (Vero) cells were grown in Dulbecco’s Modified Eagle’s (DMEM; Sigma 
Aldrich) medium containing 10% heat inactivated fetal bovine serum (Sera Care Life Sciences, 
Inc.) and 50µg/ml gentamycin.  For BAdV-3 purification, confluent MDBK cells grown in 
150mm flasks were infected with wild -type BAdV-3 at an MOI of 5. Immature and mature 
BAdV-3 virions were purified by double Cesium chloride density gradient centrifugation as 
described earlier (Tollefson et al., 1998). The purified mature virions and empty capsids were 
stored at -70
o
c in PBS containing 10% glycerol.  
 
3.2.2. Peptide synthesis and production of polyclonal antibodies 
To make antibodies against pVIII, rabbits were immunized with the individual 
conjugated peptides (500μg/rabbit) emulsified with Freund’s Complete Adjuvant (FCA) 
followed by two injections (conjugated peptide, 300 μg/rabbit) in Freund’s incomplete adjuvant 
(FIA) at four weeks apart. The peptides contained amino acids 85 to 109 (VIIIa) and 187-216 
(VIIIb) of pVIII and were synthesized based on intrinsic prediction of hydrophilicity of amino 
acid side chains using the Pioneer Peptide Synthesis system (Perkin Elmer). The peptides were 
individually conjugated to keyhole limpet hemocyanin (KLH) as a carrier molecule. Serum was 
collected ten days after the third injection and was tested for specificity by Western blot.  
For in-vitro nuclear import blocking experiment, nuclear import protein inhibitory 
peptides: importin β binding domain of importin α (IBB importin α) (10RMRKFKNKGK 
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DTAELRRRRVEVSVELRKAKKDEQILKRRNVC 
51)
) (Gorlich et al., 1996a), Ycbp80 
(
1
MFNRKRRGDFDED ENYRDFRPRMPKRQRIP
30
) (Gorlich et al., 1996b) and SR1 
(CGGGRKRRQRSRSRSRSRSR SRSRSRRRR) (Lai et al., 2001) were synthesized using 
Pioneer Peptide Synthesis system (Perkin Elmer). 
 
3.2.3. Construction of expression vectors 
Plasmids encoding glutathione-S-transferase (GST) fused importin α-1, importin α-3, 
importin α-5, importin α-7 and importin β (kindly provided by Dr.  M. Köhler) have been 
described (Depping et al., 2008). Plasmids GST-NLS-GFP, (GST fused to NLS of simian virus 
40 (SV40) T antigen) GST-RanQ69L (dominant negative mutant of Ran fused to GST) were 
kindly provided by Dr. Y. Yoneda (Tachibana et al., 2000). Plasmid pc3HA (pcDNA3 
containing 3 tandem HA tags inserted at HindIII-EcorI site) was a gift from Dr. Joyce Wilson, 
University of Saskatchewan, Canada. The construction of other plasmids is described elsewhere. 
a) Plasmid pEY.pVIII. A660bp DNA fragment containing pVIII gene was amplified by 
using PCR and primers VIII-F and VIII-R and template plasmid pFBAV-302 (Zakarchouk et al., 
2004) (Table 3.2.1). The PCR product was digested with EcoRI and ligated to AfeI and EcoRI 
digested plasmid pEYFPN1 creating plasmid pEY.pVIII. 
b) Plasmid pRSET.pVIII. A655bp DNA fragment containing pVIII gene was amplified by 
PCR using  primers  XhoI VIII F and Ecor I VIII R (Table 3.2.1) and  plasmid pFBAV302 
(Zakarchouk et al 2004) DNA as a template The PCR product was digested with XhoI and EcoRI 
and ligated to XhoI-EcoRI digested plasmid pRSET-A (Invitrogen) creating plasmid 
pRSET.pVIII. 
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c) Plasmid GST.pVIII. A 666bp HindIII (blunt end repaired by Klenow) – XhoI DNA 
fragment containing pVIII gene was isolated from plasmid pRSET A-pVIII  and ligated to 
4681bps AatII (blunt end repaired by klenow)) - XhoI digested  fragment of plasmid pGEX-5X-1 
(GE Healthcare)  creating plasmid pGST.pVIII. 
d)  Plasmid pEY.VIIId1. A 228bp DNA fragment was amplified by PCR using primers 
pVIII-D1-F and pVIII-D1-R (Table 3.2.1) and plasmid pEY.pVIII DNA as a template. The PCR 
product was digested with NheI and EcoRI and ligated to NheI and EcoRI digested plasmid 
pEY.pVIII creating plasmid pEY.VIIId1 
e)  Plasmid pEY.VIIId2. A405bp DNA fragment was amplified by PCR using primers 
pVIII-D1-F and pVIII-D2-R (Table 3.2.1) and plasmid pEY.pVIII DNA as a template. The PCR 
product was digested with NheI and EcoRI and ligated to NheI and EcoRI digested plasmid 
pEY.pVIII creating plasmid pEY.VIIId2. 
f) Plasmid pEY.VIIId3. A264 DNA fragment was amplified by PCR using primers pVIII-
D3-F and pVIII-D3-R (Table 3.2.1) and plasmid pEY.pVIII DNA as a template. The PCR 
product was digested with NheI and EcoRI and ligated to NheI and EcoRI digested plasmid 
pEY.pVIII creating plasmid pEY.VIIId3. 
g) Plasmid pEY.VIIId4. A 441bp DNA fragment was amplified by PCR using primers 
pVIII-D4-F and pVIII-D3-R (Table 3.2.1) and plasmid pEY.pVIII DNA as a template. The PCR 
product was digested with NheI and EcoRI and ligated to NheI and EcoRI digested plasmid 
pEY.pVIII creating plasmid pEY.VIIId4 
h)  Plasmid pEY.VIIId5. A 120bp DNA fragment was amplified by PCR using primers 
pVIII-D5-F and pVIII-D1-R (Table 3.2.1) and plasmid pEY.pVIII DNA as a template. The PCR 
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product was digested with NheI and EcoRI and ligated to NheI and EcoRI digested plasmid 
pEY.pVIII creating plasmid pEY.VIIId5. 
i) Plasmid pEY.VIIId6.  A 168bp DNA fragment was amplified by PCR using primers 
SnaBI-F and EcoRI-R (Table 3.2.1) and plasmid pEY.pVIII DNA as a template. The PCR 
product was digested with SnaBI and EcoRI and ligated to SnaBI and EcoRI digested plasmid 
pcDNA3.EYFP (Paterson et al., 2012) creating plasmid pEY.VIIId6. 
j) Plasmid pcEY.pVIIId1. Plasmid pEY.pVIIId1 was digested with NheI (blunt end 
repaired with T4 polymerase) and XbaI. The 997bp fragment was gel purified and cloned into 
EcoRI (blunt end repaired with T4 polymerase) and XbaI digested plasmid pc3HA creating 
plasmid pcEY.pVIIId1. 
k) Plasmid pcEY.pVIIId4. Plasmid pEY.pVIIId4 was digested with NheI (blunt end 
repaired with T4 polymerase) and XbaI. The 1210bp fragment was gel purified and ligated to  
EcoRI (blunt end repaired with T4 polymerase) and XbaI digested plasmid pc3HA  creating 
plasmid pcEY.pVIII4.  
l) Plasmid pNLS.EYFP. A 833bp DNA fragment was amplified by PCR using primers 
NLS-EY-HindIII-F and NLS-EY-XbaI-R (Table 3.2.1) and plasmid pVIIId1 DNA as a template. 
The PCR product was digested with HindIII and XbaI and ligated to HindIII and XbaI digested 
plasmid pcDNA3 creating plasmid pNLS. EYFP. 
m) Plasmid pNLSGFP-βgal. A 67bp DNA fragment was amplified by PCR using primers 
NLS-EY-HindIII-F and gbeta-NheI-R (Table 3.2.1) and plasmid pVIIId1 DNA as a template. 
The PCR product was digested with HindIII and NheI and ligated to HindIII and NheI digested 
plasmid pCMVGFP-βgal (Wu & Tikoo, 2004) creating plasmid pNLSGFP-βgal. 
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3.2.4. Mass Spectrometry 
 Proteins from mature BAdV-3, immature BAdV-3 or lysates of BAdV-3 infected 
MDBK cells were separated by 10% or 15% sodium dodecyl sulphate (SDS) polyacrylamide gel 
electrophoresis (PAGE) or 4 – 15% precast gradient gel (Bio-Rad). The separated proteins were 
electrophoretically transferred onto Polyvinylidene fluoride (PVDF; Bio-Rad) membrane by wet 
transfer method. The membranes were then blocked with 10% skimmed milk at +4
o
c overnight. 
Western blots were performed using α-pVIIIa and/or α-pVIIIb polyclonal primary 
antibodies (1:300) followed by alkaline phophatase conjugated goat anti-rabbit secondary 
antibody (Jackson Immunoresearch) diluted 1:10,000 or IRdye 680 donkey anti-rabbit IgG (Li-
COR). For visualization of protein bands, the SDS-PAGE gels were stained with Coomassie blue 
for 30 minutes and de-stained with a de-stain solution (40% methanol, 10% acetic acid). For 
Mass spectrometry analysis, the desired protein bands were cut from the 4-15% precast gradient 
gel after staining with coomassie brilliant blue and sent for analysis to PBI, Saskatoon. 
 
3.2.5. Confocal microscopy 
 MDBK cells at 80% confluency in 2 well slides (Thermo scientific) were infected 
with wild-type BAdV-3 using a Multiplicity of infection (MOI) of 5. At 36hrs post infection, the 
cells were fixed with 3.7% para formaldehyde for 15min, blocked with 2% goat serum for 15min 
and permeabilized with Triton X-100 for 5min. The permeabilized cells were incubated with 
primary antibody (pVIIIa serum or pVIIIb serum, 1:300) in 0.1M PBS for 1hr at room 
temperature. The pVIII-antibody complex was detected by Cy-2 conjugated goat α-rabbit 
secondary antibody (Jackson Immunoresearch) and the cells were mounted in medium  
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Table 3.2.1. List of primers 
Primer name Primer sequence 
VIII-F 5’-CATATGAGCAAAGAAATTCCCACAC 
VIII-R 5’-GAATTCCGCTATAACCGCTCACAG 
XhoI VIII F 5’-ACTCGAGATGAGCAAAGAAATTCCCA 
EcorI VIII R 5’-AGAATTCAGCTATAACCGCTCACAGAG 
pVIII-D1-F 5’ CCGCTAGCCATATGAGCAAAGAAATTCCC 
pVIII-D1-R 5’ GAATTCCTCTGGGATCAATCAG 
pVIII-D2-R 5’ CGAATTCCGGTGAGCGGGATAAGGGTTCG 
pVIII-D3-F 5’ GCTAGCATGGCCTCCTGCTTAAGACCAGAT 
pVIII-D3-R 5’ CGAATTCCGCTATAACCGCTCACAGAGTTTGC 
pVIII-D4-F 5’ TAGCTAGCATGCAGTGGGCCGCCCACCTCATCAAAC 
pVIII-D5-F 5’ GGCTAGCATGGGACCTGATATGATCCACGACGTT 
SnaBI-F 5’ GCGGCCCATCTACGTATTAGTCATCGCTATTAC 
EcorI-R 5’ TGAATTCCAAGGATGCGGTTTTGGGCGTCAC 
NLS-EY-HindIII-F 5’ GAAGCTTATGACTCAGTCGGCCATTACCGCCACTCC 
NLS-EY-XbaI-R 5’ TAGCCCTCTAGAGTCGCGGCCGCTTAC 
gbeta-NheI-R 5’ GGCCGCTAGCTCTGGGATCAATCAGATTCCTGGG 
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containing DAPI (Vectashield) and visualized under Zeiss LSM 5 laser scanning con-focal 
microscope. 
3.2.6. Transfection assay 
Monolayers of Vero cells (60-70% confluent) in two well chamber slides were incubated 
with Opti-MEM I reduced serum media (Gibco) for 2hrs prior to transfection. The cells were 
transfected with 1µg / well of individual plasmid DNA using Lipofectamine 2000 (Invitrogen). 
After 36hrs post transfection, the cells were visualized as described above. 
 
3.2.7. Recombinant protein expression and protein purification 
Glutathione S-transferase (GST) and GST fusion proteins were purified using GST beads 
(GE Health care) as per the instructions of the manufacturer. The recombinant proteins: GST-
NLS-GFP and GST-RanQ69L (Imamoto et al., 1995), importins- α-1, α-3, α-7 and β (Friedrich 
et al., 2006, Melen et al., 2003) were expressed in E.coli BL21 cells and purified as previously 
described (Imamoto et al., 1995; Paterson et al., 2012). The purified proteins were dialyzed using 
Slide-A-Lyzer dialysis cassette (Thermo scientific). The concentrations of the proteins were 
measured by Bradford assay (Bio Rad) using Ultrospec
®
 3000 spectrophotometer (Pharmacia 
Biotech).  
 
3.2.8. GST-pull down assay 
Plasmid pRSET.pVIII DNA (0.8µg) was used to synthesize radio-labeled pVIII in-vitro 
by utilizing a TNT T7 Coupled Reticulocyte Lysate System (Promega) in the presence of [
35
S]-
methionine (Perkin Elmer). Prior to use, glutathione sepharose beads were washed three times 
with GST binding buffer (0.54M NaCl, 2.7mM KCl, 10.15mM Na2HPO4, 1.75mM KH2PO4, 
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0.01M MgCl2, 1µg/ml each Aprotinin and Leupeptin, 1% Triton X-100, 1mM PMSF and DNAse 
I). Fifteen µgs of each GST or GST fusions of importins- α-1, α-3, α-5, α-7, or β were incubated 
individually with 20µl of glutathione sepharose beads plus 10µl of in-vitro synthesized pVIII at 
+ 4
o
c over night on a nutator. The beads were washed three times, 10min each with PBS. The 
bead bound proteins were separated by using 10% SDS-PAGE and were fixed in de-stain 
solution (200ml methanol, 100ml glacial acetic acid and 700ml double distilled H2O) for 30min 
and dried onto filter paper at 80
o
c for 2hrs. Subsequently, the the dried gel was exposed to a 
phosphor screen (Kodak) overnight and visualized on a Molecular Imager FX  (Bio-Rad). 
 
3.2.9. In-vitro nuclear import assay 
The in vitro nuclear import assay was carried out using digitonin (selectively 
permeabilizes the cell membrane leaving the nuclear membrane intact) permeabilized MDBK 
cells as described (Adam et al., 1990) with some modifications (Paterson et al., 2012). Briefly, 
the cells that were incubated with complete transport solution containing GST-NLS-GFP were 
processed as described (Paterson et al., 2012). The cells incubated with complete transport 
solution containing GST.pVIII were permeabilized using 0.05% Triton X-100 in PBS for 5min, 
then stained with anti-pVIII (a or b) serum followed by Cy3 conjugated goat anti-rabbit IgG. 
Finally, the cells were washed in PBS and mounted on slides in Vectashield mounting medium 
containing DAPI and visualized under Zeiss LSM 5 laser scanning con-focal microscope. 
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3.3. RESULTS  
3.3.1. Sequence analysis of pVIII protein 
To identify conserved regions in pVIII proteins of different adenoviruses we used the 
computer program BLOSUM 62 application in Clone manager version 9.3.
 
As seen in Figure 
3.3.1, sequences at the N-terminus and C-terminus appear conserved in pVIII homologues from 
fourteen different adenovirus species including BAdV-3.  Secondly, BAdV-3 pVIII amino acid 
sequence was analyzed using different online databases to identify canonical intracellular 
localization signals. None of them predicted the presence of a classical NLS in BAdV-3 pVIII. 
 
3.3.2. Analysis of expression of pVIII by Western blot 
To characterize BAdV-3 pVIII, pVIII protein specific anti-sera pVIIIa and pVIIIb were 
generated against peptides VIIIa (THVEMPRNEVLEQHLTSHGAQIA) and VIIIb 
(LNPYSGPPDSYPDQFIRHYNVYSNSVSGYS), respectively. Sera collected after the final 
protein boost was analyzed by Western blot.  As seen in Figure. 3.3.2A, mixture of anti-pVIIIa 
and anti-pVIIIb sera detected a 24 kDa protein between 12 to 48 hrs post BAdV-3 infection. 
Interestingly, an additional protein of 8 kDa was detected between 24-48 hrs post infection 
(Figure. 3.3.2A). No such proteins could be detected in mock infected cells (Figure. 3.3.2A, lane 
Cx).   
3.3.3. Detection of pVIII in mature and immature BAdV-3 
To determine the identity of the two proteins and if pVIII is part of the virions, immature 
and mature virions were purified from BAdV-3 infected MDBK cells by double cesium chloride 
density gradient centrifugation technique (Figure. 3.3.2B). Proteins from mature virions, empty 
capsids, and lysates of mock or BAdV-3 infected MDBK cells were analysed by Western blot  
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Figure 3.3.1 Areas of amino acid identity between BAdV-3 pVIII and 14 homologues of 
adenovirus pVIII. The numbers on the right corresponds to the different adenoviruses. The 
GenBank Accession number of each sequence is also included. ; Number 1 (BAdV-3; 
AAD09733.1);  2 (BAdV A; , YP_094045.1),  3 ( Duck adenovirus 1; CAA68124.1),  4 (Fowl 
adenovirus 10; AAB88 280.1),  5 (HAdV-2;  AAB42039.1), 6  (HAdV-4; AAN64737.1, 7 ( 
HAdV-5;  CAA26780.1),  8  (HAdV-7; AP_000554.1),  9 (murine adenovirus 3; 
YP_002822222.1),  10 (Ovine adenovirus A; AP_000018.1), 11 (Ovine adenovirus D; 
NP_659528.1), 12 (porcine adenovirus-3BAA76972.1), 13 (Simian adenovirus 25; 
AP_000319.1), 14 ( Tree shrew adenovirus;  YP_068076.1) and 15 (Canine adenovirus 2, 
AAB22306.1) 
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using anti-pVIIIa sera (panel C) or anti-pVIIIb sera (panel D). As seen in Figure3.3.2C, anti-
pVIIIa sera detected a band of 24 kDa in empty capsids (lane b) and BAdV-3 infected cells (lane 
c). No such protein could be detected in mature virions (lane d) or mock infected MDBK cells 
((lane a). Anti-pVIIIb sera detected proteins of 24 kDa and 8 kDa in BAdV-3 infected cells 
(Figure 3.3.2D, lane c; Fig. 3.3.2H). Only 24 kDa protein is detected in empty capsids (Figure 
3.3.2D, lane b; Fig. 3.3.2H). Similarly, only 8 kDa protein is detected in mature BAdV-3 virions 
(Figure 3.3.2D, lane d; Figure3.3.2H), which corresponds to one of the adenovirus specific 
protease cleavage product (Figure3.3.2 H). No such protein was detected in immature virions 
using anti-pVIIIb (Figure 3.3.2D, lane b). In addition, a higher molecular weight protein of ~110 
kDa could be detected in BAdV-3 infected cells (Figure 3.3.2D, lane c), purified empty capsids 
(Figure. 3.3.2D, lane b) or mature BAdV-3 virions (Figure 3.3.2D; lane d). Based on Mass 
spectrometry analysis, the ~110kDa protein was identified as hexon. 
To determine if association between pVIII and hexon is through a disulfide bond, the 
samples were treated with 40% (Figure 3.3.2E; lane a), 30% (Figure 3.3.2E; lane b), 20% (Figure 
3.3.2E lane c) of β-mercaptoethanol before analyzing by Western blot. As seen in Figure 3.3.2E, 
no significant difference could be detected in the pattern of the expression of cleaved fragment of 
pVIII or hexon (lanes a-c). To determine if pVIII-Hexon interaction is specific, proteins from 
mock or BAdV-3 were ananalyzed by Western blot using GST-pVIII absorbed anti-pVIII sera. 
As seen in Figure 3.3.2F, preabsorption of anti-pVIII with GST-pVIII purified protein abolished 
the detection of both pVIII and hexon protein in BAdV-3 infected cells (lane b). However, anti-
pV serum detected a specific protein of 56 kDa in same BAdV-3 infected cells (lane b). No such 
protein could be detected in mock infected cells (lane a) 
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To determine the localization of pVIII in infected cells, Proteins from nuclear or 
cytoplasmic fractions purified from BAdV-3 infected cells were separated by 15% SDS-PAGE 
and analyzed by Western blot. As seen in Figure 3.3.2G, anti pVIII detected a 24 kDa protein in 
both nuclear and cellular fraction of BAdV-3 infected cells. As expected, anti-fibrillarin serum 
detected fibrillarin protein in purified nuclear fraction but not in purified cytoplasmic fraction of 
BAdV-3 infected cells. 
 
3.3.4. Sub cellular localization of pVIII 
To determine the intracellular localization of pVIII, MDBK cells were infected with 
BAdV-3 and analyzed by immuno-staining using anti-pVIII (a and b) sera. As seen in Figure 
3.3.3, pVIII localizes both in the cytoplasm and in the nucleus of BAdV-3 infected cells (panel 
a). No fluorescence was observed in uninfected MDBK cells (panel b). To examine if nuclear 
localization of pVIII requires any other protein, Vero cells were transfected with plasmid 
pEY.pVIII (1µg/well of 2 well chamber slide) DNA and examined under laser scanning con-
focal microscope 36 hrs post transfection. As seen in Figure 3.3.3, (panel c), pVIII localizes in 
the nucleus and in the cytoplasm of transfected cells and appears in the form of dots. 
   
3.3.5. In-vitro nuclear import of pVIII 
To investigate the biochemical details of nuclear import of pVIII, we performed in vitro 
nuclear import assay with digitonin permeabilized MDBK cells. The plasma membranes of 
MDBK cells seeded on cover slips were permeabilized with 40µg/ml of digitonin and transport 
mixes were prepared as indicated in the materials and methods. GST.pVIII was used as a cargo  
 
c) 
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Figure 3.3.2 Western blot (A) Proteins from the lysates of MDBK cells infected with wild-type 
BAdV-3 at an MOI of 5 collected at indicated times post infection were separated by 15% SDS-
PAGE gel, transferred to PVDF membrane and probed in Western blot using mixture of anti-
pVIIIa and α-pVIIIb antibodies. Uninfected MDBK cell lysates (Cx) were used as a negative 
control. β-actin was used as a loading control. Sizeof markers in kDa are indicated on the left. 
The pVIII proteins are indicated by arrows on the right. (B) CsCl2 purification. Purified empty 
capsids and mature virion bands after double Cesium chloride density gradient centrifugation. 
(C, D, E & F) Analysis of pVIII of BAdV-3 in mature and immature virus.  (C) Proteins 
from the lysates of mock infected MDBK cells (a), BAdV-3 infected MDBK cells (c), CsCl2 
purified  empty capsids (b) or mature virions (d) were separated by 15% SDS-PAGE and 
analyzed by Western blot using anti-pVIIIa, Size marker (M) bands in kDa are indicated on the 
right. The  hexon and pVIII proteins are indicated by arrows on the left (D) Proteins from the 
lysates of mock infected MDBK cells (a), BAdV-3 infected MDBK cells (lane c), CsCl2 purified 
empty capsids (lane b) or mature BAdV-3 virions (lanes d) were separated by 15% SDS-PAGE 
and analyzed by Western blot using anti-pVIIIb serum. (E) Samples in lanes a, b and c are 
mature virions treated with 40, 30 and 20% β-ME, respectively. Size markers in kDa are 
indicated on the right. The hexon and pVIII proteins are indicated by arrows on the left (F) 
Proteins from lysates of  mock infected (lane c)  or BAdV-3 infected (Lane b) infected MDBK 
cells were separated by 15%SDS-PAGE and analysed by Western blot using anti-pVIII serum 
pre-absorbed with purified GST-pVIII protein. Anti-serum detecting BAdV-3 pV was used as a 
control. (G) Proteins from lysates of nuclear or cytoplasmic fractions isolated from BAdV-3 
infected cells were separated by 15% SDS-PAGE and probed in Western blot with anti-fibrillarin 
serum (nuclear marker) or anti-pVIII serum. (H) BAdV-3 pVIII cleavage fragments. Schematic 
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of potential polypeptides after cleavage at predicted protease cleavage sites (shown by arrows) of 
BAdV-3 pVIII. Expected sizes of cleavage fragments in kDa are depicted. The location of pVIII 
specific peptides VIIIa (AA 85-109) and VIIIb (AA 187-216) used for producing antisera pVIIIa 
and pVIIIIb, respectively is depicted. 
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Figure 3.3.3 Sub cellular localization of pVIII.  MDBK cells were infected with wild-type 
BAdV-3 at an MOI of 5 (a1-a3) or mock infected (b1-b3). Vero cells were transfected with 1µg 
of plasmid pEY.pVIII DNA (panel c1-c3). At 36 hrs post infection or 48 hrs post transfection, 
the sub cellular localization of pVIII  in the cells were visualized by indirect 
immunofluorescence (a1-a3; b1-b3)  using α-pVIIIa & b serum as primary antibody and cy-2 
conjugated goat anti rabbit antibody as a secondary antibody or direct fluorescence (c1-c3) under 
laser scanning LSM 5 Confocal Microscopy. The nuclei were stained with DAPI (a2, b2, c2).  
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protein and a well characterized GST-NLS-GFP (Adam et al., 1990) was used as a positive 
control for nuclear transport.  
As expected, GST-NLS-GFP, a control cargo containing classical importin- α/ β 
dependent NLS was efficiently imported into the nucleus in the presence of complete transport 
mixture (Figure 3.3.4; panel a). No such import could be detected in the absence of reticulocyte 
lysate (source of cytosolic nuclear transport factors) (Figure 3.3.4 panel b) or ATP regenerating 
system (Figure 3.3.4; panel c). Similarly, GST-pVIII was efficiently imported into the nucleus in 
the presence of complete transport mixture (Figure 3.3.4; panel g). No such nuclear import could 
be detected in the absence of rabbit reticulocyte lysate (panel h) or ATP regenerating system 
(panel i). To determine if nuclear transport is mediated by a Ran-dependent mechanism, the  
nuclear import was analyzed in the presence of the GTPase deficient RanQ69L mutant 
(preloaded with 10mM GTP), As seen in Figure 3.3.4, addition of GTPase deficient RanQ69L 
protein, which promotes disassembly of nuclear import complexes (Richardson et al., 1988) 
completely inhibited the nuclear import of GST-NLS-GFP (panel d) and GST-pVIII (panel j). In 
addition, nuclear import of both GST-NLS-GFP and GST-pVIII proteins was effectively 
inhibited, when the experiment was performed on ice in the presence of complete transport mix 
(Figure 3.3.4; panel f, l).  Addition of WGA, a lectin that binds glycosylated nucleoporins and 
inhibits nuclear pore complex function also inhibited nuclear import of GST-NLS-GFP (panel e) 
and GST-pVIII cargo proteins (panel k). 
 
3.3.6. Identification of nuclear localization domain of pVIII  
To identify the domain(s) responsible for nuclear localization of pVIII, a panel of 
plasmids encoding mutant pVIII proteins fused in frame to EYFP gene was constructed (Figure 
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Figure 3.3.4 Nuclear import assay in digitonin permeabilized cells. MDBK cells were 
permeabilized with 40µg/ml of digitonin and incubated with GST-NLS-GFP (panels a-f) or 
GST.pVIII (panels g-l) in the presence (panels a, d, g, j) or absence (panels b, c, h, i) of indicated 
components of the transport mixture. The permeabilized cells were treated with WGA before 
addition of complete transport mixture (panels e, k) or the experiment with complete transport 
mix was performed at 4
0
C The pictures were taken using Laser scanning LSM 5 Confocal 
Microscope. 
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3.3.5A) and their expression analyzed by Western blot using anti GFP antibody (Abcam) (Figure 
3.3.5B). Vero cells (~70% confluent) were transfected with individual plasmid DNAs and 
analyzed by confocal microscopy at 36hrs post transfection. As seen in Figure 3.3.5C, deletion of 
amino acids 1-131 (pEY.pVIIId3) (panel d) and 1-72 (pEY.pVIIId4) (panel e) resulted in the 
localization of pVIII in the cytoplasm of the transfected cells. In contrast, deletion of amino acids 
73 to 216 (pEY.pVIIId1) (panel b) or 132-216 (pEY.pVIIId2) (panel c) resulted in the 
localization of pVIII in the nucleus of the transfected cells. Similarly, deletion of amino acids 1-
36 and 73-216 (pEY.pVIIId5) (panel f) or 1-55 and 73-216 (pNLS.EYFP) (panel h) yielded 
nuclear localization of mutant proteins, In contrast, deletion of 57-216 (pVIIId6) (panel g) 
showed localization exclusively in the cytoplasm.  This suggested that potential NLS of pVIII 
appears to be located between amino acid 56-72.To assess if the identified NLS region of pVIII 
is able to direct the nuclear import of a hetrologous cytoplasmic GFP-β-gal fusion protein (Wu 
and Tikoo, 2004), Vero cells were transfected with plasmid pNLS GFP.βgal (amino acids 57-72 
of pVIII fused in frame with GFP-β-gal) or plasmid pCMVGFP.βgal DNAs and analysed by 
confocal microscopy after 36 hrs post transfection. As seen in Figure 3.3.5C  amino acids 57-72 
of pVIII (panel j) were able to partially direct the heterologous protein into the nucleus, while 
pCMVGFPβ-gal localized solely in the cytoplasm (panel i). 
 
3.3.7. Interaction of pVIII with importins 
Interaction of proteins with the members of importin super family mediate nuclear transport 
through nuclear pore complexes localized in the nuclear envelop. To determine the involvement 
and identification of the cellular import receptors, GST-pull down assay was performed, importin 
79 
 
 
  (A) 
 
7
9
 
 
80 
 
  
(C)    
        
 
 
(B) 
81 
 
Figure 3.3.5 (A) Schematic representation of BAdV-3 pVIII. The number above the domain 
represents amino acid number in pVIII. Thick box represents BAdV-3DNA, hollow box 
represent EYFP\GFP DNA. Thick box with white dots represent beta-Gal DNA. Dotted lines 
represent deleted regions. The name of the plasmid is on the left. The name of the protein is on 
the right. (B) Western blot. 293T cells seeded on 6well plates were transfected with 2µg of each 
indicated DNA. 36hr post transfection the cells were lysed with RIPA buffer and run on 12% 
SDS-PAGE gel and Western blot was performed using anti GFP serum (Abcam), followed by 
goat anti rabbit IRDye680. Anti actin antibody was used as a loading control. (C) Confocal 
microscopy. About 70% confluent Vero cells were transfected with 1µg of each plasmid: 
pEY.pVIII (panel a), pEY.VIIId1 (panel b), pEY.pVIIId2 (panel c), pEY.VIIId3 (panel d), 
pEY.VIIId4 (lane e), pEY.VIIId5 (lane f), pEY.pVIIId6 (lane g), pNLS.EYFP (lane h), pCMV 
GFP.βgal (i) or pNLSGFP.βgal (J) in two well chamber slides. The intracellular localization of 
the expressed proteins was examined under Laser scanning LSM 5 Confocal Microscope.  
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- α-1, α-3, α-5, α-7 and β1 were expressed as GST fusion proteins in E. coli (BL21) and purified 
(Figure 3.3.6A).  Purified GST alone or GST fusion proteins coupled to glutathione-Sepharose 
beads were individually incubated with radiolabelled pVIII synthesized in-vitro in the presence 
of [
35
S]-methionine using plasmid pRSET. pVIII DNA, pcEY.pVIIId1, pcEY.pVIIId4,  
pNLS.EYFP or pEYFPN1 and TNT T7 Coupled Reticulocyte Lysate System. The protein bound 
to beads was separated by 10 or 15% SDS-PAGE and visualized by autoradiography. As seen in 
Figure 3.3.6B, pVIII interacts with importins- α-1 (lane 3), α-3 (lane 2) and α-7 (lane 4). 
However, pVIII appears to interact preferentially with importin- α-3. No such binding was 
observed when purified GST alone (lane 6), GST-importin- α-5 (lane 5) or GST-importin β1 
(lane 1) bound to GS beads were used to pull down pVIII.  Radiolabelled IVTT pVIII was used 
as input control (lane 7). 
Like pVIII (Figure 3.3.6C, lane 2), GST-importin α-3 interacts with radiolabelled 
EY.pVIIId1 containing deletion of amino acid 73-216 (Figure 3.3.6C, lane 3). No interaction was 
observed between GST-importin α-3 and EY.pVIIId 4 containing deletion of amino acid 1-72 
(Figure 3.3.6C, lane 5).  Finally, like pVIII (Figure 3.3.6D, lane 4) or EY.pVIIId1 (Figure 
3.3.6D, lane 5), GST-importin- α-3 bound to GST beads was able to bind to NLS.EYFP (EYFP 
fused to amino acid 57-72) (Figure 3.3.6D, lane 2). No interaction was observed when GST-
importin- α3 was used to pull down EYFP (Figure 3.3.6, lane 3) or GST alone was used to pull 
down NLS.EYFP (Figure 3.3.6D lane 6). 
 
3.3.8. Nuclear import of pVIII in the presence of inhibitory peptides 
To further confirm the involvement of importins in the nuclear import of pVIII, we 
performed nuclear import blocking assays using specific peptides that can selectively block the 
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Figure 3.3.6 In-vitro interaction of pVIII with transport receptors. (A). Schematic diagram 
of BAdV-3 pVIII. The solid box represents BAdV-3 pVIII DNA, open box represent EYFP 
DNA. Open box with white dots represent HA tag.  The amino acid numbers of pVIII protein are 
depicted. Plasmid names are on the left and protein names are on the right (B) Coomassie 
brilliant blue staining of purified transport receptors. (C-E) GST pull down assay.  (C) In-
vitro transcribed and translated (IVTT) radio labeled pVIII (lane 7) was incubated with each 
importins- α-1 (lane 3), α-3 (lane 2), α-7 (lane 4), α-5 (lane 5), β-1 (lane 1) or GST (lane 6). (D) 
IVTT radiolabelled individual wild-type pVIII (lane 2), cEY.pVIIId1 (Lane 4), EYFP (lane 8) or 
cEY.pVIIId4 (lane 6) was incubated with importin- α-3 (lanes 1, 3, 5 and 7, respectively) or 
IVTT radiolabelled pVIII with GST (lane 9). (E) IVTT radiolabelled NLS.EYFP (lane 1) or 
wild-type pVIII (lane 4) was incubated with importin- α-3 (lanes 2 and 5, respectively) or IVTT 
radio labelled NLS EYFP was incubated with GST (lane 6) or IVTT radiolabelled EYFP with 
importin- α-3 (lane 3), respectively. The incubation was performed overnight at +40c on a nutator 
and pulled down with glutathione sepharose beads. The proteins were separated by 10% SDS-
PAGE. Subsequently, the gel was exposed to phosphor screen overnight and visualized on a 
Molecular Imager FX using Quantity One software. 
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activities of importin- α/β (Gorlich et al., 1996a,b) or transportin 3 (Lai et al., 2001). Specific 
peptides representing 41 amino acid importin- β binding domain of importin α [IBB importin- α 
(Gorlich et al., 1996a)], importin-  binding domain of Ycbp80 protein (Gorlich et al., 1996b; 
Welch et al., 1999) and a 29 amino acid peptide containing eight RS repeats flanked by two 
arginine rich stretches ([SR1], Lai et al., 2001) were synthesized and added individually to the 
transport mix with 1mM concentration (50-fold molar excess). As expected (Figure 3.3.7A), 
addition of Ycbp80 peptide (panel b) or IBB domain peptide (panel c) to the transport mixture 
blocked the import of GST-NLS-GFP to the nucleus. Similarly, (Figure 3.3.7B) addition of 
Ycbp80 peptide (panel b) or IBB domain peptide (panel c) to the transport mixture blocked the 
import of GST-pVIII.  The transport of either GST-NLS-GFP (Figure 3.3.7A) or GST-pVIII 
(Figure 3.3.7B) was not affected in the presence (panel d) or absence (panel a) of SR1 peptide 
(binds to transportin-SR1) to transport mixture.   
 
3.4. DISCUSSION 
Adenovirus protein pVIII is the least characterized core protein. It is present as 120 
copies/virion (Reddy et al., 2010) and appears to be involved in linking the core of the virus with 
the inner surface of the adenovirus capsid (Rohn et al., 1997) thus playing a role in the stability 
of virion structure (Liu et al., 1985). Recent study suggests that porcine adenovirus-3 pVIII 
interact with IVa2, which may suggest its role in genome packaging (Singh et al., 2005). 
Moreover, cleavage of core proteins including pVIII by adenovirus protease appears essential for 
maturation of progeny virions (Gastaldelli et al., 2008). Although pVIII synthesized as precursor 
protein is present in empty capsids, only the cleaved form of pVIII protein is present in mature 
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adenovirus virion (Chelius et al., 2002; Takahashi et al., 2006). The present study was performed 
to 
 
 
 Figure 3.3.7 In-vitro nuclear import blocking of pVIII with specific peptides. 
Digitonin permeabilized MDBK cells grown on cover slips were incubated with complete 
transport mix containing either IBBrpl23a (panel b), IBB importin-α (panel c), SR1 peptide 
(panel d) or complete transport mix without inhibitory peptides (panel a). The cells were 
analyzed by Laser scanning LSM 5 Confocal Microscopy. 
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characterize and determine the functional domains of bovine adenovirus-3 pVIII.   
The pVIII mRNA is predicted to encode protein of 216 amino acids, which is expressed 
as a 24kD precursor pVIII protein detected first between 12-24 hrs post infection. Like HAdV-5 
(Vellekamp et al., 2001), the pVIII is also detected in the immature but not in mature BAdV-3 
capsids. In contrast, 8kDa cleaved pVIII could be detected in mature BAdV-3 capsids. This 
suggests that BAdV-3 protease cleaves pVIII at potential cleavage site 
143
LGGG S
147
 
generating the C- terminal 70 amino acid polypeptide, which is part of the mature BAdV-3 
virion.  By using mass spectrometric analysis purified virions, the N-terminal 112 residues (Liu 
et al., 2003), C-terminal 70 residues (Takahashi et al., 2006) or both N-terminal (112 residues) 
and C-terminal (70 residues) fragments of pVIII were detected in HAdV-5 virions (Blanche et 
al., 2001; Chelius et al., 2002). However, recent CryoEM studies suggest that both N-terminus 
and C-terminus fragments are present in mature virions (Liu et al., 2010). We detected only the 
C-terminal fragment in BAdV-3 virions. It is possible that our inability to detect N-terminal 
pVIII fragment in BAdV-3 virions could be due to less sensitivity of Western blot assay. 
Alternatively, it is possible that only C-terminal 8 kDa protein of pVIII is present in mature 
BAdV-3 virions. Support for the latter comes from the fact that anti-pVIIIb sera raised against 
peptide (amino acid 187-216) could detect C-terminal (amino acid 147-216) 8kDa cleavage 
fragment (Figure 3.3.2D, lane d; Figure 3.3.2E, lanes a-c) in purified virions. In contrast, anti-
pVIIIa serum raised against peptide (amino acid 85-109) could detect full length pVIII in empty 
capsids and BAdV-3 infected cells, suggesting its binding affinity was sufficient to detect pVIII 
in virions. However, no potential N-terminal (amino acid 1-112) cleavage fragment in mature 
virions (Figure 3.3.2C, lane d). 
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High-resolution structural studies suggested that pVIII interacts with hexon and IIIa 
protein in capsid of adenovirus (Martin et al., 2012). Both the precursor and cleaved form of 
BAdV-3 pVIII appear to be tightly associated with110 kDa protein hexon protein, and binding 
does not appear to be due to the formation of disulphide bond. Similar association has been 
observed between hexon and pVIII of egg drop syndrome virion (EDS) (Rohn et al., 1997), 
which may suggest that pVIII stabilizes the virion during and after biogenesis of the viral 
particles (Liu et al., 1985). 
pVIII dominantly localizes to the nucleus and appears in the form of multiple punctuate 
dots in transfected and infected cells. This distinct pattern of pVIII in the nucleus suggests the 
presence of the protein in viral DNA replication compartments and its potential involvement in 
BAdV-3 replication. A similar pattern of expression has been indicated for ICP4, ICP8 and VP5 
proteins of herpes simplex virus-1 (de Bruyn et al., 1998) and BZLF1 proteins of Epstein - Barr 
virus (Daikoku et al., 2005), which are essential for viral DNA replication.  
  Several proteins transported to the nucleus possess classical NLSs containing one or two 
clusters of basic amino acids. However, recent reports have identified non classical NLSs in 
proteins which help them to locate to the nucleus (Christophe et al., 2000). Interestingly, analysis 
of BAdV-3 pVIII protein sequence did not identify the presence of classical NLSs. Since 
proteins less than ~ 40 kDa can passively diffuse into the nucleus through nuclear pore 
complexes (Lim et al., 2008), it is possible that detection of 24 kDa BAdV-3 pVIII in nucleus 
could be due to passive diffusion. However, pVIII fused to a cytoplasmic protein EYFP, a 
protein too large to diffuse through the nuclear pore, is predominantly localized in the nucleus of 
transfected cells. This suggested that pVIII may contain a non-classical NLS and is actively 
transported to the nucleus. Several observations support this conclusion. First, deletion mutant 
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analysis of intracellular localization ofBAdV-3 pVIII proteins (fused in-frame with EYFP) by 
confocal microscopy suggested that amino acid 57-72 contain a potential NLS. Secondly, 
migration of pVIII to nucleus is inhibited at 4
o
C, in the absence of ATP. Thirdly, the nuclear 
import of pVIII is inhibited in the presence of WGA [which blocks active transport, but not the 
free diffusion of macromolecules through the NPC (Yonenda et al., 1987)]. 
  Active transport to the nucleus involves binding of protein NLS to the transportin and 
imporin-α/β heterodimer in the cytoplasm (Gorlich et al., 1995; Imamoto et al., 1995). This NLS 
recognition complex then docks to the nuclear pore complex (Newmeyer & Forbes, 1988; 
Richardson et al., 1988) and is subsequently translocated through the pore by an energy 
dependent and Ran dependent mechanism (Newmeyer et al., 1988, Richardson et al., 1988, 
Yoneda et al., 1987).  The inability of BAdV-3 pVIII to enter into the nucleus in the absence of 
reticulocyte lysate indicates the involvement of cytosolic nuclear import receptors for its 
transport. Interestingly, SR1 peptide, which inhibits transportin- 3 mediated nuclear import did 
not affect the nuclear localization of pVIII. In contrast, IBB importin peptide (inhibits binding of 
importin- α to importin- β) and Ycbp80 peptide (which competes for binding to importin- α) 
inhibits the nuclear transport of pVIII. These results suggest that nuclear transport of BAdV-3 
pVIII is mediated by imporin-α/β pathway. 
In addition, the transport of BAdV-3 pVIII from the cytoplasm to the nucleoplasm is Ran 
dependent. Transport receptors use RanGTP binding as a means to regulate their interactions 
with cargoes or adaptor molecules (Jakel & Gorlich, 1998).  The Ran GTP gradient across the 
nuclear envelope has been proposed to control transport receptor-substrate interactions in a 
compartment-specific manner (Gorlich et al., 1996b).  
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The presence of different isoforms of importin-α may imply that each isoform imports 
specific substrates into the nucleus (Goodwin & Whitehouse, 2001). However, it is well 
described that all importin-α isoforms can import most cargo proteins with a comparable 
efficiency (Kohler et al., 1999). pVIII binds in-vitro with importins-α-1, α-3 and α-7 signifying 
the effective manipulation of more than one receptor for passage into the nucleus. Similar results 
have been reported for the nucleoprotein (NP) of influenza virus (Wang et al., 1997), EBNA-1 
protein of Epstein Barr virus (Kieff, 1996) and ORF57 protein of γ-2 herpesvirus (Goodwin & 
Whitehouse, 2001), which bind importin-α-1 and α-5.  
In conclusion, our data demonstrates that pVIII is a nuclear protein associated with hexon 
that is expressed late in infection. It requires nuclear import factors and a non-conventional 
nuclear localization signal(s) for localization to the nucleus. Moreover, while the N-terminus 
contains domains involved in interactions with importins and nuclear localization, the C -
terminus 70 amino acids appears to be incorporated in mature virion. 
 
 
 
 
 
 
 
 
 
 
91 
 
4. TRANSITION FROM SECTION-3 TO SECTION-5 
In Section-3 the molecular properties of pVIII including its intracellular dynamics have been 
characterized. To further understand the significance of pVIII in virus host interaction, I 
investigated the interaction of BAdV-3 pVIII with cellular proteins and determined the biological 
relevance of the interactions. 
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5.  INTERACTION OF DDX-3 AND BOVINE ADENOVIRUS-3 pVIII MODULATE 
CELLULAR mRNA TRANSLATION BY EXCLUDING eIFs FROM THE CAP 
BINDING COMPLEX 
 
5.1. INTRODUCTION 
DDX3, a member of DEAD (Asp-Glu-Ala-Asp) box family RNA helicases (Ditton et al., 
2004; Gross et al., 2007; Tarn and Chang, 2009), is a 73kDa nucleo-cytoplamic shuttling protein 
and is biologically active both in the nucleus and the cytoplasm (Lee et al., 2008; Lai et al., 
2008).  DDX3 is involved in transcription, pre-mRNA splicing, mRNA export, translation, 
mRNA turn over (Rocak and Linder, 2007; Kwong et al., 2005) and regulation of innate 
immunity (Oshiumi et al., 2010). Even though there are conflicting reports about the role of 
DDX3 in cap-dependent translation, evidence over the years support the role of DDX3 in 
promoting translation initiation (Lee et al., 2008; Lai et al., 2008; Geissler et al., 2012;Shih et al., 
2012; Lai et al., 2010). More recently, DDX3 is suggested to be involved in translation initiation 
of a subset of mRNAs that carry long 5’ UTR (Lai et al., 2008) or RNA stem loop at their 5’ 
UTR (Lai et al., 2008; Soto-Rifo et al., 2012). DDX3 may modulate of cellular mRNA 
translation by interacting with specific eukaryotic translation initiation factors like eIF4E and 
PABP (Shih et al., 2012; Shih et al., 2008), eIF2 (Lai et al., 2008), and eIF3 (Lee et al., 2008). 
Similarly, there is strong evidence for the involvement of Ded1, the yeast homologue of DDX3, 
in translation initiation (Berthelot et al., 2004; Marsden et al., 2006; Chuang et al., 1997; De La 
Cruz et al., 1997). More recently, ATP dependent activation of translation initiation and 
interactions with the components of the translation machinery was established for Ded1. 
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However, interestingly, translation of stalled mRNAs in-vitro is repressed by Ded1 (Hilliker et 
al., 2011).  
Analysis of interaction of viral proteins with cellular proteins has not only helped in 
defining the role of cellular proteins in virus replication cycle but also their role in cellular 
processes. For instance, interaction of vaccinia virus K7 protein with DDX3 revealed the role of 
DDX3 in TBK1/IKKε mediated IRF activation (Schroder et al., 2008). The interaction of viral 
proteins with cellular proteins is of vital importance in the regulation of virus replication, growth 
and survival. One of these processes involves the translation of mRNAs. Different viruses utilize 
various strategies to inhibit translation of capped cellular mRNA to facilitate their life cycle. For 
example; Rubella virus capsid protein inhibits protein translation by sequestering PABP (Ilkow 
et al., 2008), Picornaviruses like FMD virus inhibit cap-dependent protein synthesis by cleaving, 
eIF4A and eIF4G (Belsham et al., 2000) and viral RNA translation is retained through the use of 
an internal ribosome entry sequence whose translation is not inhibited by the cleavage 
Correspondingly, calciviruses inhibit host cell cap dependent translation by cleaving eIF4GI and 
eIF4GII (Willcocks et al., 2004). Likewise, adenoviruses facilitates their replication by altering 
cellular architecture and host cell gene expression (Burgert et al., 2002; Hodge and Scharff, 
1969; Martinez-Palomo and Granboulan, 1967; Martinez-Palomo et al., 1967; Philips and 
Raskas, 1972; Puvion-Dutilleul et al., 1994; Zhai et al., 1994) using mechanisms that include 
inhibition of transport of cellular mRNAs (Beltz and Flint, 1979) and inhibition of translation of 
cellular capped mRNAs (Dolph et al., 1988; Huang and Schneider, 1991). Although someof the 
cellular processes affected by adenoviruses are understood, little is known about the identity of 
the proteins (viral or cellular) and the mechanisms involved (Russell, 2000). 
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Recently interest in DDX3 has been stimulated on account of its significance in the 
development of cancer (Chao et al., 2006; Botlagunta et al., 2008; Chang et al., 2006; Bol et al., 
2013) and the life cycle of important pathogens, including vaccinia virus (Schroder, 2010), 
hepatitis B virus (Wang and Ryu, 2010; Yu et al., 2010), hepatitis C virus (Ariumi et al., 2007; 
Oshiumi et al., 2010, Owsianka and Patel, 1999; Mamiya and Worman, 1999; You et al., 1999) 
and human immunodeficiency virus (HIV)-1 (Liu et al., 2011; Yedavalli et al., 2004). Moreover, 
interaction of DDX3 with a viral protein has defined the new role of DDX3 in the induction of 
innate immunity (Schroder et al., 2008). Here, we provide evidence suggesting a role for DDX3 
in capped mRNA translation and demonstrate that the interaction of a bovine adenovirus-3 late 
protein pVIII with DDX3 inhibits cellular capped mRNA translation by depleting DDX3 and 
associated eIFs (eIF3, PABP and eIF4E) from the cap binding complex while not affecting the 
stability of cellular mRNAs.   
 
5.2. MATERIALS AND METHODS 
5.2.1. Cell lines and viruses  
African green monkey kidney (Vero) cells were grown in Dulbecco’s Modified Eagle’s 
(DMEM; Sigma Aldrich) medium containing 10% heat inactivated fetal bovine serum (FBS) 
(Sera Care Life Sciences, Inc.). Madin Darby Bovine Kidney (MDBK) cells were grown in 
minimum essential medium (MEM; Sigma Aldrich) containing 5% FBS. Wild type bovine 
adenovirus (BAdV)-3 was used to infect MDBK cells at an MOI of 5. 
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5.2.2. Antibodies 
Anti-pVIII recognizes a protein of 24kDa in BAdV-3 infected cells (Ayalew et al., 2014). 
Anti-DBP recognizes a protein of 48 kDa in BAdV-3 infected cells (Zhou et al., 2001). Anti-
DDX3, anti-eIF4G, anti eIF4E, anti eIF3, anti PABP and fluorescence conjugated goat anti-
mouse IgG-FITC (Santa Cruz Biotechnology, Inc, USA), Cy-3 conjugated goat anti- rabbit 
antibody (Jackson Immuno Research), Alexa Flour 680 goat anti-rabbit IgG antibody (Molecular 
Probes) or IRDye 800 conjugated goat anti-mouse IgG (Li-COR biosciences, Cat # 926-32210) 
and anti-HA (Sigma Aldrich, Cat # H9658)   and anti β-actin MAb (Sigma Aldrich, Cat # 
A5441) were purchased.  
 
5.2.3. Plasmid construction  
Plasmid pcDNA3-RLuc-POLIRES-FLuc (Poulin et al., 1998), containing the poliovirus 
IRES was a gift from Dr. Nahum Sonenberg, McGill University, Montreal, Canada. Plasmid 
pcDDX-3 was a gift from Dr. Arvind H. Patel, MRC-University of Glasgow, Center for Virus 
Research, University of Glasgow, UK. and plasmid pcDNA3.1(neo)3HA DNA was a gift from 
Dr. Joyce Wilson, University of Saskatchewan. The construction of plasmid pGEX-100K 
expressing GST.100K fusion protein has been described (Kulshreshtha and Tikoo, 2008). 
Plasmid GC.linker and plasmid GN.linker were a gift from Dr. Abraham Loyter, Hebrew 
University, Jerusalem.  
a) pcDNA.3HA. The cDNA coding for 3HA epitopes was amplified by PCR by using 
primers 3HA-F and 3HA-R (Table 5.2.1), and plasmid pcDNA3.1 (neo)3HA DNA as a template. 
The PCR product was digested with HindIII-EcoRI and ligated to HindIII-EcoRI digested 
plasmid pcDNA3.1 (-) (Invitrogen) creating plasmid pcDNA.3HA.  
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b) pHA.DX3. A 2035bp EcoRI-BamHI fragment was isolated from plasmid pcDDX-3 
and ligated to EcoRI -BamHI digested plasmid pcDNA.3HA creating plasmid pHA.DX3.  
c) pEY.VIII. A 660bp DNA fragment containing pVIII gene was amplified by PCR using 
primers VIII-F and VIII-R (Table 5.2.1), and plasmid pFBAV302 (Zakhartchouk et al., 1998) 
DNA as a template. The PCR product was digested with EcoRI and ligated to AfeI (blunt end 
repaired with T4 polymerase) - EcoRI digested plasmid pEYFPN1 (Clontech) creating plasmid 
pEY.VIII. 
d) Bovine DDX3 yeast expression plasmids. A 1938bp DNA fragment was amplified by 
PCR using primers DDX3-F and DDX3-R (Table 5.2.1), cDNA (synthesized from RNA isolated 
from MDBK cells) as a template, digested with EcoRI-BamHI and ligated to EcoRI-BamHI 
digested plasmid pGBKT7 or pGADT7 creating plasmid pGB.DX3 and pGA.DX3, respectively.  
e) pVIII yeast expression plasmids. A 660bp DNA fragment containing pVIII gene was 
amplified by PCR using primers VIII-F and VIII-R (Table 5.2.1), and plasmid pFBAV302 
(Zakhartchouk et al., 1998) DNA as a template. The PCR product was digested with EcoRI and 
ligated to NdeI (blunt end repaired with T4 polymerase)-EcoRI digested plasmids pGBKT7 or 
pGADT7 creating plasmids pGB.pVIII and pGA.pVIII, respectively. 
f)  pGST.pVIII. A 666bp Hind III (blunt end repaired with T4 polymerase) - XhoI 
fragment of plasmid pR.pVIII was ligated to AatII (blunt end repaired with T4 polymerase) - 
XhoI digested plasmid pGEX-5X-1 (GE Healthcare) creating plasmid pGST.pVIII.  
i) pGST.DDX3. A 2062bp BamHI (blunt end repaired with T4 polymerase)-NotI 
fragment was isolated from pHA.DX3 and ligated to SalI (blunt end repaired with T4 
polymerase) -NotI digested plasmid pGEX-5X-2 (GE Health Care) creating plasmid 
pGST.DDX3. 
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j) pC.pVIIIhav. A 693bp fragment was amplified by PCR using primers hpVIII-F and 
hpVIII-R (Table 5.2.1), and plasmid pH5-R (Zakhartchouk et al., 1999) DNA as a template. The 
PCR product was digested with BamHI - XhoI and ligated to BamHI- XhoI digested plasmid 
pcDNA.3HA creating plasmid pC.pVIIIhav. 
k) pC.pVIIIpav. A 681bp fragment was amplified by PCR using primers PpVIII-F and 
PpVIII-R (Table 5.2.1), and plasmid pGADT7-pVIII (Singh et al., 2005) DNA as a template. 
The PCR fragment was digested with BamHI- EcoRI and ligated to BamHI-EcoRI digested 
plasmid pcDNA.3HA creating plasmid pC.pVIIIpav.  
 
5.2.4. Yeast II hybrid assay 
The Matchmaker two hybrid system3 using Saccharomyces cerevisiae (Clontech) was 
used to detect the interactions between pVIII and DDX3 as described (Kulshreshtha and Tikoo, 
2008). The pVIII gene was cloned in-frame to GAL4 DNA binding domain (pGB.pVIII) or 
GAL4 activation domain (pGA.pVIII). Similarly, DDX3 gene was cloned in-frame to GAL4 
DNA binding domain (pGB.DX3) or in-frame to GAL4 activation domain pGA.DX3). Yeast 
AH109 cells (Clontech) were co-transformed with either pGA.DX3 or pGB.pVIII or pGA.pVIII 
and pGB.DX3 plasmid DNAs. The growth and selection of positive clones was performed as 
described earlier (Kulshreshtha and Tikoo, 2008; Singh et al., 2005). DNA was isolated from 
positive clones and sequenced for confirmation.  
 
5.2.5. Recombinant protein expression and protein purification 
The recombinant GST-fusion proteins were expressed in Escherichia coli BL21 cells as 
described (Kulshreshtha and Tikoo, 2008). Glutathione S-transferase (GST), GST-pVIII and  
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Table 5.2.1 List of primers 
Primer name Primer Sequence 
VIII-F 
VIII-R 
DDX3-F 
DDX3-R 
3HA-F 
3HA-R 
hp-VIII-F 
hpVIII-R 
PpVIII-F 
PpVIII-R 
Fir-F 
Fir-R 
5’-CATATGAGCAAAGAAATTCCCACAC 
5’-GAATTCCGCTATAACCGCTCACAG 
5’-GCGAATTCATGAGTCATGTGGCGGTGG 
5’-GCGGATCCACGTTACCCCAGTCAAC 
5’-ATAAAGCTTCGCCACCATGGATTACCCATACGATGTTCCTGAC 
5’-CTAGAATTCGCCCGGGCCAGCGTAATCTGGAACGTCATATGG 
5’-GCGGATCCATGAGCAAGGAAATTCCCACGCCCTAC 
5’-ATCTCGAGTCATCAGTCGTAGCCGTCCGCCGAGTC 
5’-GCGGATCCATGAGCAAACAAATCCCCAC 
5’-CGAATTCTCAGTCATAGCCTGCTACAGAGTCCG 
5’- CGTGCCAGAGTCTTTCGACA   
5’- ACAGGCGGTGCGATGAG 
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GST-DDX3 fusion proteins were purified using Glutathione sepharose beads (GE Health care) as 
per the instructions of the manufacturers. The purified proteins were dialyzed using Slide-A-
Lyzer dialysis cassette (Thermo Scientific). The concentrations of the proteins were measured by 
Bradford assay (Bio Rad) using Ultrospec® 3000 spectrophotometer (Pharmacia Biotech). 
 
5.2.6. In-vitro transcription, translation and Co-immunoprecipitation assay 
Individual plasmid DNAs (0.8µg) were used to synthesize [
35
S] (Perkin Elmer) labeled 
human adenovirus (HAdV)-5 pVIII (pC.pVIIIhav) and porcine adenovirus (PAdV)-3 pVIII 
(pC.pVIIIpav) proteins or unlabeled DDX3 (pcHA.DX3) in-vitro by utilizing a TNT T7 Coupled 
Reticulocyte Lysate System (Promega). Equal amounts of proteins (unlabeled DDX3 and labeled 
HAdV-5 pVIII or unlabeled DDX3 and labeled PAdV-3 pVIII) were mixed together and 
incubated for 4-6hrs at 4
o
C. The individual mixture was immunoprecipitated either with anti-
DDX3 serum or rabbit pre-immune sera coupled to protein A sepharose beads. The bound 
proteins were separated by 10% sodium dodecyl  sulfate (SDS)-polyacrylamide gel 
electrophoresis (PAGE), fixed in de-stain solution (200ml methanol, 100ml glacial acetic acid 
and 700ml ddH20) for 30min and dried.  Subsequently, the gel was exposed to a phosphor screen 
(Kodak) and visualized on a Molecular Imager FX using Quantity One software (Bio-Rad). 
 
5.2.7. In-vitro binding assay 
pHA.DX3 (0.8µg) was used to synthesize radio-labeled DDX3 protein in-vitro by 
utilizing a TNT T7 Coupled Reticulocyte Lysate System (Promega) in the presence of 30Ci of 
[
35
S]-methionine (Perkin Elmer). Prior to use, glutathione sepharose (GST) beads were washed 
three times with GST binding buffer (0.54M NaCl, 2.7mM KCl, 10.15mM Na2HPO4, 1.75mM 
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KH2PO4, 0.01M MgCl2, 1µg/ml each Aprotinin and Leupeptin, 1% Triton X-100, 1mM PMSF 
and DNAse I). Purified  GST, GST-pVIII or GST-DDX3 fusion protein (15μg each) was 
incubated individually with 20µl of glutathione sepharose beads (GE Health Care) plus 10µl of 
in-vitro synthesized indicated proteins at +4
o
C on a nutator. After overnight incubation, the 
beads were washed three times, 10min each with 0.1M PBS. The bound proteins were analyzed 
as described above. 
 
5.2.8. Immunoprecipitation and Western blot 
MDBK cells were infected with BAdV-3 at an MOI of 5. Vero cells (6 x 10
5
/well) in 1 
well of 6 well plate were co-transfected with 2g of each plasmid (pHA.DX3 and pEY.pVIII or 
pHA.DX3 and pEYFPN1) DNA. At 36hrs post infection or 48hrs post transfection, the cells 
were lysed, immunoprecipitated with indicated protein specific antibodies, separated by 10% 
SDS-PAGE, transferred to PVDF membrane and probed by Western blot using indicated protein 
specific antibodies as described (Poulin et al., 1998).  
 
5.2.9. Confocal microscopy 
Monolayers (60-70% confluent) of Vero cells (5x10
4
/well) in two well chamber slides 
were incubated with Opti-MEM I reduced serum media (Gibco). After 2hrs of incubation, the 
cells were transfected with indicated plasmid DNA(s) (1-2g/plasmid DNA/well) using 
Lipofectamine 2000 (Invitrogen). After 36hrs post transfection, the cells were fixed with 3.7% 
paraformaldehyde, permeabilized with 0.05% Triton X-100 and blocked with 2% goat serum. 
Subsequently, the cells were incubated with protein specific antibody in 0.1M PBS for 1hr at 
room temperature, followed by specific secondary antibody for 1hr. Finally, the slides were 
101 
 
mounted with mounting medium containing DAPI (Vectashield) and visualized under Zeiss 
LSM 5 laser scanning confocal microscope.  
Monolayers (90% confluent) of MDBK cells (1x10
5
cells/well) grown on two well 
chamber slides were mock infected or infected with wild type BAdV-3 at an MOI of 5. At 24hrs 
post infection, the cells were fixed with 3.7% paraformaldehyde, immunostained and visualized 
as described above. 
 
5.2.10. In-vitro synthesis and translation of capped and uncapped mRNA 
 Firefly luciferase mRNAs were synthesized in-vitro in the absence (IRES) or presence 
(capped) of 40mM Ribo m7GpppG cap analogue (Promega) using T7-RiboMax RNA production 
system. 10μl of prewashed GST-beads were loaded with different concentrations of (50, 100, 
250, 350, 550, 750ngs) of either GST-pVIII or GST proteins and incubated for 2hrs at +4
o
c with 
15µl of rabbit reticulolcyte lysate. Subsequently, the mixtures were centrifuged and the 
supernatants were used for the translation of the synthesized capped and uncapped mRNAs. 
Finally, luciferase assay (Promega) was performed in a luminometer as per the company’s 
procedure. 
 
5.2.11. Dual luciferase assay 
 To examine the effect of pVIII on the translation of IRES (Polio virus IRES) or Cap 
dependent translation in 293T cells, a bicistronic luciferase assay was performed using a plasmid 
DNA expressing a single transcriptional unit in which translation of renilla luciferase is cap-
dependent while translation of firefly luciferase is cap-independent (IRES dependent). The cells 
grown in six well plates were co transfected with 2µg/well of a bicistronic reporter plasmid 
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pcDNA3-RLuc-POLIRES-FLuc and 4µg/well of either plasmid pEY.pVIII DNA or plasmid 
pEYFP N1 DNA. At 48hrs post transfection, Firefly luciferase (FLuc) and Renilla reniformis 
luciferase (RLuc) activities were measured in a luminometer by using a dual luciferase assay kit 
(Promega) as per the company’s procedure. Expression of EYFP was used to normalize the 
transfection efficiency. 
 
5.2.12. Cellular protein synthesis assay  
The monolayers of MDBK cells in 6 well plates were mock infected or infected with 
BAdV-3 at a MOI of 5 or monolayers of Vero cells grown in 6 well plates were transfected with 
indicated concentrations of plasmid pEY.pVIII or pEYFPN1. At different times post 
transfection, the cells were starved in media without methionine for 2hrs before labeling with 
100 Ci of [35S] methionine for 10min. The radiolabelled cells were collected and lysed with 
RIPA buffer containing protease inhibitor cocktail. Proteins from radiolabelled cell lysates were 
separated by 10% SDS-PAGE. The gel was fixed, exposed to a phosphor screen (Kodak) 
overnight and visualized on a Molecular Imager FX using Quantity One software (Bio-Rad). 
 
5.2.13. Analysis of DDX3 and eIFs in-vitro 
To determine whether the reduction in the level of the translation of capped luciferase 
mRNA in the presence of pVIII is due to the reduction in the level of eIFs, initially 10l of Flexi 
rabbit reticulo Lysate was incubated with 10l of GST bead preloaded with 750ng of either GST 
or GST-pVIII fusion protein at +4
o
C and centrifuged for 10min. Finally, the supernatant and 
pellet were collected and analyzed by Western blot using anti-DDX3 or anti -eIF specific 
antibodies, followed by Alexa Flour 680 goat anti rabbit IgG (Molecular Probes) or IRDye 800 
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conjugated goat-anti-mouse IgG (Li-COR biosciences) as secondary antibody. The membranes 
were scanned using Odyssey LiCOR infrared scanning system and the intensity of the bands 
measured by Odyssey Software v2.1. Similarly, 50μl of the cytoplasmic fraction of cells were 
incubated with 10μl of GST beads (loaded with 750ng of either GST or GST-pVIII fusion 
protein) at +4
o
C and centrifuged for 10min. Finally, the samples were analyzed by Western blot 
as described above. 
 
5.2.14. 7 -Methyl Guanosine Cap binding assay 
MDBK, VIDO R2 or DDX3 negative (DDXshRNA knockdown) VIDO R2 cells grown 
on 6 well plates were infected with 5 MOI of BAdV-3. 293T cells grown on 6 well plates were 
transfected either with 2µg/well of plasmid pEYFPN1 or pEY.pVIII DNAs. At 36hrs post 
infection or transfection, the cells were lysed with RIPA buffer containing protease inhibitor 
cocktail and centrifuged at 10,000rpm. The supernatants were incubated with 50µl of 7-methyl 
GTP sepharose beads (GE Healthcare) on a nutator overnight at +4
o
c.  The beads were then 
washed three times five minutes each and boiled with protein loading dye with 10% beta 
mercaptoethanol. Proteins were separated by 10%SDS-PAGE gel, transferred to nitrocellulose 
and probed in Western blot using anti- DDX3 or anti-eIF specific antibody followed by Alexa 
Flour 680 goat anti rabbit IgG (Molecular Probes)  or IRDye 800 conjugated goat anti-mouse 
IgG (Li-COR biosciences) as secondary antibody. The expression of pVIII in BAdV-3 infected 
cells or EY.pVIII in transfected cells was checked by Western blot using anti-pVIII serum. 
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5.2.15.  Electrophoretic mobility shift assay (EMSA) 
Confluent MDBK cells grown in 6 well plates were starved with media without 
phosphate for 1hr before radiolabelling with 30µciof [
32
P] UTP (Perkin Elmer, Cat # 
BLU007H250UC, 3000Ci/mml). After labeling for 1 hr, the cytoplasmic RNA was extracted 
using SurePrep
TM
 nuclear or cytoplasmic RNA purification kit (Fisher Bioreagents). Finally, 
poly A
+
 RNA was purified using Oligotex
®
 mRNA mini kit (Qiagen). The purity of the RNA 
was further checked by digestion with either RNase or DNase enzymes followed by gel 
electrophoresis. Subsequently, RNA EMSA was carried out using a modified protocol by 
Yakhnin et al, 2012. Radiolabeled (10,000 cpm) RNA probe of oligo dt purified polyA RNA was 
incubated with 500ng of GST alone, or GST fusion proteins  GST.pVIII or GST.100K (BAdV-3 
100K) plus 10µg yeast tRNA (Ambion) at room temperature. After incubation for 30 mins, the 
reaction mixture was separated by 4% acrylamide native gel for 4-6 hr at 150 V before the gel 
was dried, exposed onto a phosphor screen (Kodak) and scanned on a Molecular Imager FX 
using Quantity One software (Bio-Rad). 
 
5.2.16. Real time PCR 
 MDBK cells were mock infected or infected with wild type BAdV-3 at an MOI of 5. The 
cells were collected at different times post infection and cytoplasmic RNA was extracted using 
SurePrep
TM
 nuclear or cytoplasmic RNA purification kit. cDNA was synthesized using 
Superscript II (Invitrogen) followed by real time PCR using SYBR green and primers targeting 
different species of bovine housekeeping genes (Lisowski et al., 2008). pcDNA3-RLuc-
POLIRES-FLuc and pEY.pVIII or EYFP NI plasmid transfected 293T cells were collected at 
36hrs post transfection and RNA was extracted using SurePrep
TM
 nuclear or cytoplasmic RNA 
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purification kit. cDNA was synthesized using Superscript II (Invitrogen) followed by real time 
PCR using SYBR green and primers targeting RLuc-POLIRES-FLuc mRNA using primers Fir-F 
and Fir-R (Table 5.2.1) 
 
5.3. RESULTS 
5.3.1. Interaction of BAdV-3 pVIII with cellular proteins 
Initially, proteomic analysis of the nucleoli of BAdV-3 infected and uninfected MDBK 
cells identified a number of nucleolar proteins, which were hypothesized to be involved in 
BAdV-3 infection (Patel and Tikoo, unpublished data). Since one of these proteins was DDX3 
we hypothesized it to be important for BAdV-3 replication. We initially determined if DDX3 
interacted with any BAdV-3 protein using matchmaker GAL4 Yeast two hybrid assays. Our 
results indicated that BAdV-3 pVIII interacted with DDX3 (Figure 5.3.1). The interactions were 
confirmed by GST-pull down assays (Figure 5.3.2A) and co immunoprecipitation assays using 
transfected cells (Figure 5.3.2B, C). Moreover, confocal microscopy also suggested that pVIII 
co-localized with DDX3 around the perinuclear region and in the cytoplasm of transfected cells 
(Figure 5.3.3 panel h1-h4) or BAdV-3 infected cells (Figure 5.3.3 panel g1-g4). However, DDX3 
localized diffusely in the cytoplasm in uninfected MDBK or untransfected Vero cells (Figure 
5.3.3 panels a & b). Plasmid DNA expressed DDX3 also localized diffusely in the cytoplasm 
(Figure 5.3.3 Panel c). Additionally, pVIII is localized both in the cytoplasm and in the nucleus 
in BAdV-3 infected (Figure 5.3.3 panel e) or pEY-VIII transfected (Figure 5.3.3 panel f) cells. 
No pVIII was detected in uninfected MDBK cells (Figure 5.3.3 panel d).  
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Finally, using co-immunoprecipitation coupled with Western blot analysis, we 
determined the interaction of DDX3 with pVIII in BAdV-3 infected MDBK cells.  As seen in 
Figure 5.3.2, DDX3 specific protein could be detected in the lysates of BAdV-3 infected MDBK  
 
 
 
Figure 5.3.1. Yeast two hybrid analysis. The AH109 yeast cells were co-transfected with 
plasmid (pGB.pVIII and pGA.DX3; pGB.pVIII and pGADT7; pGB.pDX3 and pGA.pVIII or 
pGB.DX3 and pGADT7) DNAs and streaked on a selective medium containing X--gal but 
lacking Leu, Trp, His and Ade.  
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Figure 5.3.2 Interaction of DDX3 with BAdV-3 pVIII. (A) GST pull down assay.  Purified 
GST or GST-pVIII fusion protein immobilized on Glutathione-Sepharose 4B beads, incubated 
with in-vitro translated [
35
S] methionine labeled HA tagged DDX3 were separated by 10% SDS-
PAGE and detected by autoradiography. (B &C) Co-immunoprecipitation in transfected cells. 
Proteins from the lysates of cells co-transfected with either pHA.DX3 and pEY.pVIII or 
pHA.DX3 and pEYFPN1 were immunoprecipitated with anti-pVIII serum (B) or anti-HA (C), 
separated by 10% SDS-PAGE and transferred to nitrocellulose membrane. The separated 
proteins were probed in Western blot using anti-HA MAb (B) or anti-pVIII serum (C). (D)  Co-
immunoprecipitation in BAdV-3 infected cells. Proteins from the lysates of mock or BAdV-3 
infected MDBK cells were immunoprecipitated with anti-pVIII serum, separated by 10% SDS-
PAGE, transferred to nitrocellulose membrane and probed in Western blot using anti-DDX3 
MAb. Immunoprecipitation (IP). Western blot (WB). 
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Figure 5.3.3 Confocal microscopy. MDBK cells mock infected (panel a, d) or infected with 
BAdV-3 (panels e, g) VERO cells untransfected (panel b) or transfected with indicated plasmid 
(panels c, f, h) DNA, were fixed 36hrs post-infection/transfection. The subcellular localization of 
DDX3 (panels a,b,c,g2,h2) protein was visualized by indirect immunofluorescence (panels 
a,b,c,g2,h2) using anti-DDX3 MAb and fluorescein conjugated goat anti mouse IgG-FITC 
(panels a, g2), anti-DDX3 MAb and Cy3 conjugated goat anti -mouse (pane b) secondary 
antibody,   anti-HA MAb and Cy3 conjugated goat anti -mouse (pane b) secondary antibody  
(panel c,h2). The subcellular localization of pVIII (panels d,e,f,g1,h1) was visualized by direct 
fluorescence (panels f,h1) or indirect immunfluorescene using anti-pVIII serum and Cy3 
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conjugated goat anti -rabbit secondary antibody  (panels d,e,g1). Nuclei were stained with DAPI 
in each panel. A merge of the images is shown. Enlarged panel g4 and h4 is shown with arrows. 
cells immunoprecipitated with anti- pVIII serum and probed in Western blot with anti-DDX3 
MAb (panel D).  
 
5.3.2. Interaction of DDX3 with pVIII of HAdV-5 and PAdV-3 
To verify if interaction of DDX3 with pVIII is conserved among members of 
Mastadenovirus genus, purified GST or GST-DDX3 (Figure 5.3.4A) fusion protein bound to 
Sepharose beads was individually incubated with in-vitro transcribed and translated radio-labeled 
[
35
S] HAdV-5 pVIII or PAdV-3 pVIII. After washing, the bound proteins were separated on 10% 
SDS-PAGE and visualized by autoradiography. As seen in Figure 5.3.4B, radiolabelled HAdV-5 
pVIII or PAdV-3 pVIII protein interacted with GST-DDX3 fusion protein but not with GST 
protein alone. 
Next, we performed co-immunoprecipitation assay to corroborate the results of GST pull 
down assay. The in-vitro translated unlabeled DDX3 was incubated with in-vitro translated 
radiolabeled HAdV-5 pVIII or PAdV-3 pVIII for 4-6 hr at 4
o
C before immunoprecipitating with 
antibodies against DDX3. The co-immunoprecipitated radiolabeled proteins were separated on 
10% SDS-PAGE and visualized by autoradiography. As seen in Figure 5.3.4C, radiolabeled 
HAdV-5 pVIII or PAdV-3 pVIII co-immunoprecipitated with unlabeled DDX3 using anti-DDX3 
serum. 
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5.3.3. BAdV-3 pVIII affects cellular protein synthesis 
To determine if BAdV-3 infection inhibits the synthesis of cellular proteins at late times post 
infection, mock or BAdV-3 infected MDBK cells were pulsed for short duration with [
35
S] 
methionine at different times post infection. Proteins from the lysates of the labeled cells were 
 
 
Fig. 5.3.4 Interaction of DDX3 with PAdV-3 & HAdV-5 pVIII. (A) Coomassie blue staining 
of GST.DDX3 protein.  (B) GST-pull down assay.  Purified GST or GST-DDX3 fusion protein 
immobilized on Glutathione-Sepharose 4B beads, incubated individually with in-vitro translated 
[
35
S] methionine labeled PAdV-3 pVIII or HAdV-5 pVIII, separated by 10% SDS-PAGE and 
detected by autoradiography. (C) Co-immunoprecipitation. Radio labeled in-vitro transcribed 
and translated HAdV5 pVIII or PAdV-3 pVIII was incubated with in-vitro transcribed and 
translated unlabelled DDX3 protein. Proteins were immunoprecipitated with either anti-DDX3 
serum or rabbit pre immune sera, separated by 10% SDS-PAGE and autoradiographed. 
Immunoprecipiation (IP). 
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separated by 10% SDS-PAGE and analyzed by autoradiography. As seen in Figure 5.3.5A, 
compared to mock infected MDBK cells, reduction in cellular protein synthesis is apparent in 
BAdV-3 infected cells at 18hrs post infection, which coincides with the detection of expression 
of pVIII (a late protein) in BAdV-3 infected cells. By 36hrs to 48hrs post infection, there is 
significant decrease in cellular protein synthesis, which coincides with steady expression of 
pVIII protein (Figure 5.3.5A).  
To determine if expression of pVIII alters the cellular protein synthesis, Vero cells were 
transfected with indicated plasmid DNA, labeled with [
35
S] methionine, and analyzed by SDS-
PAGE. As seen in Figure 5.3.5B, there was noticeable reduction in the synthesis of cellular 
protein in cells transfected with plasmid pEY.pVIII DNA than in cells transfected with plasmid 
pEYFPN1 DNA at 24hrs to 48hrs post transfection. Moreover, the reduction in cellular protein 
synthesis appeared to depend on the amount of plasmid DNA used for transfection (Figure 
5.3.5C). 
 
5.3.4. BAdV-3 pVIII affects translation of capped mRNAs 
To determine the effect of pVIII on mRNA translation, mRNAs were synthesized in-vitro 
in the absence (IRES) or presence (capped) of 40mM Ribo m7GpppG cap analogue (Promega) 
using T7-RiboMAX RNA production system. The synthesized mRNAs (Figure 5.3.6A) were 
translated in the presence of purified GST or fusion protein GST.pVIII. As seen in Figure 
5.3.6A, GST-pVIII protein significantly inhibited the in-vitro translation of capped but not of 
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uncapped luciferase mRNA. No such effect could be observed in the presence of GST on the 
translation of capped or uncapped luciferase mRNAs.  
 
 
Figure 5.3.5 Protein synthesis in BAdV-3 infected cells. (A) Monolayers of MDBK cells were 
mock infected or infected with BAdV-3 at a MOI of 5.  (B &C) Monolayers of VERO cells were 
transfected with indicated amounts of plasmid DNAs.  At indicated times post infection (A) or 
transfection (B, C), the cells were pulse labeled with [
35
S] methionine for 10mins. The 
radiolabelled proteins were separated by 10% SDS-PAGE and analysed by autoradiography. 
Proteins from the lysates of radiolabeled cells (A, B or C) were subjected to SDS-PAGE and 
Western blot using anti-pVIII serum, or anti β-actin MAb.  
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Figure 5.3.6 Effect of pVIII on capped mRNA translation. (A). In-vitro.  The TNT® T7 
luciferase DNA (Promega) (i) was transcribed in-vitro in the absence (IRES) or presence 
(capped) of 40mM Ribo m7GpppG cap analogue (Promega) using RiboMAX RNA production 
system-T7 (Promega). The in-vitro synthesized capped and uncapped luciferase mRNAs  (ii) 
were translated in the supernatant collected after centrifugation of mixture of Flexi Rabbit 
Reticulo Lysate (Promega) incubated with Glutathione sepharose beads preloaded with GST-
VIII or GST protein alone. The level of luciferase activity was measured using a luciferase kit 
(Promega) on a Luminometer (Turner Designs Inc). The results are shown as relative luciferase 
activity (iii) (B) In-vivo. 293T cells were transfected with plasmid DNAs (2μg of pcDNA3-
RLuc-POLIRES-FLuc (i) and either 4μg of pEY.pVIII or 4μg of pEYFPN1). At 36hrs post 
transfection, Firefly luciferase (FLuc) and Renilla reniformis luciferase (RLuc) activities were 
measured in a luminometer by using a dual luciferase assay kit (Promega) as per the company’s 
procedure. Expression of EYFP was used to normalize the transfection efficiency. The results are 
shown as luciferase activity (iii). The level of cytoplasmic RLuc-POLIRES-FLuc mRNA both in 
EY.pVIII and EYFP expressing plasmid transfected cells was quantified by RT-PCR (ii).  
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To examine the effect of BAdV-3 pVIII on the translation of capped and uncapped mRNA 
translation in-vivo, a bicistronic luciferase assay was performed. The 293T cells were co-
transfected with plasmid pcDNA3-RLuc-POLIRES-FLuc (producing a single transcriptional unit 
in which the translation of renilla luciferase is cap-dependent while translation of firefly is cap 
independent [IRES dependent]) DNA and either plasmid pEY-pVIII or plasmid pEYFPN1 DNA 
using a dual luciferase assay kit (Promega) as per the company’s procedure. As shown in 
Figigure 5.3.6B, in the presence of EY-pVIII, the cap dependent translation of renilla luciferase 
mRNA (capped) was significantly reduced compared to IRES dependent translation of firefly 
luciferase mRNA (capped) in 293T cells. In contrast, there was no significant difference in the 
translation of renilla luciferase (cap-dependent) mRNA or firefly luciferase (IRES dependent) in 
293T cells in the presence of EYFP protein (Figure 5.3.6B). Moreover, cytoplasmic RLuc-
POLIRES-FLuc mRNA levels appeared similar in EY.pVIII or EYFP expressing plasmid 
transfected 293T cells (Figure 5.3.6B). 
 
5.3.5. pVIII reduces the level of DDX3 and translation initiation factors (eIFs) 
from cap binding complex 
To determine if the interaction of pVIII and DDX3 also affects the level of eIFs, the 
pellet and supernatant fractions of the rabbit reticulocyte lysate incubated with glutathione 
sepharose beads preloaded with purified GST-pVIII or GST were analyzed by Western blot 
using protein specific antibodies. As seen in Figure 5.3.7A, addition of GST-pVIII in reticulo 
lysate reduced the amount of DDX3, eIF3β, eIF4G and PABP in supernatant fraction relative to 
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the amount of DDX3, eIF3, eIF4G or PABP in supernatant fraction when purified GST alone 
was added to reticulo Lysate (Figure 5.3.7A). Similarly, addition of GST-pVIII in cytoplasmic  
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Figure 5.3.7. The effect of pVIII on levels of eIFs. The cytoplasmic fraction of MDBK cells 
(50µl) or Flexi Rabbit Reticulo -Lysate (10µl)  were incubated with either 10µl of GST beads 
loaded with 750ng of purified GST-VIII protein or 10µl of GST beads loaded with 750ng of 
purified GST protein for 2hrs at +4
o
C and centrifuged for 10min. The supernatant and the pellet 
from both reticulo lysate (A,C) or cytoplasmic fraction (B,D) were separated by 10% SDS-
PAGE gel and analyzed by Western blot using indicated protein specific antibodies and Alexa 
Flour 680 goat anti-rabbit IgG antibody or IRDye 800 conjugated goat anti-mouse IgG as 
secondary antibody. The intensity of the bands was analyzed by Odyssey Software v2.1. Error 
bars (C, D) indicate S.E of means for three separate experiments. Total amount of indicated 
protein in cytoplasmic fraction of MDBK cells (panel D) or reticulo-lysate (panel C) was 
estimated by Western blot analysis of parallel sample before adding GST or GST.pVIII fusion 
protein. The amount of each protein retained in the beads (pellet) relative to the total amount is 
plotted. Supernatant (S); Pellet (P). 
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fraction of MDBK cells reduced the amount of DDX3, eIF3β, eIF4G and PABP in supernatant 
fraction (Figure 5.3.7B) compared to the amount of DDX3, eIF3β, eIF4G and PABP in 
supernatant fraction when purified GST alone was added to cytoplasmic fraction of MDBK cells 
(Figure 5.3.7B). The amount of each protein retained in the beads (pellet) relative to the total 
amount is plotted (Figure 5.3.7C & D). 
 
5.3.6. BAdV-3 infection or pVIII expression reduces the level of DDX3 and 
translation eIFs in-vivo 
To determine the effect of BAdV-3 on the constituents of cap binding complex, the 
cleared cell lysates from mock infected or BAdV-3 infected MDBK cells collected at 36hrs post 
infection were incubated individually with 7-methyl GTP-Sepharose beads (GE Healthcare). The 
captured components of cap-binding complex were identified by Western blot using protein 
specific antibodies. As seen in Figure 5.3.8, no significant difference could be observed in the 
level of eIF4G in mock or BAdV-3 infected cells. However, significant decrease in the levels of 
DDX3, eIF3, eIF4E and PABP proteins was observed in BAdV-3 infected cells compared to 
mock infected cells. However, pVIII was not retained in the 7-methyl GTP resins. Moreover, 
anti-pVIII serum detected the expression of pVIII in BAdV-3 infected cells.  
On the other hand, to determine if interaction of BAdV-3 pVIII with DDX3 affects the 
constituents of cap binding complex, the cleared lysates from pVIII expressing plasmid 
transfected cells collected at 36hrs post transfection were incubated separately with 7-methyl 
GTP-Sepharose beads. The captured components of cap-binding complex were identified by 
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Western blot using protein specific antibodies. As seen in Figure 5.3.8, no significant difference 
could be observed in the level of eIF4G in cells transfected with plasmid pEY.pVIII or plasmid  
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Figure 5.3.8 m7GTP-sepharose binding assay.  The supernatant of the lysates of the 
cells collected at 36 hrs post BAdV-3 infection of MDBK cells (mock or BAdV-3) or 
transfection of 293T cells with plasmid DNAs (pEY.pVIII or pEYFPN1 DNA) were incubated 
with m7GTP sepharose cap affinity beads. After washing, the bound proteins were analyzed by 
Western blot using indicated protein specific antibodies and IRDye 800 conjugated goat anti-
mouse IgG or Alexa Flour 680 goat anti-rabbit IgG as secondary antibody. The intensity of the 
bands of the Western blot in all cases was analyzed by Odyssey Software v2.1. The relative 
amount of proteins in BAdV-3 infected or pEY.VIII transfected cell lysates that are retained in 
the 7-methyl GTP resins as compared to mock infected or pEYFPN1 transfected cells, 
respectively (i.e. considering the amount of protein in mock infected or pEYFPN1 transfected 
cell lysates that are retained in the 7-methyl GTP resins as 100%) is plotted. Error bars indicate 
S.E of means for three separate experiments. Proteins from the lysates of BAdV-3 infected or 
transfected cells were separated by 10% SDS-PAGE and probed in Western blot using anti-pVIII 
serum. 
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pEYFP.NI DNA. However, there was significant decrease in the levels of DDX3, eIF3, eIF4E 
and PABP proteins in cells transfected with plasmid pEY.pVIII DNA than the cells transfected 
with plasmid pEYFP.N1 DNA. Interestingly, pVIII was not retained in the 7-methyl GTP resins. 
The expression of EY.pVIII fusion protein in transfected cells or pVIII in infected cells was 
detected using anti pVIII serum.  
 
5.3.7. pVIII does not interact directly with eIFs 
To determine if pVIII interacts directly with eIFs, the cytoplasmic fractions of VIDO R2 
cells (Reddy et al., 1999) and DDX3 knocked down VIDO R2 cells (Section 7) were collected, 
incubated with purified GST or GST-VIII, centrifuged to collect supernatant and pellet fractions 
and analyzed by Western blot. As seen in Figure 5.3.9A, addition of GST-pVIII reduced the 
amount of DDX3, eIF3β, eIF4G and PABP in supernatant of DDX3 positive VIDO R2 cells. No 
such decrease was observed in the amount of DDX3, eIF3β, eIF4G and PABP in supernatant 
fraction when purified GST-VIII was added to cytoplasmic fraction of DDX3 knocked down 
VIDO R2 cells. 
To determine if BAdV-3 infection degrades eIFs, VIDO R2 cells were mock infected or 
infected with BAdV-3. At 36hrs post infection, the proteins from cell lysates were analysed by 
10% SDS-PAGE using protein specific antibodies. β-actin was used as a loading control. As 
seen in Figure 5.3.9B, significant level of PABP, eIF3β, eIF4G, DDX3 and eIF4E could be 
detected in BAdV-3 infected cells. 
 
5.3.8. Interaction of pVIII with PolyA containing mRNA 
To assess the possibility of the interaction of pVIII with RNA, 
32
P (UTP) labeled Poly A  
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Figure 5.3.9 Interaction of pVIII with eIFs.  (A) The cytoplasmic fraction (50µl) of DDX3 
positive or negative VIDO R2 cells were incubated with 10µl of beads loaded with 750ng of 
purified GST-VIII protein for 2hrs at 4
o
C and centrifuged for 10min. The supernatant and the 
pellet from both cytoplasmic fraction were separated by 10% SDS-PAGE gel and analyzed by 
Western blot using indicated protein specific antibodies and IRDye 800 conjugated goat anti-
mouse IgG or  Alexa Flour 680 goat anti rabbit IgG as secondary antibody. Total amount of 
indicated protein in cytoplasmic fraction of indicated cells was estimated by Western blot 
analysis before adding GST.pVIII fusion protein. (B). Proteins from the lysates of mock infected 
or BAdV-3 infected MDBK cells collected at 36hrs post infection were separated by 10% SDS-
PAGE and analysed by Western blot using protein specific antibody and anti-rabbit IRDye 800 
conjugated goat anti-mouse IgG (Li-COR biosciences) or Alexa Flour 680 goat anti-rabbit IgG 
as secondary antibody. β-actin was used as a loading control.  
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containing mRNA was purified from the cytoplasmic fraction of MDBK cells and RNA 
electrophoretic mobility shift assay was performed using purified GST alone or  fusion proteins  
GST.pVIII, GST.100K. As seen in Figure 5.3.10, GST.pVIII did not interact with the cellular 
poly A RNA. As expected (Cuesta and Schneider, 2004) GST.100K interacts with cellular polyA 
mRNA. Similarly, no interaction was observed between the cellular polyA RNA and GST. 
 
5.3.9. Cytoplasmic mRNA levels of selected bovine genes in BAdV-3 infected 
cells 
 To examine whether cytoplasmic mRNA levels are affected or their stability 
compromised, cDNAs were synthesized from cytoplasmic mRNAs purified from mock infected 
cells or BAdV-3 infected cells collected at different time points post infection. Real time PCR 
was performed using primers targeting different species of bovine housekeeping genes (Lisowski 
et al., 2008). The results indicate that (Figure 5.3.11) as compared to mock infected cells, the 
level of cytoplasmic mRNAs is not altered in BAdV-3 infected cells even at 48hrs post infection 
Moreover, the integrity of cellular mRNAs appears intact during BAdV-3 virus infection. The 
detection of expression of DNA binding protein in BAdV-3 infected cell lysates by Western blot 
using anti-DBP serum (Zhou et al., 2001) to confirm virus infection. 
 
5.4. DISCUSSION 
DDX3 is a member of the ATPase super family II of RNA helicases (Silverma et al., 2003) and 
is involved in RNA metabolism (Schroder, 2011). Targeting of DDX3 by a viral protein has also 
established its role in TBK1/IKKε mediated IRF activation and INFβ promoter induction 
(Schroder et al., 2008). So far, proteins encoded by few viruses have been shown to maneuver  
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Figure 5.3.10 Electrophoretic mobility shift assay. (A) Oligo dT column purified cellular 
polyA RNA undigested (UN) or digested with either DNase or RNAse enzymes was analyzed by 
agarose gel electrophoresis. (B) [
32
P] (UTP) Labeled (10000 cpm) polyA containing cellular 
RNA purified from the cytoplasmic fractions of MDBK cells was incubated either with 500ng of 
GST alone , BAdV-3 pVIII fused to GST (GST.pVIII) or BAdV-3 100K fused to GST 
(GST.100K) fusion protein for 30min, separated by 4% acrylamide native gel and detected by 
autoradiography.  
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Figure 5.3.11 RT-PCR. MDBK cells were infected with 5 MOI of BAdV-3. At indicated times 
post infection cytoplasmic RNA was purified and cDNA synthesized and RT-PCR performed 
using specific primers targeting the indicated bovine housekeeping genes as described in the 
materials and methods. Western blot was performed using anti-BAdV-3 DBP (DNA binding 
protein) to confirm productive infection. Error bars indicate S.E of means for three separate 
experiments. 
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and alter the normal function of DDX3 in cells (Schroder, 2011). Vaccinia virus K7 protein 
inhibits interferon production by interacting with DDX3, which is involved in the activation of 
interferon regulatory factor (IRF) by directly binding with TBK1 and IKKє (Schroder et al., 
2008). The core protein of the hepatitis C virus abrogates interferon production by associating 
with DDX3 (Breiman et al., 2005). Similarly, the hepatitis B virus polymerase inhibits IRF 
signaling via its interaction with DDX3 (Wang and Ryu, 2010; Yu et al., 2010). Besides, Rev 
protein of HIV exports intron containing viral transcripts from the nucleus into the cytoplasm by 
binding with DDX3 through the CRM1 dependent export pathway (Yedavalli et al., 2004). 
The exact role of DDX3 in cap dependent translation is not clear. While some reports 
indicate that DDX3 acts as a general translation initiation factor (Lee et al., 2008; Geissler et al., 
2012), another report indicate that DDX3 promotes the translation of a subset of selected 
mRNAs with structured mRNAs at their 5’ end (Soto-Rifo et al., 2012). In addition, Ded1 (the 
yeast homologue of DDX3) have been shown to promote general translation initiation by 
enhancing the formation and resolution of an eIF4F-mRNA complex (Hilliker et al., 2011) 
However, Shih et al., 2008 reported DDX3 as a translation repressor. Here, we provide evidence 
for the role of DDX3 in cap dependent mRNA translation and report that interaction of DDX3 
with BAdV-3 pVIII alters the translation of cellular mRNAs by depleting eukaryotic initiation 
factors from the cap binding complex. This may selectively allow translation of BAdV-3 specific 
mRNAs at late times post infection leading to efficient replication of BAdV-3. 
Like human adenovirus-5 (Huang and Schneider, 1991; Yueh and Schneider, 1996), global 
cellular protein synthesis was inhibited at late times post BAdV-3 infection, which appears to be 
linked with the activity of adenovirus late protein(s). Since DDX3 acts to promote cap dependent 
translation initiation (Geissler et al., 2012; Soto-Rifo et al., 2012), the interaction of DDX3 with 
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pVIII may interfere with translation of cap dependent mRNAs. Several observations support this 
speculation. First, the inhibition of cellular protein synthesis observed at late times post infection 
correlates with the expression of pVIII in BAdV-3 infected cells. Secondly, expression of pVIII 
in transfected cells alters cellular protein synthesis in dose and time dependent manner. Thirdly, 
in-vitro translation of only capped luciferase mRNAs is inhibited in the presence of purified 
GST-VIII, but not in the presence of GST alone. Fourthly, pVIII does not alter the mRNA 
stability or transport to the cytoplasm. Finally, translation of only capped renilla luciferase 
mRNA is inhibited in transfected cells expressing EY.pVIII but not in transfected cells 
expressing EYFP.  
Translation of eukaryotic mRNAs involves the binding of mRNA cap (5’m7GpppN) 
structure to cap binding protein complex (eIF-4F), which include eIF4E, eIF4A and eIF4G 
(Jackson et al., 2010) proteins. However, alterations in one or more eIFs may impair the cap 
dependent translation of cellular mRNAs (Hinnebusch and Lorsch, 2012; Jivotovskaya et al., 
2006). A number of viruses inhibit host protein synthesis (Bushell and Sarnow, 2002; Schneider 
and Mohr, 2003) by modifying the activity of eukaryotic initiation factors, which are required for 
bringing ribosomes to capped mRNAs (Feigenblum and Schneider, 1993), by sequestration of 
PABP (Ilkow et al., 2008), cleaving eIF4G and/or dephosphorylation of 4E-BP1 (You et al., 
1999), or decreasing the activity of eIF4E (Burgui et al., 2007; Connor and Lyles, 2002) by 
direct binding of viral protein(s) with eIFs.   
Previously it was reported that direct binding of adenovirus 100K to eIF4G induces under 
phosphorylation of eIF4E by displacing Mnk1 leading to the inhibition of cap-dependent  
translation (Cuesta and Schneider, 2004; Cuesta and Schneider, 2000). A different strategy 
appears to be adopted by BAdV-3 pVIII protein to alter the host protein synthesis. Although eIFs 
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are not degraded in BAdV-3 infected cells, the availability of eIFs for binding to mRNA cap 
(5’m7GpppN) structure appears to be depleted in BAdV-3 infected or pVIII transfected cells.  
Absence of binding of pVIII to eIFs in DDX3 depleted cells suggest pVIII does not appear to 
interact directly with eIFs. Since DDX3 interacts with translation initiation factors including 
eIF3, eIF4E and PABP (Lee et al., 2008; Lai et al., 2008; Shih et al., 2012; Shih et al., 2008), the 
interaction of pVIII with DDX3 depletes DDX3 along with associated eIFs from cap binding 
protein complex and thus inhibiting cellular protein synthesis in BAdV-3 infected cells. 
Recent reports suggest that DDX3 promotes cap dependent translation initiation by directly 
interacting with eukaryotic initiation factor eIF3 in an RNA independent manner (Yedavalli et 
al., 2004; Lai et al., 2008; Lee et al., 2008; Geissler et al., 2012). The eIF3 is a multi-subunit 
mammalian initiation factor, which binds to 40S ribosomal subunit preventing premature joining 
of 40S and 60S ribosome subunits, and also interacts with eIF4G to help to recruit m
7
G capped 
mRNAs promoting the formation of 43S pre-initiation complex (Jackson et al., 2010). It is 
possible that interaction of pVIII with DDX3 sequesters both DDX3 and eIF3 modulating the 
efficient formation of 43S preinitiation complexes thus affecting the translation of capped 
mRNAs.  Our results demonstrate that addition of pVIII cause significant reduction in the 
amount of available eIF3 and DDX3, thus limiting the translation of capped mRNAs in-vitro or 
in-vivo. Similarly, m
7
GTP Cap analog captured significantly reduced level of DDX3 and eIF3 
from extracts of BAdV-3 infected or pVIII expressing plasmid DNA transfected cells. However, 
such preinitiation complexes are loaded on adenovirus late mRNAs (Yueh and Schneider, 1996). 
It is possible that interaction of BAdV-3 pVIII with DDX3 does not affect the formation of 43S 
pre initiation complex, but impairs the ability of eIF3 to interact with eIF4G thus abolishing the 
association of 43S complex with capped mRNAs. Vpg protein of Norwalk virus interacts with 
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eIF3 and inhibits translation of capped mRNAs possibly by interfering with interaction of eIF4G 
with eIF3 (Daughenbaugh et al., 2003). Moreover, no pVIII was detected in m7GTP resins 
which rules out the possibility of the competitive binding of pVIII with m7GTP cap. 
 Earlier reports suggested that binding of adenovirus late protein 100K to eIF4G may 
displace kinase Mnk1, thus affecting the phosphorylation of translation eukaryotic initiation 
factor eIF4E (Cuesta and Schneider, 2000; Cuesta and Schneider, 2004). Under-phosphorylation 
of eukaryotic initiation factor eIF4E late (~40hrs) in adenovirus infected cells is thought to 
destabilize the interaction of cap structure of cellular mRNAs with eIF4F in 43S initiation 
complex (Huang and Schneider, 1991; Yueh and Schneider, 1996).  Although reduced 
phosphorylation of eIF4E is usually associated with inhibition of cellular capped mRNAs 
translation (Huang and Schneider, 1991), the specific mechanism is still not clear.  
Binding of adenovirus 100K to eIF4G does not affect the binding of eukaryotic initiation 
factors eIF4E, eIF4A and PABP to cap initiation complex eIF4F in-vivo (Cuesta and Schneider, 
2000). Similarly, interaction of DDX3 with pVIII in transfected or virus infected cells did not 
affect the binding of eIF4G with 7-Methyl Guanosine Cap structure analog. In contrast, 
interaction of DDX3 with pVIII significantly diminished the binding of not only eIF3 but also 
eIF4E or PABP to 7 -Methyl Guanosine Cap structure analog. While PABP mediates binding of 
eIF4E and eIF4A to capped and polyadenylated mRNAs by interacting with eIF4G (Brook et al., 
2012), eIF4E is the least abundant protein of translation initiation complex, thus it controls the 
rate of formation of eIF4F complex (Jackson et al., 2010). It is possible that availability of 
diminished amount of PABP and /or eIF4E affect the assembly of eIF4F complex in infected 
cells.  Indeed, earlier reports suggest that limited availability of eIF4E (Feigenblum and 
132 
 
Schneider, 1993: Edgil et al., 2006) or PABP (Piron et al., 1998) in cap initiation complex, eIF4F 
inhibit translation of capped mRNAs. 
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6. TRANSITION FROM SECTION-5 TO SECTION-7 
So far, I described the characterization of pVIII and its role in modulating the cap 
dependent cellular mRNA translation by interacting with DDX3. In the next section, I explored 
the role of pVIII-DDX3 interaction in enhancing the translation of BAdV-3 late mRNAs 
containing tripartite leader sequences (TPL) at 5’end of mRNAs.  
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7. DDX3 AND pVIII INTERACT WITH THE TRIPARTITE LEARDER (TPL) OF 
BAdV-3 AND ENHANCE TRANSLATION OF LATE VIRAL mRNAs AND 
PRODUCTION OF PROGENY VIRIONS  
 
7.1. INTRODUCTION 
Adenoviruses are non enveloped icosahedral DNA viruses that infect a wide variety of 
hosts.  In infected cells, members of Mastadenovirus genus produce virus specific transcripts in 
four distinct phases including pre-early, early, intermediate and late. Although early gene 
expression does not require viral DNA replication, the late gene expression is dependent on 
initiation of DNA replication. Late transcription is controlled by the major late promoter (MLP) 
and produces transcripts that primarily encode structural proteins. All late transcripts contain an 
identical 5’ non-coding segment called the tripartite leader (TPL) and are divided into different 
classes depending on the usage of polyadenylation signals. The TPL enhances the translation of 
mRNAs in infected and transfected cells. The TPL of BAdV-3 is 205 nucleotides long and is 
derived from three exons (Reddy et al., 1998). Bovine adenovirus (BAdV)-3 is being 
characterized at the molecular level (Baxi et al., 2000; Kulshreshtha et al., 2004; Reddy et al., 
1998; Reddy et al., 1999a; Wu and Tikoo, 2004; Xing and Tikoo, 2007; Zakhartchouk et al., 
1998; Zakhartchouk et al., 1999; Zhou and Tikoo, 2001; Zhou et al., 2001) with the aim of 
understanding the virus cell interactions. Like other members of Mastadenoviruses, the late 
transcriptional units of BAdV-3 genome are divided in to seven classes L1-L7 (Reddy et al., 
1998). The late transcript region-6 (L6) of BAdV-3 encodes 100K, 33K and pVIII proteins 
(Reddy et al., 1998). Earlier, we demonstrated that BAdV-3 pVIII, a protein of 216 amino acids 
long containing two recognizable adenovirus protease specific cleavage sites (
108AGG↓G and 
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LGGG↓S) (Reddy et al., 1998) and predominantly localizes to the nucleus by interacting with 
importin(s)  (Ayalew et al., 2014).  
Viruses depend on host cell processes and factors for productive replication. Studying 
cellular targets of viral proteins often gives a novel insight about the functional importance of the 
protein and in designing efficient therapeutic and viral manipulation strategies. We have 
previously identified DDX3, member of the family of DEAD (Asp-Glu-Ala-Asp) box RNA 
helicases (Ditton et al., 2004; Gross et al., 2007; Tarn and Chang, 2009), as a cellular target of 
pVIII. We have also demonstrated that pVIII inhibits the translation of cellular capped mRNAs 
by depleting eIF3, eIF4E and PABP from the cap-binding complex without affecting levels and 
integrity of cytoplasmic mRNA (Chapter 5). 
Recent reports have suggested the involvement of DDX3 in the replication of vaccinia 
virus (Schroder et al., 2008), hepatitis B virus (Wang and Ryu, 2010; Yu et al., 2010), hepatitis C 
virus (Ariumi et al., 2007; Oshiumi et al., 2010; Owsianka et al., 1999; You et al., 1999) and 
human immunodeficiency virus (HIV)-1 (Liu et al., 2011; Yedavalli et al., 2004). Here, we 
report a decrease in formation of functional 80S ribosomes in pVIII expressing plasmid 
transfected cells. Alternatively, DDX3 and pVIII interact with the TPL of BAdV-3 and enhance 
the translation of RNAs containing TPL at their 5’ ends. Moreover, we demonstrate that DDX3 
is required for efficient production of progeny virus at late times post-infection. 
 
7.2. MATERIALS AND METHODS 
7.2.1. Cells and Viruses 
Madin-Darby bovine kidney (MDBK) cells, HeLa cells and 293T cells were grown in 
minimum essential medium (MEM; Sigma Aldrich) containing 5% FBS (SeraCare Life 
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Sciences, Inc.). VIDO R2 cells (Reddy et al., 1999) were grown in MEM containing 10% FBS. 
Wild-type BAdV-3 was propagated in MDBK cells (20). Cotton rat lung (CRL) cells were 
grown in MEM containing 2% FBS (Du et al., 2010). 
 
7.2.2. Antibodies 
Production of anti-DNA binding protein (Zhou et al., 2001) and anti-fiber (Wu and 
Tikoo, 2004) antibodies have been described earlier. Anti-hexon antibodies generated against 
BAdV-3 hexon recognize a protein of 98 kDa in BAdV-3 infected cells (Kulshreshtha et al., 
2004). Anti-pVIII recognizes a protein of 24kDa in BAdV-3 infected cells (Ayalew et al., 2014). 
Anti-DDX3 serum (Santa Cruz Biotechnology, Inc, USA), goat anti-rabbit IRDye
®
 680 and Goat 
anti-mouse IRDye680 (Mandel Scientific Company, Inc, Canada) were purchased. 
 
7.2.3. Construction of plasmid DNAs 
The construction of plasmids pLV-DDX3i#7, pMD2.G and pcMV-∆R8.91 (a gift from 
Dr. Yasuo Ariumi, Okayama University, Japan) have been described earlier (Ariumi et al., 
2007). Plasmid pC.VIII (Gaba and Tikoo, unpublished) contains BAdV-3 pVIII gene cloned in 
plasmid pcDNA3 (Invitrogen).   
Plasmid pGL-bMLP: the major late promoter (MLP) of BAdV-3 with the tripartite leader 
was cloned into plasmid pGL upstream of a firefly luciferase reporter gene. Initially, the MLP 
was amplified by PCR using “ GCCGCGGGGAGTGCCTC TGTCTTCTAAATAGAGGATG” 
as a forward primer and “AAGCTTGGCGCGCCATCA TATGGTGCACACCCACTAGCAAT”  
as  a reverse primer and plasmid PUC304A+ (Du and Tikoo, 2010) DNA as a template. The PCR 
137 
 
product was digested with SacII and HindIII restriction enzymes and ligated into SacII and 
HindIII digested plasmid pGL (Promega) creating plasmid pGL-bMLP.  
To clone the spliced form of TPL downstream of the MLP, a 217bp DNA fragment was 
amplified by RT PCR using primers using  primers (forward: 5’-
ATCATATGTGACGGTGCTTCCGC GTGGCATCC-3’; reverse: 5’-
GGCGCGCCCTTGTGACTGCGACTGGT TAGAAGT-3’) and RNA purified from MDBK 
cells 36 hr post infection with BAdV-3.  The RT-PCR amplified 217bp fragement was digested 
with AscI and NdeI enzymes and cloned into AscI and NdeI digested pGL-bMLP creating 
plasmid pGL-bMLP-TPL. 
Plasmid  pGE.VIII. A 666bp Hind III (blunt end repaired with T4 polymerase) - XhoI 
fragment of plasmid pR.pVIII was ligated to AatII (blunt end repaired with T4 polymerase) - 
XhoI digested plasmid pGEX-5X-1 (GE Healthcare) creating plasmid pGE.pVIII.  
Plasmid pGST.DDX3. A 2062bp BamHI (blunt end repaired with T4 polymerase)-NotI 
fragment was isolated from pHA.DX3 and ligated to SalI (blunt end repaired with T4 
polymerase) -NotI digested plasmid pGEX-5X-2 (GE Healthcare) creating plasmid 
pGST.DDX3. 
 
7.2.4. Recombinant protein expression and protein purification 
The recombinant GST-fusion proteins were expressed in Escherichia coli BL21 cells as 
described (Zhou and Tikoo, 2001). Glutathione S-transferase (GST), GST-pVIII and GST-DDX3 
fusion proteins were purified using GST beads (GE Healthcare) as per the instructions of the 
manufacturers. The purified proteins were dialyzed using Slide-A-Lyzer dialysis cassette 
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(Thermo Scientific). The concentrations of the proteins were measured by Bradford assay (Bio- 
Rad) using Ultrospec® 3000 spectrophotometer (Pharmacia Biotech).  
 
7.2.5. Production of lentivirus 
Lentiviruses expressing DDX3 shRNA or scrambled shRNA were produced as described 
(Al Yacoub et al., 2007). About 5.8 x 10
6
 293T cells were seeded in 10 cm
2
 petri-dish in 6 ml 
complete DMEM containing 10% FBS. After overnight incubation, the cells were transfected 
with three plasmids pLV-DDX3i#7 (36g; transfer vector), pMD2.G (18µg; envelope vector) 
and pcMV-∆R8.91 (18µg; packaging construct) using calcium phosphate method as described 
(Du et al., 2010). After 5hr of incubation, the media was removed and replaced with 8ml of 
advanced DMEM containing 2% FBS, 0.01mM cholesterol, 0.01mM lecithin and 1x chemically 
defined lipid concentrate (Invitrogen). After 36hrs of incubation, the supernatant was collected, 
centrifuged at 1500rpm and passed through 0.45µm filter. Finally, the virus titer was quantified 
using an HIV-1 p24 antigen capture kit (Clontech) before storing at 70
o
C. 
 
7.2.6. Lentivirus transduction 
VIDO R2 cells (Reddy et al., 1998) grown in 12 well plate (1x10
5
/well) were treated with 
8µg/ml of polybrene for 15 min and transduced with lentivirus. After overnight incubation at 
37
o
C, the media was replaced with selection media containing DMEM, 2% serum and 10g/ml 
of puromycin. The media was changed every 3-4 days until appearance of puromycin resistant 
cell clones. The DDX3 gene silencing in selected puromycin resistant clones was verified by 
Western blot using DDX3 specific antibodies. 
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7.2.7. Tetrazolium/Formazan (XTT) assay 
VIDO R2 (DDX3 positive) or VIDO R2kd (DDX3 knockdown) cells (1.5 x 10
4
/well) 
were seeded in 96 well plates. After overnight incubation, XTT (Sigma Aldrich) was 
reconstituted with MEM without FBS at a concentration of 1mg/ml and filter sterilized with a 
0.2µm syringe filter. Fifty µl of 5mM of Phenazine methosulfate (PMS) (Sigma Aldrich) was 
added to 5ml of XTT solution (1mg/ml). A volume of the reconstituted XTT solution equal to 
20% of the culture medium to be tested was added to the cells. Finally, the cultures were 
incubated for 4hrs at 37
o
C and the absorbance was measured at 450nm in an ELISA multi-well 
plate reader. 
 
7.2.8. Viral replication in DDX3 silenced bovine cells 
The indicated cells grown in 6 well plates were infected with wild-type BAdV-3 at an 
MOI of 5. At different times post-infection, the cells were lysed in the medium by freeze-
thawing five times. The virus titer was determined by TCID50 in MDBK cells.  
 
7.2.9. Virus mRNA and protein synthesis in DDX3 silenced bovine cells 
To analyze the viral mRNA in the cytoplasm of BAdV-3 infected cells, the cells seeded 
in 6 well plates were infected with wild-type BAdV-3 at an MOI of 5.  At 48 hr post-infection, 
the cytoplasmic RNA was extracted by SurePrep
TM 
Nuclear or Cytoplasmic RNA purification kit 
(Fisher Bioreagents) as per the company’s protocol. The concentration of the RNAs was 
measured by NanoDrop and cDNA was synthesized using equal amounts of RNA from DDX3 
positive VIDO R2 or DDX3 knocked down VIDOR2kd cells by using Superscript II reverse 
transcriptase (Invitrogen) and random hexamers. Real-time PCR reactions were performed by 
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iCycler iQ
TM
 real-time PCR detection system (Bio-Rad) and the amplifications were performed 
using the SYBR green PCR master mix (Bio-Rad) using specific primers (Table 7.2.1). The RT-
qPCR products were separated by agarose gel and the data was analyzed by Microsoft Office 
Excel 2007. 
To determine the level of viral proteins in BAdV-3 infected cells, the cells seeded in 6 
well plates were infected with wild-type BAdV-3 at an MOI of 5.  At the indicated times post 
infection,  proteins from the lysates of the infected cells were separated by 10% SDS-PAGE, 
transferred to a nitro-cellulose membrane and probed by Western blot using protein specific 
antibodies followed by goat anti-rabbit IRDye®680 as secondary antibody. β-actin was used as a 
loading control. Finally, the Western blots were scanned by using Odyssey® infrared imaging 
system (LI-COR). The intensity of the bands was measured by Odyssey software. 
 
7.2.10. Luciferase assay 
DDX3 Knockdown VIDO R2kd or wild type 293T cells were co-transfected with 
plasmid pEYFP.VIII + pGL-bMLP (containing only BAdV-3 MLP) or pEYFP.VIII + pGL-
MLP-TPL (containing BAdV-3 MLP and TPL).  At 36hrs post transfection, the cells were lysed 
and the firefly luciferase activity was measured in a luminometer by using a luciferase assay kit 
(Promega) as per the manufacturer’s instructions. The experiment was performed two times in 
triplicates. 
 
7.2.11. RNA- Electrophoretic mobility shift assay (EMSA) 
The EMSA was carried out following a modification of the protocol by Yakhnin et al, 
2012.  About 10,000 cpm 
32
P (UTP) radiolabeled RNA probe of in-vitro transcribed firefly  
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Table 7.2.1. List of primers 
Primer name Primer sequence 
Hexon-F 
Hexon-R 
5’-ATGGTCCTACTGCACATCGCCGTTC 
5’-CTGCCTAAACTGCGTATTGTTAGGG 
Fiber-F 
Fiber-R 
5’-ATGAAGAGAAGTGTGCCCCAGGAC 
5’-CACCTTGTCATCGGTTACCGTGAG 
pIX-F 
pIX-R 
5’-ATGGCCGAGGAAGGGCGCATTTATGTG 
5’- GTTAACTTGGCCGCCCACAAGGTTAGCCTGCAC 
pVIII-F 
pVIII-R 
5’-CGGCCGCAGGTGCCAGTCAAGATTACTC 
5’-CCTCTACAAACTGCCTGGATCCTATGC 
DBP-F 
DBP-R 
5’-ATGAATCGCAGCGGTGACTTAACGCGAGCC 
5’-GTCGTCCCCAGGCCTGCGACTTTTAAC 
100k-F 
100k-R 
5’-ATCAGCGGCCAGAGAACGACACTGAGC 
5’-TCTTGGGTGGTACCTTGGGACAAAAGAG 
pV-F 
pV-R 
5’-GGCCTCCTCTCGGTTGATTAAAGAAG 
5’-ACTACGTAAGTCGGTTCCGGCACGGCCACAGC 
IVa2-F 
IVa2-R 
5’-TGCTGGATGGAGATGTACTAGACCAC 
5’-TGCTGCTTTGAGGAACCAGAGTTCCTGTG 
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luciferase RNA with different 5’UTR (i.e. TPL, IRES or Cap) was allowed to bind with 500ng of 
GST, GST.DDX3 or GST.VIII fusion protein plus 10µg yeast tRNA (Ambion) at room 
temperature for 30min. Afterwards, the reaction mixture was run in a 4% acrylamide native gel 
for 4-6 hr at 150 V and the gel was dried, exposed onto a phosphor screen (Kodak) and scanned 
on a Molecular Imager FX using Quantity One software (Bio-Rad). 
 
7.2.12. Polysome profile analysis, RNA and protein purification  
293T cells grown in 100mm dish were transfected with plasmid pcDNA3 or pcVIII 
DNAs. At 40hrs post transfection, cyclohexamide was added to the medium with a final 
concentration of 50 μg/ml and the cells were further incubated for 30 min at 37oC. Subsequently, 
the cells were washed twice with cyclohexamide containing PBS and collected in 2ml tubes. 
Then, polysome extraction buffer was added and the cells were incubated on ice for 10 min 
andcentrifuged to pellet the nuclei. The supernatants were then collected and OD values were 
measured at 260nm on a NanoDrop. A 5%-50% linear sucrose gradient was prepared in 
ultracentrifuge tubes and equal OD units from pcDNA3 or pcpVIII transfected cells were 
applied. The gradient was centrifuged at 36000 rpm for 2 hr and 30 min at 4
o
C. From each tube 
21 fractions of ~550μl were collected and absorbance was measured at 260nm and plotted on 
graph using Microsoft Excel.  RNA and proteins were extracted from each fraction using Trizol 
reagent following the manufacturer’s instructions. RNA was analysed by Agilent 2100 
Bioanalyser instrument. Proteins from 1-16 fractions were separated by 12% SDS-PAGE gel, 
transferred onto nitrocellulose membrane and probed with anti DDX3 and anti-pVIII antibodies.  
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7.3.RESULTS 
7.3.1. shRNA mediated knockdown of DDX3 
A lentivirus vector mediated RNA interference was used to knock down DDX3 
expression in bovine cells. Initially, we attempted to knockdown DDX3 expression in BAdV-3 
permissive (MDBK, CRL) cells (Figure 7.3.1A) or non-permissive (HeLa) cells (Figure 7.3.1B). 
Although, we were able to knockdown DDX3 expression in HeLa cells (Figure 7.3.1B; 2), our 
repeated attempts to knockdown DDX3 expression in MDBK or CRL (Figure 7.3.1A) cells 
proved futile. Earlier studies have suggested that inability to efficiently knockdown DDX3 
expression could be due to high level of expression or stability of DDX3 in these cells (Schroder 
et al., 2008; Yedavalli et al., 2004). 
In contrast, we were able to knockdown DDX3 expression in BAdV-3 permissive VIDO 
R2 cells (Figure 7.3.1C). Briefly, lentiviral particles containing DDX3 shRNA (Ariumi et al., 
2007) were used to transduce VIDO R2 cells. After isolating puromycin resistant clones, the 
knockdown of DDX3 expression was determined by Western blot using anti-DDX3 serum. As 
seen in Figure 7.3.1C, one (clone 5) of the six puromycin resistant clones was viable (panel D) 
and showed significant reduction (96%) in the expression of DDX3 (panel C).  This clone was 
designated as VIDO R2kd.  Similarly, puromycin resistant clone obtained by transducing VIDO 
R2 cells with lentivirus containing scrambled shRNA was designated as VIDO R2s. 
 
7.3.2. Virus titer in VIDO R2kd cells 
To determine the biological function of DDX3 during BAdV-3 infection, we determined 
the titer of BAdV-3 in VIDO R2kd cells. The cells were infected with wild type BAdV-3 at an 
MOI of 5. At indicated times post infection, the infected cells were collected, freeze-thawed and  
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Figure 7.3.1. shRNA mediated knockdown of DDX3 in cells. MDBK and CRL (A), Hela (B) 
or VIDO R2 (C) cells were transduced with lentivirus vectors harboring DDX3 shRNA and 
selected with puromycin (10g/ml). After 7 days, proteins from the lysates of puromycin 
resistant cells were separated by 10% SDS-PAGE, transferred to nitrocellulose and probed in 
Western blot using anti-DDX3 MAb followed by IRDye800 conjugated anti-mouse secondary 
antibody (A, B) or anti-DDX3 serum followed by goat anti-rabbit IRDye
®
 680 as secondary 
antibody (C). -actin is included as a loading control (B, C). XTT assay (D). The viability of 
VIDO R2 or VIDO R2kd (DDX3 knock down VIDO R2 clone 5) cells was determined by XTT 
assay as described in the materials & methods. Molecular weight markers are indicated in kilo 
Daltons (kDa). 
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Figure 7.3.2. BAdV3 titer in DDX3 positive or DDX3 knockdown VIDO R2 cells. Near 
confluent monolayers of VIDO R2s or VIDO R2kd cells were infected with wild-type BAdV-3 
at an MOI of 5. At indicated times post-infection, the infected cells were freeze-thawed and virus 
was titrated on MDBK cells as described in the text. (A) BAdV-3 titer in VIDO R2s and VIDO 
R2kd cells, (B) Bar diagram depicting BAdV-3 titer in VIDO R2kd cells relative to VIDO R2s.  
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the cell lysate was used to determine the BAdV-3 titer by TCID50 assay. As seen in Figure 7.3.2, 
compared to VIDO R2s, shRNA knockdown of DDX3 in VIDO R2kd cells resulted in 3-fold, 
18-fold, 63-fold and 210-fold reduction in virus titers at 12, 24, 36 and 48hrs post-infection 
(panels A,B), respectively. 
 
7.3.3. BAdV-3 protein specific mRNA in VIDO R2kd cells 
To determine if DDX3 knockdown affects the accumulation of late viral mRNAs in the 
cytoplasm of infected cells, RT-qPCR was performed using BAdV-3 gene specific primers 
(Table 7.2.1). As seen in Figure 7.3.3, there was no significant difference in the accumulation of 
early (DBP) or intermediate (pIX, pIVa2) protein specific viral mRNAs in the cytoplasm of 
BAdV-3 infected VIDO R2s or VIDO R2kd cells late  (48hrs) in infection (panels A,B). 
Similarly, there was no significant difference in the accumulation of late protein (penton, hexon) 
specific viral mRNAs in the cytoplasm of BAdV-3 infected VIDO R2s or VIDO R2kd cells late 
in infection (48hrs). 
 
7.3.4. BAdV-3 specific protein synthesis in VIDO R2kd cells 
To determine the effect of DDX3 knockdown on translation of BAdV-3 protein specific 
mRNAs, the level of BAdV-3 proteins produced in infected cells was determined by Western 
blot using protein specific antibodies, goat anti-rabbit IRDye®680 secondary antibody and 
Odyssey® infrared imaging system (LI-COR). As seen in Figure 7.3.4, there was no significant 
difference in the level of DBP (early protein) in BAdV-3 infected VIDO R2s or VIDO R2kdcells 
late (48 hrs) in infection (panels A, B). In contrast, there was significant difference in the level of 
fiber or  
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Figure 7.3.3. RT-PCR. (A) Analysis of ethidium bromide-stained RT-PCR products.  
Products of RT-PCR using DNAse-treated RNA isolated from BAdV-3 infected cells at 48hrs 
post-infection as a template were synthesized using primers pairs (Table 1). Size markers are 
shown in base pairs (bps). (B)  Comparison of normalized Ct values of cytoplasmic mRNA 
levels of early, intermediate and late BAdV-3 gene products. β-actin was used as a house 
keeping gene. 
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Figure 7.3.4. Western blot. (A) Proteins from the lysates of BAdV-3 infected cells 
collected at different times (0-48hrs) post-infection were separated by 10 % SDS-PAGE, 
transferred to nitrocellulose and probed in Western blot using protein specific antibodies 
followed by goat anti-rabbit IRDye
®
 680 as secondary antibody. -actin is used as a loading 
control. (M) Protein markers. (B) The intensity of the protein bands in “A” was measured using 
Li-COR Odyssey software and normalized values were plotted using Microsoft Excel 2007. 
149 
 
hexon (both late proteins) proteins in BAdV-3 infected VIDO R2 or VIDO R2kd cells late 
(48hrs) in infection (panels A, B). 
 
7.3.5. Luciferase assay 
The late transcription units of BAdV-3 are transcribed from the Major Late Promoter 
(MLP). The mRNAs transcribed from the MLP contain an identical 5’ non-coding segment 
called the tripartite leader (TPL) which is 205 nucleotides long in BAdV-3 and is derived from 
three exons (Figure 7.3.5A). To study the effect of DDX3 on the translation of late BAdV-3 
mRNAs, the major late promoter of BAdV-3 with the tripartite leader was cloned into pGL 
vector (Addgene) upstream of a firefly luciferase reporter gene. Subsequently, the effect of 
DDX3 on the translation of late viral mRNA translation was studied  by co-transfecting DDX3 
knockdown (kd) or positive 293T cells (Figure 7.3.5B) with either plasmids pEYFP.VIII +  pGL-
bMLP (containing only BAdV-3 MLP) or plasmids  pEYFP.VIII + pGL-MLP-TPL (containing 
BAdV-3 MLP and TPL). As seen in Figure 7.3.5C, the expression of the reporter gene is 
significantly higher in pGL-bMLP-TPL transfected DDX3 positive cells as compared to 
DDX3kdcells. No such difference was observed in the expression of the luciferase reporter gene 
in DDX3 positive or DDX3kd 293T cells co-transfected with plasmid pGL-bMLP + pEYFP.VIII 
(Figure 7.3.5C).  
 
7.3.6. Interaction of pVIII and DDX3 with TPL of BAdV-3 
TPL enhances the translation of viral mRNAs in infected and transfected cells (Dolph et 
al., 1988). Since the translation of a firefly reporter gene with 5’ TPL under the control of MLP 
was enhanced in DDX3 positive 293T cells in the presence of pVIII, we investigated the  
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Figure 7.3.5 (A) The nucleotide sequence of major late promoter (MLP) and tripartite 
leader (TPL) of BAdV-3. (B) shRNA mediated knockdown of DDX3 in 293T cells. 293T 
cells were transduced with lentivirus vectors containing DDX3 shRNA and selected with 
puromycin (10g/ml). After 7 days, proteins from the lysates of puromycin resistant cells were 
separated by 10% SDS-PAGE, transferred to nitrocellulose and probed by Western blot using 
anti-DDX3 MAb followed by IRDye800 conjugated anti-mouse secondary antibody. -actin is 
included as a loading control.   (C). Reporter gene expression. DDX3 knockdown or positive 
293T cells were co-transfected with either pEYFP.VIII and pGL-bMLP (containing only BAdV-
3 MLP) or pGL-MLP-TPL (containing BAdV-3 MLP and TPL). The absolute expression of 
firefly luciferase was measured 36hrs post transfection in a luminometer. (D & E) 
Electrophoretic mobility shift assay. 
32
P (UTP) radiolabeled RNA probe of in-vitro transcribed 
firefly luciferase RNA with different 5’UTR (i.e. TPL, IRES or 5’caps) was allowed to bind with 
500ng of GST, GST-DDX3, GST-100K or GST.VIII protein at room temperature for 30min. 
Subsequently, the reaction mixture was run on a gel and autoradiographed
153 
 
possibility of the interaction of pVIII and DDX3 with mRNAs of different 5’ UTR. We initially 
tried to examine whether BAdV-3 TPL interacts with DDX3 and pVIII using GST-fused purified 
proteins. As expected (Cuesta and Schneider, 2004), GST.100K interacts with TPL 
(Figure7.3.5D). Similarly, both GST.pVIII and GST-DDX3 interacts with the TPL. No such 
interaction was observed between TPL and GST alone. Similarly, GST alone, GST.DDX3 or 
GST.pVIII fusion proteins did not show any interaction with 5’ pol IRES or Cap containing 
RNA (Figure 7.3.5E) 
 
7.3.7. Polysome profile analysis, RNA and protein purification and Western blot 
in pEY. VIII transfected cells 
 To monitor the efficiency of protein translation in 293T cells transfected with plasmid 
pcDNA3 or pc.VIII DNAs, polysome profile analysis was performed using sucrose gradient 
centrifugation technique. Based on 28S and 18S ribosomal RNA profiles, fractions 4 to 7, 7 to 
10, 10 to 16 and 16 to 21 are identified as 40S, 60S, 80S and polysome fractions, respectively 
(Figure 7.3.6A, B). As shown in Figure 7.3.6, more free 40S and 60S and less 80S ribosome 
were observed in cells transfected with plasmid pcVIII DNA than in cells transfected with 
plasmid pcDNA3 DNA. In addition, the polysome peaks are lower in pc.VIII DNA than in 
pcDNA3 transfected cells (Figure 7.3.6A). To determine the presence of pVIII or DDX3 in 
different fractions, proteins were purified from the different fractions and probed by Western blot 
using either anti-pVIII or anti DDX3 antibody. As shown in Figure 7.3.6C, both DDX3 and 
pVIII were detected only in the fractions containing 40S ribosome and not in any of the other 
fractions. 
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Figure 7.3.6. (A) Polysome profiling.  293T cells transfected with plasmid pc.VIII or pcDNA 
were collected 40 hr post transfection. The cells were lysed and the supernatants were added to a 
5%-50% linear sucrose gradient and centrifuged at 36000rpm for 2hr 30min at 4
o
C. 21 fractions 
of ~550μl were collected and absorbance was measured at 260nm and plotted on graph using 
Microsoft Excel. The graph shows 40S, 60S, 80S and polysome peaks. (B, D) Analysis of 18S 
and 28S ribosmomal RNAs. RNA was extracted from each fraction of pCpVIII (B) or 
pCDNA3 (D) transfected cell lysates using Trizol reagent as per the manufacturer’s instructions. 
RNA was analysed by Agilent 2100 Bioanalyser instrument. (C, E). Western blot. Proteins 
extracted from fractions 1-16 of pCpVIII (C) or pCDNA3 (E) transfected cell lysates were run 
on a 12% SDS gel, transferred onto nitrocellulose membrane and probed with anti DDX3 or anti 
pVIII antibodies.  
pCDNA3 
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7.4. DISCUSSION 
The interaction of viral proteins with cellular proteins is of vital importance in the 
regulation of virus replication, growth and survival. To properly understand their significance in 
the cells, identification of the interactions, understanding the extent to which they take place, and 
determining the consequences of such interactions are very essential (Phizicky et al., 1995). 
Earlier, we demonstrated that BAdV-3 pVIII is expressed as 24kDa protein in BAdV-3 infected 
or gene transfected cells, and is transported to the nucleus by interacting with importin(s) 
(Section 3). We also documented a novel interaction between BAdV-3 pVIII and a cellular 
protein DDX3 (Section 4). Here we report that DDX3 appears to be essential for efficient 
replication of BAdV-3. We also demonstrate that knockdown of DDX3 affects the translation of 
BAdV-3 late protein mRNAs without altering cellular protein translation in infected cells. 
Furthermore, both pVIII and DDX3 interacts with BAdV-3 TPL. With polysome profile 
analysis, we also show an overall decrease in cellular mRNA translation in pVIII expressing 
plasmid transfected cells.  
The DEAD (Asp-Glu-Ala-Asp) box protein DDX3 is a member of the ATPase super 
family II helicases (Silverman et al., 2003), that is involved in various aspects of RNA 
metabolism (Kwong et al., 2005; Rocak and Linder, 2004). So far, viral proteins encoded by 
vaccinia virus, hepatitis B virus, hepatitis C virus and HIV have been shown to interact with 
DDX3 (Ariumi et al., 2007; Owsianka and Patel, 1999; Schroder et al., 2008; Wang and Ryu, 
2010; Yedavalli et al., 2004; Yu et al., 2010; Lee et al., 2008), which appears to be required for 
efficient replication of these viruses.  DDX3 is implicated in translation initiation (Lee et al., 
2008; Parsyan et al., 2011) and may regulate cellular mRNA translation by interacting with 
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specific translation initiation factors eIF4E, eIF2, PABP and eIF3 (Lai et al., 2008; Lee et al., 
2008; Shih et al., 2008; Shih et al., 2011).  
Knockdown of DDX3 resulted in significant reduction in the BAdV-3 yield, without 
altering the viability of the cells suggesting that DDX3 is required for efficient production of 
progeny virus. Interestingly, the reduction in virus production in VIDO R2kd (DDX3 knocked 
down) cells correlates with the degree of cellular protein synthesis inhibition in BAdV-3 infected 
VIDO R2s cells at late times (24-48hrs) post infection. It is possible that the reduction in the 
production of progeny BAdV-3 late in infection in VIDO R2kd cells could be due to reduced 
availability of BAdV-3 specific late mRNAs required for the production of progeny virions. 
However, there appeared to be no difference in the amount of BAdV-3 specific mRNAs 
(early or late) in BAdV-3 infected VIDO R2s or VIDO R2kd cells at 48hrs post-infection. 
Alternatively, it is possible that the decrease in the production of progeny BAdV-3 late in the 
infection of VIDO R2kd cells could be due to inefficient translation of BAdV-3 late mRNAs. 
Although the level of early proteins appeared unaffected at late times post-infection of VIDO 
R2s or VIDO R2kd cells, the level of late proteins produced in VIDO R2kd cells was 
significantly reduced compared to the level of late proteins produced at late time post-infection 
of VIDO R2 cells. These results suggest that the absence of DDX3 in BAdV-3 infected VIDO 
R2kd cells abolishes the selective translation of BAdV-3 late mRNAs late in infection that is 
observed in VIDO R2s cells. Earlier studies have demonstrated that inhibition of host cell protein 
synthesis enhances the translation of late adenoviral mRNAs (Zhang et al., 1994), which results 
in an increase in the production of progeny virus in infected cells. It is possible that in VIDO 
R2kd cells, both viral and cellular mRNAs may compete for the limited translation factors. 
Alternatively, it is possible that knockdown of DDX3 may affect the translation of BAdV-3 late 
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protein mRNAs which contain complex 5’ untranslated regions (UTRs) (Dolph et al., 1988). 
Indeed, a recent report suggests that DDX3 specifically promotes translation of mRNAs 
containing complex 5’UTRs (Soto-Rifo et al., 2012). The binding of both DDX3 and pVIII to 
TPL of BAdV-3 and their detection in the polysome fractions containing 40S ribosomal subunits 
suggest that both proteins may involve in the selective translation initiation of late viral mRNAs.  
In summary, we demonstrate that DDX3 is essential for efficient replication of BAdV-3 
during late times post infection possibly by augmenting the efficiency of the translation of late 
viral mRNAs and suppression of cellular protein synthesis. Moreover, we demonstrated that the 
translation of TPL containing mRNAs at their 5’ ends is enhanced in the presence of DDX3 and 
pVIII. 
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8. GENERAL DISCUSSION AND CONCLUSION 
  Determination of biological functions of different structural and non-structural proteins 
of BAdV-3 is fundamental for elucidating the virus-host interaction and development of safe and 
efficient BAdV-3 based vaccine/antigen delivery vehicles. This work was performed to 
characterize the molecular properties and functions of protein pVIII of BAdV-3 which was 
identified as an interacting partner of the cellular protein DDX3 based on yeast II hybrid 
screening. 
Using rabbit antisera raised against peptides representing N-terminus and C-terminus of 
pVIII, we detected pVIII as a 24 kDa protein starting from 12 to 24 hr post BAdV-3 infection or 
in pVIII transfected cells. The 24 kDa precursor form of BAdV-3 pVIII is present in immature 
virions, only 8 kDa cleaved portion representing “C” terminal 70 amino acids of BAdV-3 pVIII 
are incorporated in the mature virions. Similar reports have been made on pVIII of human 
adenoviruses (Chelius et al., 2002; Takahashi et al., 2006). This is consistent with the earlier 
reports that infectious virus contains only cleaved form of pVIII (Chelius et al., 2002; Takahashi 
et al., 2006) and confirms that cleavage of few structural protein by BAdV-3 protease is required 
for formation of mature infectious virion (Gastaldelli et al., 2008). 
Localization of pVIII to the nucleus in transfected cells indicate that other viral proteins 
are not involved in this process suggesting that that pVIII may contain  nuclear localization 
signal(s) involved in active transport of pVIII into the nucleus. pVIII also localizes in the 
cytoplasm (in a lesser amount compared to the amount that localizes in the nucleus) indicating 
that the protein may have multiple functions in the cytoplasm and nucleus.  Proteins that are 
transported into the nucleus in an energy dependent mechanism use soluble nuclear transport 
factors like imp-α (Gorlich et al., 1995; Imamoto et al., 1995) or transportin (Lai et al., 2001). 
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Like 52K protein of BAdV-3 (Patterson et al., 2012), the nuclear transport of BAdV-3 pVIII is 
mediated by the Imp α/β heterodimer dependent pathway, by preferentially interacting with 
Impα-3, which requires ATP and RanGTP. Ran GTP controls transport receptor-substrate 
interactions in a compartment-specific manner between the cytoplasm and the nucleus and is 
required for active transport of proteins into the nucleus (Gorlich et al., 1996b). Deletion 
mutation analysis of pVIII suggests that the “N” terminal domain contains Impα-3 interacting 
domain/nuclear localization signal. 
The appearance of pVIII in the form of punctate dots in BAdV-3 infected cells appears 
similar to the expression pattern reported for some herpesvirus essential proteins in the nucleus 
(de Bruyn et al., 1998; Daikoku et al., 2005) suggesting that pVIII may also be involved in 
replication of BAdV-3. Thus, transport of BAdV-3 pVIII to the nucleus of virus infected cells 
may be a requirement for the efficient replication of BAdV-3. Identification of nuclear 
localization signal of pVIII between amino acid 57-72 should help in determining the function of 
BAdV-3 pVIII in the nucleus by creating and analyzing recombinant BAdV-3 expressing the 
NLS deleted or point mutants of NLS of pVIII. 
A number of viral-viral and viral- cellular protein-protein interactions are important to 
modulate various cellular functions for proper adenoviral DNA replication, assembly and release 
(Cuesta and Schneider, 2004; Ostapchuk and Hearing, 2008; Perez-Romero et al., 2005; Singh et 
al., 2005; Cuesta et al., 2000). Since viral proteins may require interaction with other cellular 
proteins to perform some function (Vidalain and Tangy, 2010; Friedel and Haas, 2011), we 
determined if pVIII interacts with any cellular protein.  Moreover, using various assays, we 
confirmed that pVIII interacts with DDX3 in BAdV-3 infected cells.  It would be interesting to 
explore the absolute requirements of such interactions for efficient replication of BAdV-3 by 
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creating and analyzing recombinant BAdV-3 expressing interacting domain deleted or point 
mutants of BAdV-3 pVIII.  
Recent studies have suggested that DDX3, a member of the family of DEAD box protein 
of RNA helicases (Rocak and Linder, 2004) enhances translation initiation by interacting with 
different translation initiation factors (Shih et al., 2008; Lai et al., 2008; Shih et al., 2011; Lee et 
al., 2008). Interestingly, inhibition of cellular protein synthesis, especially during late time post 
infection (Dolph et al., 1988; Huang and Schneider, 1991) have suggested the involvement of 
one or more late adenoviral proteins in the process of inhibition of cellular capped mRNA 
translation. Our studies confirmed that pVIII-DDX3 interaction inhibit cap dependent translation 
of cellular mRNAs. Earlier studies have suggested that another late adenoviral protein 100K 
inhibit cellular protein synthesis by the displacement of the kinase Mnk1 from the eIF4F 
complex (Cuesta et al., 2004). It is possible that at different stage of replication, different viral 
proteins may be involved in altering the same cellular function suggesting that cellular proteins 
may be functionally redundant (Berk, 2005). Thus, during BAdV-3 infection pVIII and 100K 
may contribute to the overall reduction in cellular protein synthesis inhibition by employing 
different mechanisms. 
Earlier studies demonstrated the involvement of adenovirus 100K protein in inhibiting 
cellular mRNA translation and enhancing translation of adenovirus late mRNA containing TPL. 
The binding of both DDX3 and pVIII to TPL of BAdV-3 and significant reduction in the titer of 
the virus in DDX3 knock down cells suggest both proteins may be involved in the selective 
translation initiation of late viral mRNAs.  Thus, like adenovirus 100K protein (Cuesta et al., 
2004), BAdV-3 pVIII appears to inhibit cellular mRNA translation and enhance translation of 
late mRNAs containing TPL. While adenovirus 100K protein enhances the late mRNA 
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translation by ribosome shunting mechanism (Xi et al., 2004), it remains to be determined how 
binding of pVIII and DDX3 enhance the translation of late mRNAs containing TPL. 
Finally, we believe that our detailed molecular and functional characterization of BAdV-
3 pVIII gives a very good insight to the role of the protein in the life cycle of the virus. In 
addition, our data suggest that the presence of the un-translated 5’ TPL sequence helps in the 
selective translation of late BAdV-3 mRNAs in the presence of pVIII and DDX3. Thus, TPL 
may be used to achieve high transgene expression in BAdV-3 vector transduced cells which can 
be driven by the MLP promoter. This can also help in reducing the dose of the vector 
administered reducing the degree of toxicity associated with high dose.  
On the other hand, the virus titer was lower in DDX3 knock down VIDO R2 cells. 
Hence, we presume that DDX3 over expressing cell lines may support improved replication of 
BAdV-3. If this can be proven, DDX3 over expressing cells can be used for virus production 
with increased titer. 
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9. FUTURE DIRECTIONS 
The present work explored the importance of pVIII-DDX3 interaction in translation of 
cellular mRNAs and potential involvement in selective translation of BAdV-3 late mRNAs. 
Since DDX3 has also been involved in transcription, RNA splicing and induction of innate 
immunity, future work could focus on determining the effect of the interaction of DDX3 - pVIII 
in these cellular processes in BAdV-3 replication. 
Secondly, the domain of pVIII interacting with DDX3 can be identified and the biological 
function of these interactions can be determined by constructing and analyzing the mutant 
BAdV-3 expressing interacting domain deleted/point mutated pVIII. 
Finally, the mechanism by which the TPL and DDX3-pVIII interaction enhance the 
translation of late viral mRNAs could be investigated.  
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